细胞株Cell Lines 98及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV98
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID Tu 212
AC CVCL_4915
SY Tu-212; Tu212
DR BioSample; SAMN03151960
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,9
ST D5S818: 12
ST D7S820: 10
ST TH01: 8
ST TPOX: 10,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T20 ! T404
OI CVCL_1T19 ! T406 [Human HNSCC]
OI CVCL_4910 ! Tu 138
OI CVCL_1T17 ! Tu 158LN
OI CVCL_4911 ! Tu 159
OI CVCL_4914 ! Tu 182
OI CVCL_1T18 ! Tu 212LN
CA Cancer cell line
//
ID Tu 212LN
AC CVCL_1T18
SY Tu-212LN
DR BioSample; SAMN03151961
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,9
ST D5S818: 12
ST D7S820: 10
ST TH01: 8
ST TPOX: 10,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T20 ! T404
OI CVCL_1T19 ! T406 [Human HNSCC]
OI CVCL_4910 ! Tu 138
OI CVCL_1T17 ! Tu 158LN
OI CVCL_4911 ! Tu 159
OI CVCL_4914 ! Tu 182
OI CVCL_4915 ! Tu 212
CA Cancer cell line
//
ID Tu 686
AC CVCL_4916
SY Tu-686; Tu686
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tu To
AC CVCL_3328
DR CLO; CLO_0009445
DR ATCC; CRL-1298
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID TU-1
AC CVCL_M530
RX PubMed=10936422;
RX PubMed=11818668;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Tu-2449
AC CVCL_D318
SY TU2449
RX PubMed=9160879;
RX PubMed=10493969;
DI NCIt; C21932; Mouse astrocytic tumours
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID TU-ECS-1
AC CVCL_IP26
RX PubMed=27889902;
CC Doubling time: 18.2 +- 2.1 hours (PubMed=27889902).
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TU-MM-1
AC CVCL_1G72
RX PubMed=26070481;
CC Doubling time: 67.9 hours (PubMed=26070481).
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
DI NCIt; C7633; Peritoneal mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TU-OC-1
AC CVCL_L700
SY TUOC1
DR Cosmic; 1889261
RX PubMed=23430509;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 38.4 +- 3.5 hours (PubMed=23430509).
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TU-OC-2
AC CVCL_HE46
RX PubMed=26960408;
CC Characteristics: Does not express ARID1A.
CC Doubling time: 37.5 +- 3.3 hours (PubMed=26960408).
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TU-OM-1
AC CVCL_W127
SY TUOM-1
DR Cosmic; 2429305
RX PubMed=19154404;
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TU-OS-3
AC CVCL_K033
SY TUOS-3
RX PubMed=21610153;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TU-OS-4
AC CVCL_K032
SY TUOS-4
RX PubMed=21610153;
RX PubMed=23274876;
CC Doubling time: 53.3 +- 8.1 hours (PubMed=23274876).
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Tu167LN1
AC CVCL_1Q85
RX PubMed=12907203;
CC Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4912 ! Tu 167
SX Male
CA Cancer cell line
//
ID TUAT-BME-11
AC CVCL_Z083
SY BME-11
RX DOI=10.1303/aez.29.604;
CC Group: Insect cell line.
CC Breed/subspecies: Kuroko.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TUAT-BME-15
AC CVCL_Z084
SY BME-15
RX DOI=10.1303/aez.29.604;
CC Group: Insect cell line.
CC Breed/subspecies: Kuroko.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TUAT-SpLi-221
AC CVCL_Z519
SY TUAT-SpLi221; SpLi-221; SpLi221
DR CLO; CLO_0050004
DR NISES; SK0016
DR RCB; RCB0406
RX DOI=10.1303/aez.30.75;
RX PubMed=10358729;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275023
CC Group: Insect cell line.
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Female
CA Spontaneously immortalized cell line
//
ID TUB-4D
AC CVCL_GZ11
RX PubMed=2842332;
WW http://icoregon.technologypublisher.com/technology/18058
CC Selected for resistance to: ChEBI; CHEBI:48267; Tubercidin (7-deazaadenosine).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID TUBO [Human B-cell 10IHW]
AC CVCL_E858
DR dbMHC; 49048
DR ECACC; 88052045
DR IHW; IHW9045
DR IMGT/HLA; 11502
WW http://bioinformatics.hsanmartino.it/ecbr/cl45.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TUBO [Mouse mammary tumor]
AC CVCL_2A33
SY Turin-Bologna
DR EFO; EFO_0006306
RX PubMed=11046045;
WW https://cancermodels.nci.nih.gov/camod/ViewModelAction.do?unprotected_method=populateCellLines&aModelID=448
CC Breed/subspecies: BALB-neuT.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID TUBO-P2J
AC CVCL_2A34
RX PubMed=25179116;
WW http://www.ifmsa.org/About-Us/Our-Members/Asia-Pacific/KMSA/Projects/Characterization-of-Novel-Mouse-Breast-Cancer-Cell-Line-for-Spontaneous-Metatasis-focused-on-EMT
CC Breed/subspecies: BALB-neuT.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2A33 ! TUBO [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID Tucker-HSA
AC CVCL_0D01
SY TUCKER
RX PubMed=19461996;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID TuD-1
AC CVCL_5638
SY TuD1
DR IFO; IFO50103
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID TuD-1-1
AC CVCL_M862
SY TuD1-1
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5638 ! TuD-1
SX Male
CA Spontaneously immortalized cell line
//
ID TuD-1-10
AC CVCL_M871
SY TuD1-10
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5638 ! TuD-1
SX Male
CA Spontaneously immortalized cell line
//
ID TuD-1-2
AC CVCL_M868
SY TuD1-2
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5638 ! TuD-1
SX Male
CA Spontaneously immortalized cell line
//
ID TuD-1-3
AC CVCL_5639
SY TuD1-3
DR IFO; IFO50152
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5638 ! TuD-1
SX Male
CA Spontaneously immortalized cell line
//
ID TuD-1-5
AC CVCL_5640
SY TuD1-5
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5638 ! TuD-1
SX Male
CA Spontaneously immortalized cell line
//
ID TuD-1-7
AC CVCL_M869
SY TuD1-7
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5638 ! TuD-1
SX Male
CA Spontaneously immortalized cell line
//
ID TuD-1-9
AC CVCL_M870
SY TuD1-9
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5638 ! TuD-1
SX Male
CA Spontaneously immortalized cell line
//
ID TUHR10TKB
AC CVCL_5952
SY TUHR-10TKB
DR BTO; BTO:0003732
DR CLO; CLO_0050896
DR BioSample; SAMN03472180
DR CCLE; TUHR10TKB_KIDNEY
DR GEO; GSM887715
DR GEO; GSM888808
DR RCB; RCB1275
RX PubMed=17284252;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 14
ST D16S539: 13
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TUHR14TKB
AC CVCL_5953
SY TUHR-14TKB; 14T
DR BTO; BTO:0003730
DR CLO; CLO_0050897
DR BioSample; SAMN03472133
DR CCLE; TUHR14TKB_KIDNEY
DR GEO; GSM887716
DR GEO; GSM888809
DR RCB; RCB1383
RX PubMed=14534724;
RX PubMed=15604581;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TUHR16TKB
AC CVCL_5954
SY TUHR-16TKB
DR BTO; BTO:0003733
RX PubMed=17284252;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TUHR25TKB
AC CVCL_5955
SY TUHR-25TKB
DR BTO; BTO:0003735
DR RCB; RCB1680
RX PubMed=17284252;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TUHR3TKB
AC CVCL_5956
SY TUHR-3TKB
DR CLO; CLO_0050895
DR BioSample; SAMN03472175
DR RCB; RCB1187
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 10,12
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TUHR4TKB
AC CVCL_5957
SY TUHR-4TKB; 4TUHR; 4T
DR BTO; BTO:0003729
DR CLO; CLO_0050898
DR BioSample; SAMN03472178
DR CCLE; TUHR4TKB_KIDNEY
DR GEO; GSM887717
DR GEO; GSM888810
DR RCB; RCB1198
RX PubMed=14534724;
RX PubMed=15604581;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 12,13
ST TH01: 9
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TUR
AC CVCL_1775
SY TPA-U937-resistant
DR CLO; CLO_0009447
DR ATCC; CRL-2367
DR BioSample; SAMN03471833
DR ChEMBL-Cells; CHEMBL3308519
DR ChEMBL-Targets; CHEMBL2366218
DR Cosmic; 683549
DR Cosmic; 909773
DR Cosmic-CLP; 909773
DR GDSC; 909773
DR GEO; GSM186464
DR GEO; GSM1670551
RX PubMed=7720732;
RX PubMed=8398907;
RX PubMed=27397505;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID TuWi
AC CVCL_8275
SY Tu Wi
DR ATCC; CCL-31
DR BioSample; SAMN03151763
RX PubMed=566722;
RX PubMed=1246601;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a Wilms tumor.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; CCL-31; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID TV-1
AC CVCL_R817
SY Turbot Vigo-1
RX CelloPub=CLPUB00121;
CC Group: Fish cell line.
OX NCBI_TaxID=52904; ! Scophthalmus maximus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TVGH-iPSC-01-04
AC CVCL_GT31
DR BCRC; SC81032
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID TVGH-iPSC-02-07
AC CVCL_GT32
DR BCRC; SC81033
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID TVMBO
AC CVCL_M220
RX PubMed=11121133;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TW
AC CVCL_F585
SY TER253
DR IMGT/HLA; 11856
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TW-EBV-LCL
AC CVCL_J444
DR CLO; CLO_0050984
DR BioSample; SAMN03472141
DR RCB; RCB1438
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 10,14
ST D7S820: 11,12
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TW1
AC CVCL_Y013
SY hESC-TW1
DR BCRC; hESC-TW1
DR BCRC; SC81001
RX PubMed=18765016;
CC From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID TW2
AC CVCL_Y014
RX PubMed=18765016;
CC From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID TW2.6
AC CVCL_GZ05
RX PubMed=17070096;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TW3
AC CVCL_Y015
DR BCRC; SC81003
RX PubMed=18765016;
CC From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID TW4
AC CVCL_Y016
RX PubMed=18765016;
CC From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID TW5
AC CVCL_Y017
DR BCRC; SC81005
RX PubMed=18765016;
CC From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID TWERC
AC CVCL_7704
DR CLO; CLO_0009448
DR CLDB; cl4574
RX PubMed=4107530;
CC Transformant: NCBI_TaxID; 11888; Rous sarcoma virus (strain Prague C).
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7881 ! WERC
CA Transformed cell line
//
ID Twin-DS-iPSC
AC CVCL_W088
RX PubMed=24375627;
CC Miscellaneous: Twin-DS-iPSC and Twin-N-iPSC (CVCL_W087) originate from monozygotic twins discordant for trisomy 21.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID Twin-N-iPSC
AC CVCL_W087
RX PubMed=24375627;
CC Miscellaneous: Twin-DS-iPSC (CVCL_W088) and Twin-N-iPSC originate from monozygotic twins discordant for trisomy 21.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID TWNT-1
AC CVCL_J364
DR JCRB; JCRB1582
RX PubMed=12811248;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P42212; GFP.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3800; Epithelioid hemangioendothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0390 ! LI90
SX Female
CA Telomerase immortalized cell line
//
ID TWNT-4
AC CVCL_W296
RX PubMed=12953924;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C3800; Epithelioid hemangioendothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0390 ! LI90
SX Female
CA Telomerase immortalized cell line
//
ID TX-7F
AC CVCL_K256
DR CLO; CLO_0050324
DR RCB; RCB1856
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID TX-LY-172h
AC CVCL_AQ50
RX PubMed=26080839;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TX3.833
AC CVCL_U756
SY TX3-833
DR ATCC; CRL-13013
RX PubMed=11854497;
CC Discontinued: ATCC; CRL-13013; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID Tx3095
AC CVCL_6853
SY TX3095
RX PubMed=16061850;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tx3868
AC CVCL_6854
SY TX3868
DR BTO; BTO:0002128
RX PubMed=8882887;
RX PubMed=16061850;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TXM-1
AC CVCL_5643
SY TXM1
DR Cosmic; 932705
DR KCLB; 80028
RX PubMed=1826230;
CC From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC Discontinued: KCLB; 80028; probable.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TXM-13
AC CVCL_5645
SY TXM13
DR BTO; BTO:0003728
DR Cosmic; 932706
DR KCLB; 80029
RX PubMed=1826230;
RX PubMed=10987313;
RX PubMed=16462895;
CC From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC Derived from metastatic site: Brain.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,12
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8
ST FGA: 22.2,25
ST TH01: 8
ST TPOX: 10,11
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TXM-18
AC CVCL_5646
SY TXM18
DR BTO; BTO:0003983
DR Cosmic; 932707
DR Cosmic; 1238112
DR KCLB; 80030
RX PubMed=1826230;
CC From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC Derived from metastatic site: Brain.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,13
ST D3S1358: 16,19
ST D5S818: 13
ST D7S820: 7,9
ST FGA: 20
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TXM-34
AC CVCL_5647
SY TXM34
RX PubMed=1826230;
CC From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC Derived from metastatic site: Brain.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TXM-40
AC CVCL_5648
SY TXM40
DR KCLB; 80031
RX PubMed=1826230;
CC From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC Derived from metastatic site: Brain.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TY-1
AC CVCL_DG42
SY TY1
DR Cosmic; 1588565
DR GEO; GSM634740
DR GEO; GSM710425
DR GEO; GSM710441
RX PubMed=10421407;
RX PubMed=21685375;
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ty-82
AC CVCL_3220
SY TY-82
DR GEO; GSM577206
DR JCRB; JCRB1330
DR JCRB; NIHS0541
RX PubMed=1730520;
CC Discontinued: JCRB; NIHS0541 ; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 9,11
ST D7S820: 12,13
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 17,19
DI NCIt; C7569; Thymic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TY-E
AC CVCL_9V43
RX PubMed=9815546;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TY-ES
AC CVCL_S804
RX CelloPub=CLPUB00122;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TY08
AC CVCL_F712
RX PubMed=20458752;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Conditionally immortalized cell line
//
ID TY09
AC CVCL_U943
RX DOI=10.1111/cen3.12001;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F712 ! TY08
CA Conditionally immortalized cell line
//
ID TY25
AC CVCL_CW90
RX PubMed=12421930;
RX PubMed=14515261;
CC Monoclonal antibody target: UniProtKB; Q9WUL5; Mouse Pdcd1lg2/Cd273.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID TYBDC-1
AC CVCL_4W80
DR JCRB; JCRB1501
CC Derived from metastatic site: Liver.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 11,13
ST D5S818: 10,11
ST D7S820: 8,12
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 19
DI NCIt; C27813; Bile duct adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TYGBK-1
AC CVCL_J034
DR Cosmic; 2038290
DR JCRB; JCRB1499
RX PubMed=22843894;
CC Doubling time: ~48 hours(PubMed=22843894).
CC Derived from metastatic site: Lymph node.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 10
ST D16S539: 9
ST D5S818: 11,14
ST D7S820: 8
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TYGBK-8
AC CVCL_4W81
DR JCRB; JCRB1590
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 8
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TYHPC-1
AC CVCL_4W82
DR JCRB; JCRB1520
CC Derived from metastatic site: Liver.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3087; Hemangiopericytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TYK-nu
AC CVCL_1776
SY TYK-NU; TYKnu; TYKNU
DR EFO; EFO_0006766
DR BioSample; SAMN03471005
DR CCLE; TYKNU_OVARY
DR CGH-DB; 9359-4
DR ChEMBL-Cells; CHEMBL3308805
DR ChEMBL-Targets; CHEMBL1075601
DR Cosmic; 909774
DR Cosmic; 931359
DR Cosmic; 948288
DR Cosmic; 1077283
DR Cosmic; 2582803
DR Cosmic-CLP; 909774
DR GDSC; 909774
DR GEO; GSM659409
DR GEO; GSM851946
DR GEO; GSM887718
DR GEO; GSM888811
DR GEO; GSM1670552
DR JCRB; JCRB0234.0
RX PubMed=3782955;
RX PubMed=9290701;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23839242;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-312.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 45 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 9,10
ST D18S51: 13
ST D21S11: 32.2
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 10,15
ST FGA: 24
ST Penta D: 12
ST Penta E: 16
ST TH01: 9
ST TPOX: 9,11
ST vWA: 14,16
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TYK-nu.CP-r
AC CVCL_3221
SY TYK-nu (R); TYKNU CPR
DR EFO; EFO_0006767
DR CGH-DB; 383-2
DR CGH-DB; 9360-4
DR JCRB; JCRB0234.1
RX PubMed=2647872;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=25485619;
RX PubMed=27561551;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Caution: It is possible that TYK-nu.CP-r and TYK-nu-CisR (CVCL_EQ58) are the same cell line.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 9,10
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 9
ST TPOX: 9,11
ST vWA: 14,16
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1776 ! TYK-nu
SX Female
CA Cancer cell line
//
ID TYK-nu-CisR
AC CVCL_EQ58
SY Tyk-nu-cisR; TYKnuCisR; TyknuCisR
DR GEO; GSM851947
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Transcriptome analysis.
CC Caution: It is possible that TYK-nu.CP-r (CVCL_3221) and TYK-nu-CisR are the same cell line.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1776 ! TYK-nu
SX Female
CA Cancer cell line
//
ID TYLMS-1
AC CVCL_4W83
DR JCRB; JCRB1521
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8
ST vWA: 19
DI NCIt; C27904; Retroperitoneal leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TYPK-1
AC CVCL_4V78
DR JCRB; JCRB1500
RX PubMed=26124327;
CC Caution: Indicated as being from a male patient in PubMed=26124327 and from a female patient in JCRB.
CC Derived from metastatic site: Lymph node.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 9,12
ST D5S818: 10
ST D7S820: 8,14
ST TH01: 6
ST TPOX: 8,12
ST vWA: 16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TYPK-2
AC CVCL_4V79
RX PubMed=26124327;
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TYR1-hiPSC1
AC CVCL_C361
SY TYR.1.H.iPSC.1; RIi005-A
DR hPSCreg; RIi005-A
DR ISCR; 1411
DR RSCB; RSCB0067
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C362 ! TYR1-hiPSC2
OI CVCL_C363 ! TYR1-hiPSC3
OI CVCL_C364 ! TYR1-hiPSC4
OI CVCL_C365 ! TYR1-hiPSC5
OI CVCL_C366 ! TYR1-hiPSC6
OI CVCL_C367 ! TYR1-hiPSC7
SX Female
CA Induced pluripotent stem cell
//
ID TYR1-hiPSC2
AC CVCL_C362
SY TYR.1.H.iPSC.2
DR RSCB; RSCB0068
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C361 ! TYR1-hiPSC1
OI CVCL_C363 ! TYR1-hiPSC3
OI CVCL_C364 ! TYR1-hiPSC4
OI CVCL_C365 ! TYR1-hiPSC5
OI CVCL_C366 ! TYR1-hiPSC6
OI CVCL_C367 ! TYR1-hiPSC7
SX Female
CA Induced pluripotent stem cell
//
ID TYR1-hiPSC3
AC CVCL_C363
SY TYR.1.H.iPSC.3
DR RSCB; RSCB0069
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C361 ! TYR1-hiPSC1
OI CVCL_C362 ! TYR1-hiPSC2
OI CVCL_C364 ! TYR1-hiPSC4
OI CVCL_C365 ! TYR1-hiPSC5
OI CVCL_C366 ! TYR1-hiPSC6
OI CVCL_C367 ! TYR1-hiPSC7
SX Female
CA Induced pluripotent stem cell
//
ID TYR1-hiPSC4
AC CVCL_C364
SY TYR.1.H.iPSC.4
DR RSCB; RSCB0070
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C361 ! TYR1-hiPSC1
OI CVCL_C362 ! TYR1-hiPSC2
OI CVCL_C363 ! TYR1-hiPSC3
OI CVCL_C365 ! TYR1-hiPSC5
OI CVCL_C366 ! TYR1-hiPSC6
OI CVCL_C367 ! TYR1-hiPSC7
SX Female
CA Induced pluripotent stem cell
//
ID TYR1-hiPSC5
AC CVCL_C365
SY TYR.1.H.iPSC.5
DR RSCB; RSCB0071
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C361 ! TYR1-hiPSC1
OI CVCL_C362 ! TYR1-hiPSC2
OI CVCL_C363 ! TYR1-hiPSC3
OI CVCL_C364 ! TYR1-hiPSC4
OI CVCL_C366 ! TYR1-hiPSC6
OI CVCL_C367 ! TYR1-hiPSC7
SX Female
CA Induced pluripotent stem cell
//
ID TYR1-hiPSC6
AC CVCL_C366
SY TYR.1.H.iPSC.6
DR RSCB; RSCB0072
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C361 ! TYR1-hiPSC1
OI CVCL_C362 ! TYR1-hiPSC2
OI CVCL_C363 ! TYR1-hiPSC3
OI CVCL_C364 ! TYR1-hiPSC4
OI CVCL_C365 ! TYR1-hiPSC5
OI CVCL_C367 ! TYR1-hiPSC7
SX Female
CA Induced pluripotent stem cell
//
ID TYR1-hiPSC7
AC CVCL_C367
SY TYR.1.H.iPSC.7
DR RSCB; RSCB0073
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C361 ! TYR1-hiPSC1
OI CVCL_C362 ! TYR1-hiPSC2
OI CVCL_C363 ! TYR1-hiPSC3
OI CVCL_C364 ! TYR1-hiPSC4
OI CVCL_C365 ! TYR1-hiPSC5
OI CVCL_C366 ! TYR1-hiPSC6
SX Female
CA Induced pluripotent stem cell
//
ID TYS
AC CVCL_5G91
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2429552;
CC Doubling time: 44.4 hours (PubMed=2429552).
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TYUC-1
AC CVCL_4W84
DR JCRB; JCRB1512
RX PubMed=25667451;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 11
ST D7S820: 10
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C6762; Esophageal small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TZ-1
AC CVCL_R882
DR Cosmic; 2391883
RX PubMed=16826222;
DI NCIt; C7171; Acute monoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TZDR03
AC CVCL_V386
DR IMGT/HLA; 14467
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TZM-bl
AC CVCL_B478
SY TZM; JC53-bl; JC53BL-13; JC.53bl-13; JC53-bl clone 13
DR BTO; BTO:0005059
DR ChEMBL-Cells; CHEMBL3307662
DR ChEMBL-Targets; CHEMBL614612
DR NIH-ARP; 8129-442
RX PubMed=18842727;
RX PubMed=19474095;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Misspelling: Occasionally 'TZM-b1'.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID TZM-bl/FcalphaR
AC CVCL_1F83
RX DOI=10.1186/1742-4690-6-S3-P152;
CC Transfected with: HGNC; 3608; FCAR.
CC Transfected with: HGNC; 3611; FCER1G.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B478 ! TZM-bl
SX Female
CA Cancer cell line
//
ID TZM-bl/FcgammaRI
AC CVCL_1E18
DR NIH-ARP; 11798-376
RX PubMed=19458010;
RX PubMed=23408628;
CC Transfected with: HGNC; 3613; FCGR1A.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B478 ! TZM-bl
SX Female
CA Cancer cell line
//
ID TZM-bl/FcgammaRIIa
AC CVCL_1E19
DR NIH-ARP; 11795-314
RX PubMed=19458010;
CC Transfected with: HGNC; 3616; FCGR2A.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B478 ! TZM-bl
SX Female
CA Cancer cell line
//
ID TZM-bl/FcgammaRIIb
AC CVCL_1E20
DR NIH-ARP; 11797-375
RX PubMed=19458010;
CC Transfected with: HGNC; 3618; FCGR2B.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B478 ! TZM-bl
SX Female
CA Cancer cell line
//
ID TZM-bl/FcgammaRIIIa
AC CVCL_1E21
DR NIH-ARP; 11796-374
RX PubMed=19458010;
CC Transfected with: HGNC; 3619; FCGR3A.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B478 ! TZM-bl
SX Female
CA Cancer cell line
//
ID TZM-tfLC3B
AC CVCL_0A24
RX PubMed=25241145;
CC Transfected with: HGNC; 13352; MAP1LC3B.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B478 ! TZM-bl
SX Female
CA Cancer cell line
//
ID TZR
AC CVCL_4Y62
RX PubMed=9328141;
CC Selected for resistance to: ChEBI; CHEBI:90239; Tiazofurine.
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0382 ! L1210
SX Female
CA Cancer cell line
//
ID U-105MG
AC CVCL_5903
SY U-105 MG; U105MG; 105 MG; 105MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=608846;
RX PubMed=833871;
RX PubMed=2454731;
RX PubMed=4134536;
RX PubMed=4337530;
RX PubMed=4369403;
RX PubMed=6260907;
RX PubMed=9220028;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 14,18
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 17,26
ST D3S1358: 17,18
ST D5S818: 7,13
ST D7S820: 8,11
ST D8S1179: 12,14
ST FGA: 18,20
ST Penta D: 8,12
ST Penta E: 5,14
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1073MG
AC CVCL_GR52
SY U1073MG; 1073 MG
RX PubMed=608846;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 13
ST D16S539: 13,15
ST D18S51: 13,16
ST D19S433: 13.2,14
ST D21S11: 29
ST D2S1338: 19,20
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,13
ST D8S1179: 15
ST FGA: 21,23
ST Penta D: 9,13
ST TH01: 6
ST TPOX: 10,11
ST vWA: 18,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1176MG
AC CVCL_GR53
SY U1176MG
RX PubMed=27582061;
CC Miscellaneous: Gender from personal communication of Westermark B.
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 9
ST D16S539: 11
ST D18S51: 12,15
ST D19S433: 15
ST D21S11: 28,30
ST D2S1338: 19,25
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 15
ST FGA: 21.2
ST Penta D: 9,10
ST Penta E: 7,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-118MG
AC CVCL_0633
SY U-118 MG; U-118-MG; U118-MG; U118MG; U118; 118 MG; 118MG
DR BTO; BTO:0004605
DR CLO; CLO_0009451
DR ATCC; HTB-15
DR ATCC; CRL-7712
DR BioSample; SAMN03151974
DR BioSample; SAMN03472723
DR CCLE; U118MG_CENTRAL_NERVOUS_SYSTEM
DR CCRID; 3131C0001001200022
DR ChEMBL-Cells; CHEMBL3308793
DR ChEMBL-Targets; CHEMBL1075602
DR CLS; 300362/p4581_U-118_MG
DR Cosmic; 687588
DR Cosmic; 849852
DR Cosmic; 849878
DR Cosmic; 920817
DR Cosmic; 1175822
DR Cosmic; 1217672
DR Cosmic; 1571919
DR Cosmic; 1610738
DR Cosmic; 2301554
DR Cosmic; 2367553
DR Cosmic; 2550362
DR Cosmic-CLP; 687588
DR GDSC; 687588
DR GEO; GSM888812
DR GEO; GSM1374968
DR GEO; GSM1374969
DR GEO; GSM1670554
DR KCB; KCB 201302YJ
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2253244;
RX PubMed=2454731;
RX PubMed=4134536;
RX PubMed=4337530;
RX PubMed=4369403;
RX PubMed=6260907;
RX PubMed=7459858;
RX PubMed=9220028;
RX PubMed=11414198;
RX PubMed=19365568;
RX PubMed=19435942;
RX PubMed=20143388;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=27397505;
RX PubMed=27582061;
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=75
WW http://www.atcc.org/support/faqs/931ae/U118%20MG%20ATCC%20HTB15%20U138%20MG%20ATCC%20HTB16-1056.aspx
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/u118/u118cells.html
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Characteristics: Has no IDH1 mutation.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7712; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; PubMed=22570425; PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9 (ATCC; Cosmic-CLP)
ST D13S317: 9,11 (CLS; PubMed=22570425; PubMed=27582061)
ST D16S539: 12,13
ST D18S51: 13
ST D19S433: 13
ST D21S11: 27,32.2
ST D2S1338: 23,25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 14,15
ST FGA: 23 (CLS; PubMed=22570425)
ST FGA: 18,23 (PubMed=27582061)
ST Penta D: 13 (CLS)
ST Penta D: 10,13 (PubMed=22570425; PubMed=27582061)
ST Penta E: 7 (CLS; PubMed=22570425)
ST Penta E: 7,13 (PubMed=27582061)
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0020 ! U-138MG
SX Male
CA Cancer cell line
//
ID U-120MG
AC CVCL_T446
SY 120MG
RX PubMed=4337530;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID U-1231MG
AC CVCL_5G55
SY U-1231 MG; U1231MG
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 9,12
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 14,15
ST D21S11: 29
ST D2S1338: 18,25
ST D3S1358: 18,19
ST D5S818: 11,13
ST D7S820: 11,12
ST D8S1179: 11,13
ST FGA: 20,24
ST Penta D: 9,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1240MG
AC CVCL_5G54
SY U-1240 MG; U1240MG
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,13
ST D16S539: 11,13
ST D18S51: 16
ST D19S433: 13.2
ST D21S11: 29,30.2
ST D2S1338: 17
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 8,11
ST D8S1179: 10,12
ST FGA: 21
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1242MG
AC CVCL_F841
SY U-1242 MG; U1242MG
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=27582061;
CC Miscellaneous: Gender from personal communication of Westermark B.
ST Source(s): PubMed=27582061
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 13
ST D18S51: 16
ST D19S433: 14
ST D21S11: 28,31
ST D2S1338: 17,18
ST D3S1358: 17,19
ST D5S818: 9,11
ST D7S820: 9,11
ST D8S1179: 12
ST FGA: 19,22
ST Penta D: 17,19
ST Penta E: 13,15
ST TH01: 9,10
ST TPOX: 8,10
ST vWA: 15
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-1285
AC CVCL_7153
SY U1285
DR BTO; BTO:0002389
RX PubMed=2983887;
RX PubMed=6285665;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1285dox
AC CVCL_7154
SY U-1285dox(900)
DR BTO; BTO:0002391
RX PubMed=12766562;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7153 ! U-1285
SX Male
CA Cancer cell line
//
ID U-138MG
AC CVCL_0020
SY U-138 MG; U-138-MG; U138-MG; U 138 MG; U138MG; U138; 138 MG; 138MG
DR BTO; BTO:0002127
DR CLO; CLO_0009452
DR CLO; CLO_0009453
DR CLDB; cl4577
DR ATCC; HTB-16
DR BCRJ; 0239
DR BioSample; SAMN01821604
DR BioSample; SAMN01821668
DR BioSample; SAMN03472727
DR CCLE; U138MG_CENTRAL_NERVOUS_SYSTEM
DR CLS; 300363/p511_U-138_MG
DR Cosmic; 755288
DR Cosmic; 850744
DR Cosmic; 1571920
DR Cosmic; 1610739
DR Cosmic; 1746952
DR Cosmic; 2060806
DR Cosmic; 2301555
DR Cosmic; 2302317
DR DSMZ; ACC-291
DR GEO; GSM326234
DR GEO; GSM887719
DR GEO; GSM888813
DR IGRhCellID; U138MG
DR Lonza; 104
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=833871;
RX PubMed=2454731;
RX PubMed=4134536;
RX PubMed=4313504;
RX PubMed=4337530;
RX PubMed=4369403;
RX PubMed=6260907;
RX PubMed=6582512;
RX PubMed=19365568;
RX PubMed=19435942;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=27582061;
WW http://www.atcc.org/support/faqs/931ae/U118%20MG%20ATCC%20HTB15%20U138%20MG%20ATCC%20HTB16-1056.aspx
WW http://www.proteinatlas.org/learn/cellines
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0028&theme=default
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: Has no IDH1 mutation.
CC Doubling time: ~70 hours (DSMZ).
CC Omics: CNV analysis.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; DSMZ; PubMed=22570425; PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 12 (ATCC; CLS; DSMZ; PubMed=22570425)
ST CSF1PO: 11,12 (PubMed=27582061)
ST D13S317: 9,11
ST D16S539: 12,13
ST D18S51: 13
ST D19S433: 13
ST D21S11: 27,32.2
ST D2S1338: 23,25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 14,15
ST FGA: 18,23
ST Penta D: 9,13 (CLS; PubMed=22570425)
ST Penta D: 10,13 (PubMed=27582061)
ST Penta E: 7 (CLS; PubMed=22570425)
ST Penta E: 7,13 (PubMed=27582061)
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1568
AC CVCL_7155
SY U1568
DR BTO; BTO:0002390
RX PubMed=6285665;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1690
AC CVCL_D055
SY U1690
RX PubMed=2983887;
RX PubMed=2990154;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1752
AC CVCL_0565
SY U1752
DR BTO; BTO:0005386
DR MCCL; MCC:0000467
DR Cosmic; 953988
DR Cosmic; 1006541
RX PubMed=2983887;
RX PubMed=6178358;
RX PubMed=9551745;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID U-1761
AC CVCL_W848
SY U1761
RX PubMed=2990154;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-178MG
AC CVCL_A758
SY U-178-MG; U-178 MG; U178-MG; U 178 MG; U178MG; MG 178; U-178; 178 MG; 178MG
DR CCLE; U178_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849851
DR Cosmic; 849879
DR Cosmic; 1610740
DR Cosmic; 2516041
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=833871;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=4134536;
RX PubMed=4139097;
RX PubMed=4369403;
RX PubMed=19435942;
RX PubMed=22570425;
RX PubMed=25984343;
RX PubMed=27582061;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: Has no IDH1 mutation.
CC Doubling time: 45 hours (PubMed=25984343).
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425; PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11 (PubMed=22570425)
ST D13S317: 10,11 (PubMed=27582061)
ST D16S539: 10,13
ST D18S51: 14,15
ST D19S433: 14,15
ST D21S11: 28,30
ST D2S1338: 14,15
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 10 (PubMed=22570425)
ST D7S820: 8,10 (PubMed=27582061)
ST D8S1179: 13,14
ST FGA: 22,26
ST Penta D: 7,12
ST Penta E: 7,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1796MG
AC CVCL_5G61
SY U-1796 MG; U1796MG
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2454731;
RX PubMed=27582061;
CC Miscellaneous: Gender from personal communication of Westermark B.
ST Source(s): PubMed=27582061
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 12
ST D18S51: 13,18
ST D19S433: 14,15
ST D21S11: 32.2,33.2
ST D2S1338: 17
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 20,21
ST Penta D: 12,13
ST Penta E: 11,14
ST TH01: 9,9.3
ST TPOX: 9
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-1810
AC CVCL_D054
SY U1810
DR BTO; BTO:0003727
RX PubMed=2983887;
RX PubMed=2990154;
RX PubMed=9551745;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1906
AC CVCL_D075
SY U1906
RX PubMed=2983887;
RX PubMed=2990154;
RX PubMed=9551745;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-1957
AC CVCL_M493
RX PubMed=3580570;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M494 ! U-1958
SX Male
CA Cancer cell line
//
ID U-1958
AC CVCL_M494
RX PubMed=3580570;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M493 ! U-1957
SX Male
CA Cancer cell line
//
ID U-1996
AC CVCL_M495
RX PubMed=3580570;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-2 OS R1
AC CVCL_T429
RX PubMed=17096323;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0042 ! U2OS
SX Female
CA Cancer cell line
//
ID U-2 OS R2
AC CVCL_T430
SY U-2OSR2
RX PubMed=17096323;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T429 ! U-2 OS R1
SX Female
CA Cancer cell line
//
ID U-2020
AC CVCL_D076
SY U2020
RX PubMed=2983887;
RX PubMed=2990154;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-2030
AC CVCL_M581
RX PubMed=3583453;
RX PubMed=10936422;
CC Miscellaneous: Cell line has been lost (PubMed=10936422).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M585 ! U-2031
CA Cancer cell line
//
ID U-2030 TG
AC CVCL_M582
RX PubMed=3583453;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M581 ! U-2030
CA Cancer cell line
//
ID U-2031
AC CVCL_M585
RX PubMed=3583453;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M581 ! U-2030
CA Transformed cell line
//
ID U-2050
AC CVCL_D077
SY U2050
RX PubMed=2990154;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-2149
AC CVCL_W019
SY U2149
RX PubMed=2556928;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0043 ! U-2197
SX Male
CA Cancer cell line
//
ID U-2197
AC CVCL_0043
SY U2197
DR CLO; CLO_0009455
DR BioSample; SAMN03473584
DR Cosmic; 1933189
DR DSMZ; ACC-406
RX PubMed=2556928;
WW http://www.proteinatlas.org/learn/cellines
CC Doubling time: ~100-120 hours (DSMZ).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 10,13
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 6,9.3
ST TPOX: 10,11
ST vWA: 17,18
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W019 ! U-2149
SX Male
CA Cancer cell line
//
ID U-251 MG-Luc
AC CVCL_J269
DR JCRB; JCRB1386
DR JCRB; NIHS0645
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0645; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID U-251MG
AC CVCL_0021
SY U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG
DR BTO; BTO:0002035
DR CLO; CLO_0009456
DR EFO; EFO_0006498
DR CLDB; cl4583
DR CCLE; U251MG_CENTRAL_NERVOUS_SYSTEM
DR CCRID; 3111C0001CCC000058
DR CCRID; 3131C0001000700058
DR CCRID; 3142C0001000000112
DR CGH-DB; 155-1
DR ChEMBL-Cells; CHEMBL3307756
DR ChEMBL-Targets; CHEMBL615021
DR ChEMBL-Targets; CHEMBL615022
DR CLS; 300385/p534_U251_MG
DR Cosmic; 687451
DR Cosmic; 848340
DR Cosmic; 849850
DR Cosmic; 850742
DR Cosmic; 875896
DR Cosmic; 897440
DR Cosmic; 905983
DR Cosmic; 920818
DR Cosmic; 923899
DR Cosmic; 970094
DR Cosmic; 974243
DR Cosmic; 1044250
DR Cosmic; 1066235
DR Cosmic; 1092644
DR Cosmic; 1171225
DR Cosmic; 1175823
DR Cosmic; 1217673
DR Cosmic; 1312345
DR Cosmic; 1436038
DR Cosmic; 1610741
DR Cosmic; 1998487
DR Cosmic; 2367502
DR Cosmic; 2367554
DR Cosmic; 2516042
DR Cosmic; 2550363
DR Cosmic-CLP; 905983
DR ECACC; 09063001
DR GDSC; 905983
DR GEO; GSM50180
DR GEO; GSM50244
DR GEO; GSM750795
DR GEO; GSM799328
DR GEO; GSM799391
DR GEO; GSM847166
DR GEO; GSM844718
DR GEO; GSM844719
DR GEO; GSM887720
DR GEO; GSM888814
DR GEO; GSM1153398
DR GEO; GSM1181247
DR GEO; GSM1181342
DR GEO; GSM1670555
DR ICLC; HTL99014
DR IFO; IFO50288
DR KCB; KCB 200965YJ
DR Lonza; 105
DR Lonza; 1007
DR PRIDE; PXD000589
DR RCB; RCB0461
DR SKY/M-FISH/CGH; 2825
DR TOKU-E; 4005
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=608846;
RX PubMed=833871;
RX PubMed=2041050;
RX PubMed=4134536;
RX PubMed=4369403;
RX PubMed=6260907;
RX PubMed=6582512;
RX PubMed=9220028;
RX PubMed=16232199;
RX PubMed=16391870;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19435942;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24810477;
RX PubMed=25894527;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=27582061;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://dtp.cancer.gov/discovery_development/nci-60/u251_snb-19.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=57
WW https://www.kerafast.com/product/1790/u-251-mg-glioblastoma-cell-line
WW http://www.proteinatlas.org/learn/cellines
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-313.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Characteristics: Has no IDH1 mutation.
CC Doubling time: 24 hours (PubMed=25984343); 23.8 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB0461; true.
ST Source(s): CLS; Cosmic-CLP; ECACC; JCRB; PubMed=19372543; PubMed=22570425; PubMed=24810477; PubMed=27582061
ST Amelogenin: X,Y
ST Amelogenin: X (PubMed=24810477_some_subclones)
ST CSF1PO: 11,12 (CLS; Cosmic-CLP; ECACC; JCRB; PubMed=22570425; PubMed=27582061)
ST CSF1PO: 12,13 (PubMed=19372543)
ST D13S317: 10,11
ST D16S539: 12
ST D18S51: 13,15
ST D18S51: 13 (CLS; PubMed=22570425; PubMed=24810477_some_subclones)
ST D19S433: 13,15
ST D21S11: 29,30
ST D21S11: 29 (PubMed=22570425; PubMed=24810477_some_subclones)
ST D2S1338: 24 (CLS)
ST D2S1338: 22,24 (PubMed=27582061)
ST D3S1358: 16,17
ST D5S818: 11,12
ST D5S818: 11 (PubMed=24810477_some_subclones)
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 21,25
ST FGA: 20,21,25 (PubMed=24810477_some_subclones)
ST Penta D: 10,12 (CLS; PubMed=27582061)
ST Penta D: 12 (PubMed=22570425)
ST Penta E: 7,10 (CLS)
ST Penta E: 7 (PubMed=22570425; PubMed=27582061)
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-251MG (KO)
AC CVCL_2809
SY U-251 MG (KO)
DR BioSample; SAMN03472772
DR IFO; IFO50285
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID U-251MG AgCl1
AC CVCL_5G63
SY U-251 MG AgCl1; U-251 MGAgCl1
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2454731;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID U-251MG sp
AC CVCL_5G56
SY U-251 MG sp; U-251 MGsp; U-251SP
DR BTO; BTO:0005865
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=6260907;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID U-266/70
AC CVCL_0015
WW http://www.proteinatlas.org/learn/cellines
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID U-266/84
AC CVCL_0016
RX PubMed=3133230;
WW http://www.proteinatlas.org/learn/cellines
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID U-2904
AC CVCL_X504
SY U 2904
DR DSMZ; ACC-768
RX PubMed=7591289;
RX PubMed=17926183;
CC Doubling time: ~25-35 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 12
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-2932
AC CVCL_1896
SY U2932
DR EFO; EFO_0006499
DR BioSample; SAMN03473452
DR Cosmic; 1487546
DR Cosmic; 1517654
DR Cosmic; 1945196
DR DSMZ; ACC-633
DR GEO; GSM1059802
DR GEO; GSM1374971
DR PRIDE; PXD000589
RX PubMed=12533045;
RX PubMed=23295736;
RX PubMed=23292937;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 48 hours (PubMed=12533045); ~50 hours (DSMZ).
CC Omics: Cell surface proteome.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,13
ST TH01: 9.3
ST TPOX: 11,12
ST vWA: 14,17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-2940
AC CVCL_1897
SY U2940
DR BioSample; SAMN03473453
DR Cosmic; 2437272
DR Cosmic; 2479246
DR DSMZ; ACC-634
DR GEO; GSM1374972
DR Lonza; 1539
RX PubMed=16106419;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50 hours (DSMZ).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 10,12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-2946
AC CVCL_X503
DR DSMZ; ACC-795
RX PubMed=17926183;
RX PubMed=27907212;
CC Doubling time: 48 hours (PubMed=27907212); ~20-30 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 9,12
ST vWA: 17,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-2973
AC CVCL_1898
DR BioSample; SAMN03473456
DR DSMZ; ACC-642
RX PubMed=18510704;
RX PubMed=23171647;
CC Doubling time: ~35 hours (DSMZ).
CC Omics: Genome sequenced.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,20
DI NCIt; C80291; B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-2987-P3
AC CVCL_S469
RX PubMed=19543319;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S468 ! U-2987MG
SX Male
CA Cancer cell line
//
ID U-2987-P6
AC CVCL_S470
RX PubMed=19543319;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S468 ! U-2987MG
SX Male
CA Cancer cell line
//
ID U-2987MG
AC CVCL_S468
RX PubMed=16547494;
RX PubMed=19543319;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-343MG
AC CVCL_S471
SY U-343 MG; U-343-MG; U343MG; U-343; U343; 343 MG; 343MG
DR Cosmic; 849880
DR Cosmic; 2367503
DR Cosmic; 2491104
DR Cosmic; 2516043
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=4134536;
RX PubMed=4142792;
RX PubMed=4369403;
RX PubMed=6260907;
RX PubMed=11351043;
RX PubMed=21406405;
RX PubMed=22570425;
RX PubMed=25984343;
RX PubMed=26496030;
RX PubMed=27582061;
CC Doubling time: 45 hours (PubMed=25984343).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425; PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,13
ST D16S539: 9,12
ST D18S51: 23 (PubMed=22570425)
ST D18S51: 21,23 (PubMed=27582061)
ST D19S433: 13,14
ST D21S11: 31,33.2
ST D2S1338: 22,24
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 19,20
ST Penta D: 9,10
ST Penta E: 10,12
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 17 (PubMed=22570425)
ST vWA: 17,18 (PubMed=27582061)
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4773 ! U-343MGa
SX Male
CA Cancer cell line
//
ID U-343MGa
AC CVCL_4773
SY U-343 MG-A; U-343-MG-A; U343-MG-A; U-343 MGa; U343 MGa; U343MGa; U343
DR BTO; BTO:0003218
DR CLO; CLO_0009459
DR CLDB; cl4586
DR CCLE; U343_CENTRAL_NERVOUS_SYSTEM
DR CLS; 300365/p542_U-343_MGa
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=3497714;
RX PubMed=10709103;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,13
ST D16S539: 9,12
ST D18S51: 23
ST D21S11: 31,33.2
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 19,20
ST Penta D: 9,10
ST Penta E: 10,12
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S471 ! U-343MG
SX Male
CA Cancer cell line
//
ID U-343MGa 31L
AC CVCL_S472
SY U-343 MGa 31L
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=3497714;
RX PubMed=10709103;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4773 ! U-343MGa
SX Male
CA Cancer cell line
//
ID U-343MGa Cl2
AC CVCL_S474
SY U-343 MGa Cl2; U-343 MGa Cl 2
RX PubMed=2998609;
RX PubMed=3497714;
RX PubMed=6296418;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4773 ! U-343MGa
SX Male
CA Cancer cell line
//
ID U-343MGa Cl2:6
AC CVCL_S473
SY U-343 MGa Cl2:6; U-Cl2:6MG
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=2998609;
RX PubMed=3497714;
RX PubMed=10709103;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S474 ! U-343MGa Cl2
SX Male
CA Cancer cell line
//
ID U-343MGa Cl3
AC CVCL_S475
SY U-343 MGa Cl3; U-343 MGa Cl 3
RX PubMed=2998609;
RX PubMed=6296418;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4773 ! U-343MGa
SX Male
CA Cancer cell line
//
ID U-372MG
AC CVCL_5G60
SY U-372 MG; U372MG; 372 MG
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=608846;
RX PubMed=2454731;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 13,15
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 17,18
ST D3S1358: 17,18
ST D5S818: 9,11
ST D7S820: 9
ST D8S1179: 13
ST FGA: 22,23
ST Penta D: 12,14
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-373MG ATCC
AC CVCL_2219
SY U-373MG; U373 MG; U-373-MG; U-373 MG; U373-MG; U373MG; U373; 373 MG; 373MG
DR BTO; BTO:0002126
DR CLO; CLO_0009460
DR CLO; CLO_0009461
DR EFO; EFO_0001255
DR CLDB; cl4587
DR CLDB; cl4589
DR CLDB; cl4964
DR ATCC; HTB-17
DR CCLV; CCLV-RIE 0675
DR CGH-DB; 320-1
DR ChEMBL-Cells; CHEMBL3307474
DR ChEMBL-Targets; CHEMBL615024
DR Cosmic; 687589
DR Cosmic; 849849
DR Cosmic; 850825
DR Cosmic; 920819
DR Cosmic; 970093
DR Cosmic; 1066236
DR Cosmic; 1171226
DR Cosmic; 1175824
DR Cosmic; 1217674
DR Cosmic; 1294952
DR Cosmic; 1610742
DR Cosmic; 2367504
DR Cosmic; 2491105
DR ECACC; 89081403
DR GEO; GSM827314
DR IZSLER; BS TCL 89
DR JCRB; NIHS0295
DR Lonza; 334
DR Lonza; 1006
DR KCLB; 30017
DR NCBI_Iran; C455
DR PRIDE; PXD000430
DR TOKU-E; 3660
RX PubMed=833871;
RX PubMed=2253244;
RX PubMed=6260907;
RX PubMed=6582512;
RX PubMed=9220028;
RX PubMed=10074188;
RX PubMed=11351043;
RX PubMed=11414198;
RX PubMed=16232199;
RX PubMed=21406405;
RX PubMed=22570425;
RX PubMed=26496030;
WW http://www.atcc.org/support/faqs/cf245/U373%20MG%20ATCC%20HTB17-1055.aspx
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=76
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0029&theme=default
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-510.html
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated/misidentified. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Misspelling: '373MG' in Cosmic 970093.
CC Discontinued: ECACC; 89081403; probable.
CC Discontinued: JCRB; NIHS0295; true.
ST Source(s): ATCC; JCRB; KCLB; PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 12
ST D18S51: 13
ST D21S11: 29,30
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 21,25
ST Penta D: 10,12
ST Penta E: 7,10
ST TH01: 9.3 (ATCC; KCLB; PubMed=22570425)
ST TH01: 9.3,11 (JCRB)
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID U-373MG Uppsala
AC CVCL_2818
SY U-373 MG Uppsala; U-373 MG (Uppsala); U-373MG; U373 MG; U-373-MG; U-373 MG; U373-MG; U373MG; U373; 373 MG; 373MG
DR BioSample; SAMN03471311
DR ECACC; 08061901
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=4134536;
RX PubMed=4369403;
RX PubMed=19435942;
RX PubMed=27582061;
CC Characteristics: Has no IDH1 mutation.
CC Caution: This is the original U-373MG cell line established in 1973 at the University of Uppsala. The cell line distributed by most cell collections is a different cell line.
ST Source(s): ECACC; PubMed=27582061
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 12,13
ST D18S51: 14,22
ST D19S433: 13,14
ST D21S11: 28,32.2
ST D2S1338: 17,25
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 8.2,12 (ECACC)
ST D7S820: 8,12 (PubMed=27582061)
ST D8S1179: 13,16
ST FGA: 20
ST Penta D: 9,13
ST Penta E: 11,13
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-399MG
AC CVCL_1E96
SY U-399 MG; U399MG; 399 MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2454731;
RX PubMed=4369403;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 14,15
ST D19S433: 14
ST D21S11: 29,31
ST D2S1338: 17,20
ST D3S1358: 15,18
ST D5S818: 9,13
ST D7S820: 8,11
ST D8S1179: 10,13
ST FGA: 22,25
ST Penta D: 10,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-410MG
AC CVCL_W020
SY U-410 MG; U410MG; 410 MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2253244;
RX PubMed=2454731;
RX PubMed=4369403;
RX PubMed=6260907;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 13,18
ST D19S433: 14,16.2
ST D21S11: 28,31.2
ST D2S1338: 18,20
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 10,13
ST FGA: 20,22
ST Penta D: 9
ST Penta E: 7,11
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-47703 BL
AC CVCL_IW55
RX PubMed=165156;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID U-489MG
AC CVCL_1E97
SY U-489 MG; 489 MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2454731;
RX PubMed=4369403;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-495MG
AC CVCL_1E98
SY U-495 MG; 495 MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX PubMed=4369403;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-539MG
AC CVCL_1E99
SY U-539 MG; U539MG; 539 MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2454731;
RX PubMed=4369403;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 15,17
ST D19S433: 13,15
ST D21S11: 29,30
ST D2S1338: 20,25
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 21,23
ST Penta D: 12,14
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 17,19
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-563MG
AC CVCL_A757
SY U-563 MG; U563 MG; U-563-MG; U563MG; 563 MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1847665;
RX PubMed=2454731;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 16,17
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 19,21
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 8,9
ST D8S1179: 13,15
ST FGA: 21,25
ST Penta D: 9,11
ST Penta E: 10,16
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-692 MG
AC CVCL_1F00
SY 692 MG
RX DOI=10.1007/978-1-4757-1647-4_7;
RX PubMed=4369403;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-698-M
AC CVCL_0017
SY U-698 M; U-698M; U698-M; U698M; U-698; U698
DR CLO; CLO_0009462
DR EFO; EFO_0006768
DR CLDB; cl4591
DR BioSample; SAMN03471071
DR ChEMBL-Cells; CHEMBL3308280
DR ChEMBL-Targets; CHEMBL2366098
DR Cosmic; 909777
DR Cosmic-CLP; 909777
DR DSMZ; ACC-4
DR GDSC; 909777
DR GEO; GSM1374973
DR GEO; GSM1670558
RX PubMed=4136723;
RX PubMed=4369887;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.proteinatlas.org/learn/cellines
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 15,18
ST D21S11: 29,30
ST D3S1358: 14,15
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 11,13
ST FGA: 22,24
ST Penta D: 11,12
ST Penta E: 11,12
ST TH01: 6,10
ST TPOX: 8
ST vWA: 16
DI NCIt; C9360; Lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-706MG
AC CVCL_5G70
SY U-706M; U706MG
RX PubMed=7319677;
RX PubMed=27582061;
ST Source(s): PubMed=27582061
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 13,14
ST D19S433: 14,16
ST D21S11: 30,32.2
ST D2S1338: 16,20
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 12,14
ST FGA: 22,26
ST Penta D: 9,14
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5G71 ! U-706S
SX Female
CA Cancer cell line
//
ID U-706S
AC CVCL_5G71
SY U-706 S
RX PubMed=2454731;
RX PubMed=7319677;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5G70 ! U-706MG
SX Female
CA Cancer cell line
//
ID U-715-M
AC CVCL_4T89
SY U-715 M; U-715M; U-715; U715
RX PubMed=4136723;
RX PubMed=4369887;
DI NCIt; C9360; Lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-87 MG-luc2
AC CVCL_5J15
SY U87MG-luc2
CC Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124577.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0022 ! U-87MG ATCC
SX Male
CA Cancer cell line
//
ID U-87MG ATCC
AC CVCL_0022
SY U-87MG; U-87 MG; U87 MG; U-87-MG; U87-MG; U87MG; U-87; U87; 87 MG; 87MG
DR BTO; BTO:0002036
DR CLO; CLO_0009463
DR CLO; CLO_0009464
DR EFO; EFO_0005237
DR MCCL; MCC:0000469
DR CLDB; cl4592
DR CLDB; cl4594
DR CLDB; cl4595
DR CLDB; cl7166
DR ATCC; HTB-14
DR BCRC; 60360
DR BCRJ; 0241
DR BioSample; SAMN03472715
DR BioSample; SAMN03473126
DR CCLE; U87MG_CENTRAL_NERVOUS_SYSTEM
DR CCRID; 3111C0001CCC000208
DR CCRID; 3131C0001000700138
DR CGH-DB; 157-1
DR ChEMBL-Cells; CHEMBL3307575
DR ChEMBL-Targets; CHEMBL614247
DR CLS; 300367/p658_U-87_MG
DR Cosmic; 687590
DR Cosmic; 849853
DR Cosmic; 850741
DR Cosmic; 850822
DR Cosmic; 920816
DR Cosmic; 1036336
DR Cosmic; 1064099
DR Cosmic; 1066234
DR Cosmic; 1171224
DR Cosmic; 1175825
DR Cosmic; 1198263
DR Cosmic; 1217671
DR Cosmic; 1219449
DR Cosmic; 1237542
DR Cosmic; 1294951
DR Cosmic; 1610737
DR Cosmic; 1746951
DR Cosmic; 1945859
DR Cosmic; 2302316
DR Cosmic; 2367555
DR Cosmic; 2491106
DR Cosmic; 2516044
DR Cosmic; 2550364
DR Cosmic; 2568870
DR Cosmic-CLP; 687590
DR ECACC; 89081402
DR ENCODE; ENCBS424ENC
DR GDSC; 687590
DR GEO; GSM326243
DR GEO; GSM481417
DR GEO; GSM500897
DR GEO; GSM887723
DR GEO; GSM888817
DR GEO; GSM923437
DR GEO; GSM1374974
DR GEO; GSM1670559
DR ICLC; HTL00013
DR IZSLER; BS TCL 189
DR KCB; KCB 2011101YJ
DR KCLB; 30014
DR LINCS; 50868
DR Lonza; 37
DR Lonza; 808
DR NCBI_Iran; C531
DR NIH-ARP; 2188-324
DR PRIDE; PXD000589
DR PRIDE; PXD001565
DR RCB; RCB0419
DR TOKU-E; 3381
DR Wikidata; Q7863603
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=7459858;
RX PubMed=10074188;
RX PubMed=11414198;
RX PubMed=11966317;
RX PubMed=16232199;
RX PubMed=19365568;
RX PubMed=19435942;
RX PubMed=20126413;
RX PubMed=21406405;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=23325432;
RX PubMed=25894527;
RX PubMed=25984343;
RX PubMed=26496030;
RX PubMed=27397505;
RX PubMed=27582061;
WW https://en.wikipedia.org/wiki/U87
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=58
WW http://www.proteinatlas.org/learn/cellines
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/U-87_Myers_protocol.pdf
WW http://www.addexbio.com/productdetail?pid=71
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-314.html
CC Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Characteristics: Has no IDH1 mutation.
CC Doubling time: 72 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: CNV analysis.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB0419; true.
ST Source(s): AddexBio; ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=22570425; PubMed=25877200; PubMed=27582061
ST Amelogenin: X,Y (ATCC; Cosmic-CLP; KCLB)
ST Amelogenin: X (AddexBio; CLS; ECACC; PubMed=11416159; PubMed=22570425; PubMed=25877200; PubMed=27582061)
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 12
ST D18S51: 13 (CLS; PubMed=22570425)
ST D18S51: 13,14 (PubMed=11416159; PubMed=25877200)
ST D19S433: 15,15.2
ST D21S11: 28,32.2
ST D2S1338: 20,23
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 8,9
ST D8S1179: 10,11
ST FGA: 18,24
ST Penta D: 9,14
ST Penta E: 7,14
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-87MG Uppsala
AC CVCL_GP63
SY U-87MG; U-87 MG; U87 MG; U-87-MG; U87-MG; U87MG; U-87; U87; 87 MG; 87MG
DR Wikidata; Q28575999
RX DOI=10.1007/978-1-4757-1647-4_7;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2454731;
RX PubMed=4134536;
RX PubMed=4313504;
RX PubMed=4337530;
RX PubMed=4369403;
RX PubMed=27582061;
WW https://en.wikipedia.org/wiki/U87
CC Caution: This is the original U-87MG cell line established in 1968 at the University of Uppsala. The cell line distributed by most cell collections (including ATCC, CLS, ECACC, etc.) is a different cell line whose origin is not yet clear (PubMed=27582061). See U-87MG ATCC (CVCL_0022) for the cell line used by most research groups.
ST Source(s): PubMed=27582061
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9,13
ST D19S433: 14,15
ST D21S11: 28,30
ST D2S1338: 17,20
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,13
ST D8S1179: 13,14
ST FGA: 20,24
ST Penta D: 11
ST Penta E: 7,13
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 15,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-937
AC CVCL_0007
SY U937; U 937
DR BTO; BTO:0001412
DR CLO; CLO_0009450
DR CLO; CLO_0009465
DR EFO; EFO_0001257
DR MCCL; MCC:0000470
DR CLDB; cl4597
DR CLDB; cl4599
DR CLDB; cl4600
DR CLDB; cl4601
DR CLDB; cl4602
DR CLDB; cl4603
DR CLDB; cl4604
DR CLDB; cl4605
DR CLDB; cl4606
DR CLDB; cl4608
DR ATCC; CRL-1593
DR ATCC; CRL-1593.2
DR BCRC; 60435
DR BCRJ; 0242
DR BioSample; SAMN03472409
DR BioSample; SAMN03473173
DR BioSample; SAMN03473567
DR CCLE; U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000059
DR CCRID; 3131C0001000700059
DR CCRID; 3131C0001000700159
DR CCRID; 3142C0001000000078
DR ChEMBL-Cells; CHEMBL3308006
DR ChEMBL-Targets; CHEMBL612794
DR CLS; 300368/p474_U-937
DR Cosmic; 787483
DR Cosmic; 798666
DR Cosmic; 821044
DR Cosmic; 852000
DR Cosmic; 919123
DR Cosmic; 922162
DR Cosmic; 932770
DR Cosmic; 975307
DR Cosmic; 991558
DR Cosmic; 994178
DR Cosmic; 999781
DR Cosmic; 1012127
DR Cosmic; 1019837
DR Cosmic; 1067446
DR Cosmic; 1070690
DR Cosmic; 1078726
DR Cosmic; 1082516
DR Cosmic; 1086353
DR Cosmic; 1089523
DR Cosmic; 1107178
DR Cosmic; 1127260
DR Cosmic; 1150904
DR Cosmic; 1176581
DR Cosmic; 1181605
DR Cosmic; 1191692
DR Cosmic; 1465967
DR Cosmic; 1523828
DR Cosmic; 1524826
DR Cosmic; 1582388
DR Cosmic; 1601066
DR Cosmic; 1995661
DR Cosmic; 2301570
DR Cosmic; 2361376
DR DSMZ; ACC-5
DR ECACC; 85011440
DR GEO; GSM2020
DR GEO; GSM236809
DR GEO; GSM236845
DR GEO; GSM482491
DR GEO; GSM887724
DR GEO; GSM888818
DR GEO; GSM1028244
DR GEO; GSM1028245
DR GEO; GSM1374975
DR GEO; GSM1670560
DR ICLC; HTL94002
DR IFO; IFO50038
DR IMGT/HLA; 11507
DR IZSLER; BS TCL 73
DR JCRB; JCRB9021
DR KCB; KCB 200676YJ
DR KCLB; 21593.1
DR LINCS; 50869
DR Lonza; 135
DR MeSH; D020298
DR NCBI_Iran; C130
DR PRIDE; PXD001521
DR PRIDE; PXD001522
DR PRIDE; PXD001523
DR RCB; RCB1978
DR TOKU-E; 3382
DR Wikidata; Q7863610
RX PubMed=178611;
RX PubMed=1083890;
RX PubMed=6091813;
RX PubMed=6582512;
RX PubMed=8547074;
RX PubMed=8643484;
RX PubMed=9685479;
RX PubMed=9738977;
RX PubMed=10676951;
RX PubMed=11701946;
RX PubMed=12393283;
RX PubMed=15637111;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=20801507;
RX PubMed=21269460;
RX PubMed=22460905;
RX PubMed=25485619;
WW https://en.wikipedia.org/wiki/U937_cells
WW http://www.cells-talk.com/index.php/page/copelibrary?key=U937
WW http://www.proteinatlas.org/learn/cellines
WW http://www.infarktforschung.de/macrophages_cell_lines.html
WW http://www.addexbio.com/productdetail?pid=72
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-315.html
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0012&theme=default
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: Can be induced to differentiate into macrophages by several factors such as phorbol ester (PMA) and 12-O-tetradecanoyl-13-phorbol acetate (TPA).
CC Doubling time: 95-100 hours (PubMed=178611); ~30-40 hours (DSMZ).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-1593; true.
CC Discontinued: RCB; RCB1978; true.
ST Source(s): ATCC; CLS; COG; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=15637111; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12 (ATCC; CLS; COG; ECACC; JCRB; KCLB; PubMed=25877200; RCB)
ST CSF1PO: 10,12 (DSMZ; PubMed=15637111)
ST D13S317: 10,12
ST D16S539: 12
ST D18S51: 13,14
ST D19S433: 14,16
ST D21S11: 27,29 (CLS; COG; PubMed=25877200)
ST D21S11: 27 (PubMed=15637111)
ST D2S1338: 17,20
ST D3S1358: 16
ST D5S818: 12 (ATCC; CLS; COG; ECACC; JCRB; KCLB; PubMed=25877200; RCB)
ST D5S818: 10,12 (PubMed=15637111)
ST D5S818: 10,12,13 (DSMZ)
ST D7S820: 9,11
ST D8S1179: 12,13
ST FGA: 22,25
ST Penta D: 12,13 (CLS; COG; PubMed=25877200)
ST Penta D: 13 (PubMed=15637111)
ST Penta E: 13
ST TH01: 6,9.3 (ATCC; CLS; COG; DSMZ; ECACC; JCRB_IFO50038; PubMed=11416159; PubMed=15637111; PubMed=25877200; RCB)
ST TH01: 6,10 (JCRB_JCRB9021)
ST TH01: 9.3 (KCLB)
ST TPOX: 8,11
ST vWA: 15 (ATCC; KCLB)
ST vWA: 14,15 (CLS; COG; DSMZ; ECACC; JCRB; PubMed=11416159; PubMed=15637111; PubMed=25877200; RCB)
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-937 cl1-14
AC CVCL_2810
SY U937 cl1-14
DR JCRB; JCRB0116.1
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U-937 cl1-22
AC CVCL_2811
SY U937 cl1-22
DR JCRB; JCRB0116.2
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U-937 DE-4
AC CVCL_8765
DR CLO; CLO_0050122
DR BioSample; SAMN03472308
DR RCB; RCB0435
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U-937 GTB
AC CVCL_U631
SY U-937-GTB; U-937/GTB; U937/GTB; U937-GTB
DR ChEMBL-Cells; CHEMBL3308007
DR ChEMBL-Targets; CHEMBL612795
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U-937-AG
AC CVCL_X000
SY U-937 AG
RX PubMed=6748730;
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U-BLC1
AC CVCL_2738
SY UBLC1
DR CCLE; UBLC1_URINARY_TRACT
DR Cosmic; 2050467
DR Cosmic; 2212693
DR ECACC; 06013102
RX PubMed=10074925;
RX PubMed=24367658;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-CH1
AC CVCL_4988
SY UCH-1; UCH1
DR EFO; EFO_0004389
DR ATCC; CRL-3217
DR DSMZ; ACC-748
DR ENCODE; ENCBS267AAA
DR GDSC; 1503374
RX PubMed=11579460;
RX PubMed=20461036;
RX PubMed=21253487;
RX PubMed=23325432;
RX PubMed=26183925;
RX PubMed=27102572;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch1/
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/UCH1_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Doubling time: ~1 week, but can be significantly longer after recovery from liquid nitrogen freezing (DSMZ); 2 days (PubMed=26183925).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
ST Source(s): ATCC; DSMZ; PubMed=21253487; PubMed=26183925; PubMed=27102572
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D10S1248: 15
ST D12S391: 17,22
ST D13S317: 11,13
ST D16S539: 12,13
ST D18S51: 15
ST D19S433: 14
ST D1S1656: 16,16.3
ST D21S11: 28,29
ST D22S1045: 16
ST D2S1338: 17,18
ST D2S441: 12,14
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,12
ST D8S1179: 10,15
ST FGA: 20,21
ST Penta D: 11
ST Penta E: 7,10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-CH1-N
AC CVCL_4990
SY U-CH1-NIRS
RX PubMed=21914223;
CC Doubling time: ~3 days (PubMed=21914223).
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4988 ! U-CH1
SX Male
CA Cancer cell line
//
ID U-CH10
AC CVCL_1D66
SY UCH10
RX PubMed=26183925;
RX PubMed=27102572;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch10/
CC Doubling time: 14 days (PubMed=26183925).
ST Source(s): PubMed=26183925; PubMed=27102572
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 11,13
ST D18S51: 13
ST D19S433: 13,15
ST D21S11: 29,31
ST D2S1338: 19
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 9,10 (PubMed=26183925)
ST D7S820: 10 (PubMed=27102572)
ST D8S1179: 8,13
ST FGA: 24
ST Penta D: 9,13
ST Penta E: 18
ST TH01: 8,9
ST TPOX: 11
ST vWA: 16
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-CH11
AC CVCL_1D67
SY UCH11
RX PubMed=26183925;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch11-2/
CC Doubling time: 10 days (PubMed=26183925).
ST Source(s): PubMed=26183925
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 14
ST D16S539: 9,11
ST D18S51: 14
ST D3S1358: 15
ST D7S820: 9,10
ST D8S1179: 13,16
ST Penta D: 9,12
ST Penta E: 7,14
ST TH01: 6,9.3
ST TPOX: 8
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-CH12
AC CVCL_IR27
SY UCH12
RX PubMed=26183925;
CC Doubling time: 7 days (PubMed=26183925).
ST Source(s): PubMed=26183925
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D10S1248: 14,16
ST D12S391: 19,19.3
ST D13S317: 12,13
ST D16S539: 15
ST D18S51: 17,18
ST D19S433: 12,15
ST D1S1656: 13,16
ST D21S11: 27,32.2
ST D22S1045: 15
ST D2S1338: 22,23
ST D2S441: 11
ST D3S1358: 14,19
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 14
ST FGA: 23,24
ST Penta D: 12
ST Penta E: 12,15
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-CH2
AC CVCL_4989
SY UCH2
DR ATCC; CRL-3218
DR Cosmic-CLP; 1503373
DR DSMZ; ACC-749
DR GEO; GSM1670565
RX PubMed=21253487;
RX PubMed=26183925;
RX PubMed=27102572;
RX PubMed=27397505;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch2/
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/UCH1_Crawford_protocol.pdf
CC Doubling time: 4 days (PubMed=26183925); Doubling time: ~5-7 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=21253487; PubMed=26183925; PubMed=27102572
ST Amelogenin: X
ST CSF1PO: 11,12
ST D10S1248: 13,16
ST D12S391: 18,19
ST D13S317: 11
ST D16S539: 12
ST D18S51: 12,18
ST D19S433: 15.2,17
ST D1S1656: 14.3,15
ST D21S11: 29,30
ST D22S1045: 15
ST D2S1338: 24
ST D2S441: 10,11.3
ST D3S1358: 17
ST D5S818: 10,11
ST D7S820: 8,12
ST D8S1179: 13
ST FGA: 21,22.2
ST Penta D: 12,13
ST Penta E: 12,15
ST TH01: 9.3 (ATCC; DSMZ; PubMed=26183925; PubMed=27102572)
ST TH01: 6 (Cosmic-CLP)
ST TH01: 6,9.3 (PubMed=21253487)
ST TPOX: 8
ST vWA: 17
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-CH3
AC CVCL_IR25
SY UCH3
RX PubMed=26183925;
CC Doubling time: 8 days (PubMed=26183925).
ST Source(s): PubMed=26183925
ST Amelogenin: X
ST CSF1PO: 10,13
ST D10S1248: 15
ST D12S391: 17,18
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 17
ST D19S433: 13,14
ST D1S1656: 15,17
ST D21S11: 30
ST D22S1045: 11
ST D2S1338: 18,22
ST D2S441: 10,11
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 16
ST FGA: 26
ST Penta D: 10
ST Penta E: 7,14
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U-CH6
AC CVCL_IR26
SY UCH6
RX PubMed=26183925;
CC Doubling time: 14 days (PubMed=26183925).
CC Derived from metastatic site: Skin.
ST Source(s): PubMed=26183925
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D10S1248: 17
ST D12S391: 18
ST D13S317: 8
ST D16S539: 12
ST D18S51: 15
ST D19S433: 13,16.2
ST D1S1656: 17
ST D21S11: 29
ST D22S1045: 15
ST D2S1338: 18,20
ST D2S441: 11
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 12
ST FGA: 19,21
ST Penta D: 12
ST Penta E: 13,20
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-CH7
AC CVCL_IR23
SY UCH7
RX PubMed=26183925;
RX PubMed=27102572;
CC Doubling time: 7 days (PubMed=26183925).
ST Source(s): PubMed=26183925; PubMed=27102572
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D10S1248: 13
ST D12S391: 15,19
ST D13S317: 10 (PubMed=27102572)
ST D13S317: 10,12 (PubMed=26183925)
ST D16S539: 10,12
ST D18S51: 16
ST D19S433: 13,14
ST D1S1656: 17.3
ST D21S11: 30,33.2
ST D22S1045: 15
ST D2S1338: 23
ST D2S441: 10,14
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 14,16
ST FGA: 22,24
ST Penta D: 12,13
ST Penta E: 12,15
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U-HO1
AC CVCL_2220
SY U-H01
DR BioSample; SAMN03473507
DR Cosmic; 1289702
DR Cosmic; 1432042
DR DSMZ; ACC-626
DR GEO; GSM381299
DR IGRhCellID; U-HO1
RX PubMed=18253030;
RX PubMed=18820924;
CC Doubling time: ~100 hours (DSMZ).
CC Anecdotal: Andreas Mader, the first author of the paper (PubMed=18253030) describing this cell line is the patient that donated the cell line. As it is not frequent to see a patient 'acknowledged' by being an author this fact should be emphasized.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U1/HIV-1
AC CVCL_M769
SY U1
DR NIH-ARP; 165-432
RX PubMed=2449497;
RX PubMed=3313729;
CC Characteristics: Contains two copies of the HIV-1 proviral genome (strain HIV-NY5) per cell.
CC Doubling time: 36 hours (NIH-ARP).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U14
AC CVCL_9U56
RX DOI=10.1007/s11805-008-0044-0;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: Kunming.
DI NCIt; C24068; Mouse cervical carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9U22 ! L10-90
OI CVCL_9U43 ! P11-90
SX Female
CA Cancer cell line
//
ID U14-GFP
AC CVCL_9U57
RX DOI=10.1007/s11805-008-0044-0;
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: Kunming.
DI NCIt; C24068; Mouse cervical carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9U56 ! U14
SX Female
CA Cancer cell line
//
ID U1I
AC CVCL_IW88
RX PubMed=6773878;
CC Doubling time: 27.2 hours (PubMed=6773878).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Spontaneously immortalized cell line
//
ID U2-OS Tet-On
AC CVCL_V335
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_Cell_Lines
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0042 ! U2OS
SX Female
CA Cancer cell line
//
ID U2-OS-Luc Tet-On
AC CVCL_V336
SY U-2 OS-Luc teT-on; U2OSLUC Tet ON
DR CCRID; 3111C0001CCC000270
WW http://www.clontech.com/xxclt_ibcGetAttachment.jsp?cItemId=26894&minisite=10020&secItmId=16274
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V335 ! U2-OS Tet-On
SX Female
CA Cancer cell line
//
ID U251-TR3
AC CVCL_1G29
SY A172TR3; TR3
DR Cosmic; 1236361
RX DOI=10.1158/1078-0432.CCR-13-1821;
RX PubMed=19584161;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought (PubMed=19584161) to be a A-172 (CVCL_0131) derivative but shown to be a U-251MG derivative (DOI 10.1158/1078-0432.CCR-13-1821).
CC Selected for resistance to: ChEBI; CHEBI:72564; Temozolomide (TMZ).
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID U266/ADM
AC CVCL_GZ72
RX PubMed=26045737;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID U266/velR
AC CVCL_T031
RX PubMed=24286313;
CC Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID U266B1
AC CVCL_0566
SY U266-B1; U266 B1; U-266; U 266; U266; U266S; U266BL; U266 Bl; 266 Bl
DR BTO; BTO:0001594
DR CLO; CLO_0009457
DR CLO; CLO_0009458
DR EFO; EFO_0001254
DR MCCL; MCC:0000471
DR CLDB; cl4584
DR CLDB; cl4609
DR ATCC; TIB-196
DR BCRC; 60437
DR BCRJ; 0240
DR BioSample; SAMN01821605
DR BioSample; SAMN01821669
DR BioSample; SAMN03472935
DR CCLE; U266B1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 37-1
DR CGH-DB; 9155-4
DR ChEMBL-Cells; CHEMBL3308535
DR ChEMBL-Targets; CHEMBL2366315
DR Cosmic; 720795
DR Cosmic; 742953
DR Cosmic; 753615
DR Cosmic; 759903
DR Cosmic; 759912
DR Cosmic; 760401
DR Cosmic; 760647
DR Cosmic; 886087
DR Cosmic; 888019
DR Cosmic; 991555
DR Cosmic; 1424220
DR Cosmic; 1483078
DR Cosmic; 1762463
DR Cosmic; 1889513
DR Cosmic; 2081409
DR Cosmic; 2367281
DR Cosmic; 2391806
DR Cosmic-CLP; 753615
DR DSMZ; ACC-9
DR ECACC; 85051003
DR GDSC; 753615
DR GEO; GSM143345
DR GEO; GSM545498
DR GEO; GSM545499
DR GEO; GSM827442
DR GEO; GSM887721
DR GEO; GSM888815
DR GEO; GSM1374970
DR GEO; GSM1670556
DR IGRhCellID; U266B1
DR IZSLER; BS TCL 233
DR KCB; KCB 2013024YJ
DR Lonza; 807
DR NCBI_Iran; C151
RX PubMed=1643757;
RX PubMed=2537114;
RX PubMed=4097745;
RX PubMed=8943038;
RX PubMed=9685479;
RX PubMed=10087940;
RX PubMed=10557056;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=15215163;
RX PubMed=16956823;
RX PubMed=17171682;
RX PubMed=21173094;
RX PubMed=22460905;
RX PubMed=23074853;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Group: Hybridoma fusion partner cell line.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~55 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: BCRJ; 0240; probable.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10
ST D18S51: 12,14
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 13
ST FGA: 18
ST Penta D: 10,13
ST Penta E: 10,12
ST TH01: 5,7
ST TPOX: 8
ST vWA: 17
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W412 ! U268
SX Male
CA Cancer cell line
//
ID U266R
AC CVCL_C828
RX PubMed=8307198;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID U268
AC CVCL_W412
SY U-268; 268 Bm
RX PubMed=4097745;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID U28
AC CVCL_J093
DR ECACC; 93022518
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID U2OS
AC CVCL_0042
AS CVCL_L856
SY U-2 OS; U-2OS; U-2-OS; U2-OS; U20-S; U20S; 2T
DR BTO; BTO:0001938
DR CLO; CLO_0001272
DR CLO; CLO_0009454
DR EFO; EFO_0002869
DR MCCL; MCC:0000468
DR CLDB; cl53
DR CLDB; cl4579
DR CLDB; cl4580
DR CLDB; cl4581
DR CLDB; cl7217
DR ATCC; HTB-96
DR BCRC; 60187
DR BCRJ; 0304
DR BioSample; SAMN03472549
DR BioSample; SAMN03472766
DR CCLE; U2OS_BONE
DR CCRID; 3111C0001CCC000028
DR CCRID; 3131C0001000700088
DR ChEMBL-Cells; CHEMBL3307757
DR ChEMBL-Targets; CHEMBL615023
DR CLS; 300364/p489_U-2_OS
DR Cosmic; 687934
DR Cosmic; 755312
DR Cosmic; 909776
DR Cosmic; 931038
DR Cosmic; 931909
DR Cosmic; 1044081
DR Cosmic; 1044268
DR Cosmic; 1066238
DR Cosmic; 1074397
DR Cosmic; 1078392
DR Cosmic; 1082493
DR Cosmic; 1097758
DR Cosmic; 1529905
DR Cosmic; 1733128
DR Cosmic; 2009542
DR Cosmic; 2301583
DR Cosmic; 2440477
DR Cosmic-CLP; 909776
DR DSMZ; ACC-785
DR ECACC; 92022711
DR ENCODE; ENCBS200HLU
DR ENCODE; ENCBS266AAA
DR ENCODE; ENCBS953RZO
DR GDSC; 909776
DR GEO; GSE54820
DR GEO; GSM170250
DR GEO; GSM185160
DR GEO; GSM185161
DR GEO; GSM287989
DR GEO; GSM287990
DR GEO; GSM320831
DR GEO; GSM827583
DR GEO; GSM879223
DR GEO; GSM887722
DR GEO; GSM888816
DR GEO; GSM1231597
DR GEO; GSM1231598
DR GEO; GSM1231599
DR GEO; GSM1231600
DR GEO; GSM1231601
DR GEO; GSM1231602
DR GEO; GSM1231603
DR GEO; GSM1231604
DR GEO; GSM1231605
DR GEO; GSM1231606
DR GEO; GSM1231607
DR GEO; GSM1231608
DR GEO; GSM1231609
DR GEO; GSM1231610
DR GEO; GSM1356565
DR GEO; GSM1356566
DR GEO; GSM1356567
DR GEO; GSM1356568
DR GEO; GSM1356569
DR GEO; GSM1356570
DR GEO; GSM1356571
DR GEO; GSM1356572
DR GEO; GSM1356573
DR GEO; GSM1356574
DR GEO; GSM1356575
DR GEO; GSM1356576
DR GEO; GSM1356577
DR GEO; GSM1356578
DR GEO; GSM1356579
DR GEO; GSM1356580
DR GEO; GSM1356581
DR GEO; GSM1356582
DR GEO; GSM1356583
DR GEO; GSM1356584
DR GEO; GSM1356585
DR GEO; GSM1356586
DR GEO; GSM1356587
DR GEO; GSM1670557
DR GEO; GSM1676324
DR GEO; GSM1701657
DR ICLC; HTL11001
DR KCB; KCB 200962YJ
DR KCLB; 30096
DR Lonza; 676
DR PRIDE; PRD000118
DR PRIDE; PXD000157
DR PRIDE; PXD000589
DR PRIDE; PXD001220
DR PRIDE; PXD002073
DR PRIDE; PXD002117
DR PRIDE; PXD002395
DR PRIDE; PXD003754
DR TOKU-E; 3379
DR Wikidata; Q28473037
RX PubMed=833871;
RX PubMed=2823272;
RX PubMed=6081590;
RX PubMed=8275086;
RX PubMed=8617485;
RX PubMed=12645653;
RX PubMed=15150091;
RX PubMed=15736406;
RX PubMed=18359981;
RX PubMed=19787792;
RX PubMed=21519327;
RX PubMed=22068332;
RX PubMed=22278370;
RX PubMed=22460905;
RX PubMed=24618588;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://141.61.102.20/mxdb/project/show/9191407937500
WW http://www.proteinatlas.org/learn/cellines
WW http://www.cells-talk.com/index.php/page/copelibrary?key=U2-OS
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/u2/u2cells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-92.html
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/U2OS_Farnham_protocol.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~25-30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using proteomics.
CC Misspelling: Occasionally 'U-205'.
CC Misspelling: Occasionally 'U205'.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
ST CSF1PO: 12,13 (CLS; DSMZ)
ST D13S317: 13 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=25877200)
ST D13S317: 11,13 (CLS)
ST D16S539: 11,12
ST D18S51: 12,14 (CLS)
ST D18S51: 14 (PubMed=25877200)
ST D21S11: 31
ST D3S1358: 16
ST D5S818: 11 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
ST D5S818: 8,11 (CLS; DSMZ)
ST D7S820: 11,12 (ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB)
ST D7S820: 12 (PubMed=25877200)
ST D8S1179: 12,14
ST FGA: 20
ST Penta D: 9
ST Penta E: 10,13
ST TH01: 6,9.3
ST TPOX: 11,12
ST vWA: 14,18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3002MG
AC CVCL_IR56
SY U3002-MG; U3002
DR GEO; GSM1857567
DR GEO; GSM1857783
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3004MG
AC CVCL_IR57
SY U3004-MG; U3004
DR GEO; GSM1857568
DR GEO; GSM1857784
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 16,19
ST D19S433: 15.2,16.2
ST D21S11: 29,31.2
ST D2S1338: 19,24
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 20,23
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3005MG
AC CVCL_IR58
SY U3005-MG; U3005
DR GEO; GSM1857569
DR GEO; GSM1857785
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3008MG
AC CVCL_IR59
SY U3008-MG; U3008
DR GEO; GSM1857570
DR GEO; GSM1857786
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D18S51: 14,18
ST D19S433: 15
ST D21S11: 30,33.2
ST D2S1338: 19,25
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 11,15
ST FGA: 21,25
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3009MG
AC CVCL_IR60
SY U3009-MG; U3009
DR GEO; GSM1857571
DR GEO; GSM1857787
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 9
ST D18S51: 13,15
ST D19S433: 14,15
ST D21S11: 29,31
ST D2S1338: 19,25
ST D3S1358: 16,17
ST D5S818: 13
ST D7S820: 9,11
ST D8S1179: 14
ST FGA: 19,22.2
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3013MG
AC CVCL_IR61
SY U3013-MG; U3013
DR GEO; GSM1857572
DR GEO; GSM1857788
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 14
ST D16S539: 10
ST D18S51: 13,14
ST D19S433: 14
ST D21S11: 31.2,32.2
ST D2S1338: 25,26
ST D3S1358: 17,19
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 18,24
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3016MG
AC CVCL_IR62
SY U3016-MG; U3016
DR GEO; GSM1857573
DR GEO; GSM1857789
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3017MG
AC CVCL_IR63
SY U3017-MG; U3017
DR GEO; GSM1857574
DR GEO; GSM1857790
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 14,18
ST D19S433: 14,16.2
ST D21S11: 29,31.2
ST D2S1338: 20,25
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 10,15
ST FGA: 20,26
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3019MG
AC CVCL_IR64
SY U3019-MG; U3019
DR GEO; GSM1857575
DR GEO; GSM1857791
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 14
ST D16S539: 10
ST D18S51: 13,14
ST D19S433: 14
ST D21S11: 31.2,32.2
ST D3S1358: 17,19
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 18,24
ST TPOX: 8
ST vWA: 16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3020MG
AC CVCL_IR65
SY U3020-MG; U3020
DR GEO; GSM1857576
DR GEO; GSM1857792
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 11,13
ST D18S51: 16
ST D19S433: 13,15
ST D21S11: 31.2
ST D2S1338: 23,24
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 21
ST TH01: 6,7
ST TPOX: 8,11
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3021MG
AC CVCL_IR66
SY U3021-MG; U3021
DR GEO; GSM1857577
DR GEO; GSM1857793
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 13,15
ST D19S433: 14,15
ST D21S11: 28,29
ST D2S1338: 17,23
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21,25
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3024MG
AC CVCL_IR67
SY U3024-MG; U3024
DR GEO; GSM1857578
DR GEO; GSM1857794
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 14
ST D16S539: 12,13
ST D18S51: 15,17
ST D19S433: 14,15
ST D21S11: 32.2
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 10,12
ST D7S820: 8,12
ST D8S1179: 12,15
ST FGA: 19,23
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 14
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3027MG
AC CVCL_IR68
SY U3027-MG; U3027
DR GEO; GSM1857579
DR GEO; GSM1857795
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 12
ST D18S51: 16,18
ST D19S433: 13,14
ST D21S11: 30,31.2
ST D2S1338: 21,24
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 9,12
ST D8S1179: 12,14
ST FGA: 22,23
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3028MG
AC CVCL_IR69
SY U3028-MG; U3028
DR GEO; GSM1857580
DR GEO; GSM1857796
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3029MG
AC CVCL_IR70
SY U3029-MG; U3029
DR GEO; GSM1857581
DR GEO; GSM1857797
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 12,14
ST D19S433: 14,15
ST D21S11: 29,30
ST D2S1338: 17,18
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 8
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3031MG
AC CVCL_IR71
SY U3031-MG; U3031
DR GEO; GSM1857582
DR GEO; GSM1857798
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 14,18
ST D19S433: 14.2
ST D21S11: 30,33.2
ST D2S1338: 18,19
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 11,12
ST FGA: 22,24
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 18,20
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3033MG
AC CVCL_IR72
SY U3033-MG; U3033
DR GEO; GSM1857583
DR GEO; GSM1857799
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 10,12
ST D18S51: 17
ST D19S433: 14
ST D21S11: 29,32.2
ST D2S1338: 16,24
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 12,14
ST FGA: 22
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3034MG
AC CVCL_IR73
SY U3034-MG; U3034
DR GEO; GSM1857584
DR GEO; GSM1857800
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,14
ST D18S51: 13,16
ST D19S433: 13,13.2
ST D21S11: 27,28
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 15,16
ST FGA: 19,22
ST TH01: 9.3
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3035MG
AC CVCL_IR74
SY U3035-MG; U3035
DR GEO; GSM1857585
DR GEO; GSM1857801
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11,14
ST D18S51: 14,18
ST D19S433: 14,15
ST D21S11: 28,30.2
ST D2S1338: 17
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 11,12
ST FGA: 21,25
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3037MG
AC CVCL_IR75
SY U3037-MG; U3037
DR GEO; GSM1857586
DR GEO; GSM1857802
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 11,14
ST D18S51: 12,16
ST D19S433: 15
ST D21S11: 30,31.2
ST D2S1338: 25
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 21,25
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3039MG
AC CVCL_IR76
SY U3039-MG; U3039
DR GEO; GSM1857587
DR GEO; GSM1857803
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 12,14
ST D13S317: 9,13
ST D16S539: 11
ST D18S51: 12,14
ST D19S433: 12,15
ST D21S11: 29,33.2
ST D2S1338: 17,20
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 11,14
ST FGA: 21,22
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3042MG
AC CVCL_IR77
SY U3042-MG; U3042
DR GEO; GSM1857588
DR GEO; GSM1857804
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 12,13
ST D18S51: 16,19
ST D19S433: 14,15
ST D21S11: 31
ST D2S1338: 17,20
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 21,23
ST TH01: 6,7
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3046MG
AC CVCL_IR78
SY U3046-MG; U3046
DR GEO; GSM1857589
DR GEO; GSM1857805
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 11
ST D18S51: 14,16
ST D19S433: 13,14
ST D21S11: 28,31
ST D2S1338: 20,22
ST D3S1358: 14,18
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 23,25
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3047MG
AC CVCL_IR79
SY U3047-MG; U3047
DR GEO; GSM1857590
DR GEO; GSM1857806
RX PubMed=25510230;
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,13
ST D16S539: 9
ST D18S51: 14,20
ST D19S433: 14,15.2
ST D21S11: 28,31
ST D2S1338: 23
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 21,23
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3048MG
AC CVCL_IR80
SY U3048-MG; U3048
DR GEO; GSM1857591
DR GEO; GSM1857807
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 11,13
ST D18S51: 13,18
ST D19S433: 15,15.2
ST D21S11: 30,31
ST D2S1338: 23
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 9
ST D8S1179: 13,14
ST FGA: 23
ST TH01: 7,9.3
ST TPOX: 8,12
ST vWA: 14,16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3051MG
AC CVCL_IR81
SY U3051-MG; U3051
DR GEO; GSM1857592
DR GEO; GSM1857808
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3053MG
AC CVCL_IR82
SY U3053-MG; U3053
DR GEO; GSM1857593
DR GEO; GSM1857809
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 11,12
ST D18S51: 14,18
ST D19S433: 14,15
ST D21S11: 28,31
ST D2S1338: 16,24
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 10,12
ST FGA: 21,22
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3054MG
AC CVCL_IR83
SY U3054-MG; U3054
DR GEO; GSM1857594
DR GEO; GSM1857810
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 9,12
ST D18S51: 12
ST D19S433: 14,14.2
ST D21S11: 31,32.2
ST D2S1338: 23
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 13,17
ST FGA: 21,23
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3056MG
AC CVCL_IR84
SY U3056-MG; U3056
DR GEO; GSM1857595
DR GEO; GSM1857811
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3060MG
AC CVCL_IR85
SY U3060-MG; U3060
DR GEO; GSM1857596
DR GEO; GSM1857812
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 11,13
ST D18S51: 17,18
ST D19S433: 14,15
ST D21S11: 28,29
ST D2S1338: 17,24
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 10,14
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3062MG
AC CVCL_IR86
SY U3062-MG; U3062
DR GEO; GSM1857597
DR GEO; GSM1857813
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3065MG
AC CVCL_IR87
SY U3065-MG; U3065
DR GEO; GSM1857598
DR GEO; GSM1857814
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,10
ST D16S539: 11,12
ST D18S51: 12,15
ST D19S433: 13
ST D21S11: 28,30.2
ST D2S1338: 19,21
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 14,15
ST FGA: 21,25
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 14,16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3067MG
AC CVCL_IR88
SY U3067-MG; U3067
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 14,17
ST D19S433: 13,14
ST D21S11: 27,29
ST D2S1338: 17,18
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 14
ST FGA: 23
ST TH01: 9,10
ST TPOX: 8,9
ST vWA: 19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3068MG
AC CVCL_IR89
SY U3068-MG; U3068
DR GEO; GSM1857599
DR GEO; GSM1857815
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3071MG
AC CVCL_IR90
SY U3071-MG; U3071
DR GEO; GSM1857600
DR GEO; GSM1857816
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 9
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 14,14.2
ST D21S11: 30.2,31
ST D2S1338: 20,23
ST D3S1358: 16,18
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 13
ST FGA: 19,23
ST TH01: 9.3,10
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3073MG
AC CVCL_IR91
SY U3073-MG; U3073
DR GEO; GSM1857601
DR GEO; GSM1857817
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 12
ST D18S51: 12,16
ST D19S433: 13,15
ST D21S11: 29,30.2
ST D2S1338: 20,25
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 10,12
ST FGA: 19,21
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3078MG
AC CVCL_IR92
SY U3078-MG; U3078
DR GEO; GSM1857602
DR GEO; GSM1857818
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 11,12
ST D18S51: 14,15
ST D19S433: 13,15
ST D21S11: 28,29
ST D2S1338: 17,24
ST D3S1358: 14,17
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 23,25
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3082MG
AC CVCL_IR93
SY U3082-MG; U3082
DR GEO; GSM1857603
DR GEO; GSM1857819
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 9,12
ST D16S539: 12,13
ST D18S51: 12
ST D19S433: 14,15
ST D21S11: 28,31.2
ST D2S1338: 16,19
ST D3S1358: 15,16
ST D5S818: 9,12
ST D7S820: 9,13
ST D8S1179: 12,13
ST FGA: 22,25
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3084MG
AC CVCL_IR94
SY U3084-MG; U3084
DR GEO; GSM1857604
DR GEO; GSM1857820
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 11,14
ST D18S51: 12,18
ST D19S433: 13
ST D21S11: 29,30
ST D2S1338: 17,20
ST D3S1358: 15,17
ST D5S818: 11,14
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 22
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IR96 ! U3086MG
SX Male
CA Cancer cell line
//
ID U3085MG
AC CVCL_IR95
SY U3085-MG; U3085
DR GEO; GSM1857605
DR GEO; GSM1857821
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11
ST D18S51: 12,14
ST D19S433: 14
ST D21S11: 28,30
ST D2S1338: 17,18
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,15
ST FGA: 21,24
ST TH01: 6,9.3
ST TPOX: 10,11
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3086MG
AC CVCL_IR96
SY U3086-MG; U3086
DR GEO; GSM1857606
DR GEO; GSM1857822
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 11,14
ST D18S51: 12,18
ST D19S433: 13
ST D21S11: 29,30
ST D2S1338: 17,20
ST D3S1358: 15,17
ST D5S818: 11,14
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 22
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IR94 ! U3084MG
SX Male
CA Cancer cell line
//
ID U3088MG
AC CVCL_IR97
SY U3088-MG; U3088
DR GEO; GSM1857607
DR GEO; GSM1857823
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26629530
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 17,18
ST D19S433: 15,16.2
ST D21S11: 27,30
ST D2S1338: 19,24
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 23,24
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3101MG
AC CVCL_IR98
SY U3101-MG; U3101
DR GEO; GSM1857608
DR GEO; GSM1857824
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3110MG
AC CVCL_IR99
SY U3110-MG; U3110
DR GEO; GSM1857609
DR GEO; GSM1857825
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID U3117MG
AC CVCL_IS00
SY U3117-MG; U3117
DR GEO; GSM1857610
DR GEO; GSM1857826
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IS01 ! U3118MG
SX Male
CA Cancer cell line
//
ID U3118MG
AC CVCL_IS01
SY U3118-MG; U3118
DR GEO; GSM1857611
DR GEO; GSM1857827
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IS00 ! U3117MG
SX Male
CA Cancer cell line
//
ID U3121MG
AC CVCL_IS02
SY U3121-MG; U3121
DR GEO; GSM1857612
DR GEO; GSM1857828
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3123MG
AC CVCL_IS03
SY U3123-MG; U3123
DR GEO; GSM1857613
DR GEO; GSM1857829
RX PubMed=26629530;
WW http://www.hgcc.se/
CC Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID U3129MG
AC CVCL_IS04
SY U3129-MG; U3129
DR GEO; GSM1857614
CC Omics: SNP array analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID U373-MAGI
AC CVCL_1F84
SY U373-CD4
DR NIH-ARP; 3595-281
RX PubMed=7690415;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2219 ! U-373MG ATCC
SX Male
CA Cancer cell line
//
ID U373-MAGI-CCR5
AC CVCL_1F85
SY U373-MAGI-CCR5E
DR NIH-ARP; 3597-204
RX PubMed=9201229;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1F84 ! U373-MAGI
SX Male
CA Cancer cell line
//
ID U373-MAGI-CXCR4
AC CVCL_1F86
SY U373-MAGI-CXCR4CEM
DR NIH-ARP; 3596-40
RX PubMed=9201229;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 2561; CXCR4.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1F84 ! U373-MAGI
SX Male
CA Cancer cell line
//
ID U38
AC CVCL_M770
DR NIH-ARP; 1297-125
RX PubMed=3422113;
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U4.4
AC CVCL_Z820
SY u4.4
RX PubMed=3951024;
CC Group: Insect cell line.
OX NCBI_TaxID=7160; ! Aedes albopictus
HI CVCL_Z223 ! ATC-15
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID U87 MG-Red-FLuc
AC CVCL_5J12
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124577
CC Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0022 ! U-87MG ATCC
SX Male
CA Cancer cell line
//
ID U87-CD4 Clone 2
AC CVCL_X702
SY U87MG clone 2
DR NIH-ARP; 2187-19
RX PubMed=2293663;
CC Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0022 ! U-87MG ATCC
SX Male
CA Cancer cell line
//
ID U87-MG/Pt
AC CVCL_4V16
DR Cosmic; 1198264
RX CelloPub=CLPUB00268;
CC Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0022 ! U-87MG ATCC
SX Male
CA Cancer cell line
//
ID U87/DK
AC CVCL_3428
SY U87-DK; U87DK; U87 dead kinase; U87MG.deltaEGFR
DR CLDB; cl7208
DR ICLC; HTL08003
RX PubMed=9006938;
CC Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC Transfected with: HGNC; 3236; EGFR (truncated extracellular mutant with M-745).
ST Source(s): ICLC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12
ST D21S11: 28.2,32.2
ST D5S818: 11,12
ST D7S820: 8,9
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0022 ! U-87MG ATCC
SX Male
CA Cancer cell line
//
ID U87/WT
AC CVCL_3429
DR CLDB; cl7209
DR ICLC; HTL08004
CC Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
ST Source(s): ICLC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 12
ST D21S11: 28.2,32.2
ST D5S818: 11,12
ST D7S820: 8,9
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0022 ! U-87MG ATCC
SX Male
CA Cancer cell line
//
ID U87.CD4
AC CVCL_X626
SY U87/CD4; U87MG.CD4
DR NIH-ARP; 4031-20
RX PubMed=9311827;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0069&theme=default
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0022 ! U-87MG ATCC
SX Male
CA Cancer cell line
//
ID U87.CD4.CCR1
AC CVCL_X627
SY U87.CD4-CCR1
DR NIH-ARP; 4032-23
RX PubMed=9311827;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0069&theme=default
CC Transfected with: HGNC; 1602; CCR1.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X626 ! U87.CD4
SX Male
CA Cancer cell line
//
ID U87.CD4.CCR2
AC CVCL_X628
SY U87.CD4.CCR2b; U87.CD4-CCR2b
DR NIH-ARP; 4033-24
RX PubMed=9311827;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0070&theme=default
CC Transfected with: HGNC; 1603; CCR2.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X626 ! U87.CD4
SX Male
CA Cancer cell line
//
ID U87.CD4.CCR3
AC CVCL_X629
SY U87.CD4-CCR3
DR NIH-ARP; 4034-26
RX PubMed=9311827;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0071&theme=default
CC Transfected with: HGNC; 1604; CCR3.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X626 ! U87.CD4
SX Male
CA Cancer cell line
//
ID U87.CD4.CCR5
AC CVCL_X630
SY U87.CD4-CCR5
DR NIH-ARP; 4035-332
RX PubMed=9311827;
RX PubMed=15169555;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0072&theme=default
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X626 ! U87.CD4
SX Male
CA Cancer cell line
//
ID U87.CD4.CCR5.CXCR4
AC CVCL_X631
RX PubMed=15169555;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X626 ! U87.CD4
SX Male
CA Cancer cell line
//
ID U87.CD4.CXCR4
AC CVCL_X632
SY U87.CD4-CXCR4; U87 CD4+ CXCR4+
DR NIH-ARP; 4036-455
RX PubMed=9311827;
RX PubMed=15169555;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0073&theme=default
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X626 ! U87.CD4
SX Male
CA Cancer cell line
//
ID U937-DC-SIGN
AC CVCL_2Z95
DR ATCC; CRL-3253
RX PubMed=17804661;
CC Transfected with: HGNC; 1641; CD209.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/ara-C
AC CVCL_4V23
RX PubMed=21290089;
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/clone21
AC CVCL_Y170
DR CGH-DB; 9116-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/clone36
AC CVCL_Y171
DR CGH-DB; 9117-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/clone41
AC CVCL_Y172
DR CGH-DB; 9118-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/clone49
AC CVCL_Y173
DR CGH-DB; 9119-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/HIV-2MS
AC CVCL_X608
DR NIH-ARP; 127-109
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/UK110
AC CVCL_Y174
SY UK110
RX PubMed=8845304;
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937/UK711
AC CVCL_Y175
SY UK711
DR CGH-DB; 9120-4
RX PubMed=7957669;
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937(CD59-)
AC CVCL_8932
SY CD59- U937
RX PubMed=7518799;
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID U937(CD59+)
AC CVCL_8927
SY CD59+ U937
DR CLO; CLO_0009466
DR CLDB; cl682
DR ECACC; 95102435
RX PubMed=7518799;
CC Discontinued: ECACC; 95102435; probable.
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID UA-S2
AC CVCL_E859
SY BUA
DR dbMHC; 49049
DR ECACC; 94071430
DR IHW; IHW9328
DR IMGT/HLA; 11508
WW http://bioinformatics.hsanmartino.it/ecbr/cl328.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UACC-1012
AC CVCL_M448
SY UACC 1012; UACC1012; University of Arizona Cell Culture-1012
RX PubMed=10952317;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-1022
AC CVCL_4035
SY UACC 1022; UACC1022; University of Arizona Cell Culture-1022
RX PubMed=10952317;
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-1097
AC CVCL_M449
SY UACC 1097; UACC1097; University of Arizona Cell Culture-1097
RX PubMed=10952317;
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-1118
AC CVCL_DG48
SY UACC 1118; UACC1118; University of Arizona Cell Culture-1118
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-1179
AC CVCL_4036
SY UACC 1179; UACC1179; University of Arizona Cell Culture-1179
DR ATCC; CRL-3127
RX PubMed=9778046;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 8
ST vWA: 16
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-1227
AC CVCL_4037
SY UACC 1227; UACC1227; University of Arizona Cell Culture-1227
RX PubMed=12115485;
RX PubMed=19383853;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-1237
AC CVCL_4038
SY UACC 1237; UACC1237; University of Arizona Cell Culture-1237
RX PubMed=12115485;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-1256
AC CVCL_M450
SY UACC1256
RX PubMed=10952317;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-1273
AC CVCL_G297
SY UACC 1273; UACC1273; University of Arizona Cell Culture-1273
RX PubMed=10952317;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-1273EV
AC CVCL_4039
SY UACC 1273EV; UACC1273EV
DR BTO; BTO:0005064
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G297 ! UACC-1273
SX Male
CA Cancer cell line
//
ID UACC-1308
AC CVCL_DG39
SY UACC 1308; UACC1308; University of Arizona Cell Culture-1308
DR BTO; BTO:0005895
RX PubMed=23039341;
RX PubMed=24879157;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-1529
AC CVCL_M451
SY UACC 1529; UACC1529; University of Arizona Cell Culture-1529
RX PubMed=10952317;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-1598
AC CVCL_4040
SY UACC 1598; UACC1598; University of Arizona Cell Culture-1598
DR ATCC; CRL-3128
DR BioSample; SAMN03471713
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 13
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 7,9
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-182
AC CVCL_S728
SY UACC 182; UACC182; University of Arizona Cell Culture-182
DR Cosmic; 1020265
RX PubMed=10918183;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-1940
AC CVCL_IN96
SY UACC 1940; UACC1940; University of Arizona Cell Culture-1940
DR BTO; BTO:0005896
RX PubMed=24879157;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-2087
AC CVCL_4041
SY UACC 2087; UACC2087; University of Arizona Cell Culture-2087
DR ATCC; CRL-3180
RX PubMed=9778046;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,10
ST D16S539: 11
ST D7S820: 10,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-239
AC CVCL_S729
SY UACC 239 UACC239; University of Arizona Cell Culture-239
DR Cosmic; 1020266
RX PubMed=10918183;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-2534
AC CVCL_M452
SY UACC 2534; UACC2534; University of Arizona Cell Culture-2534
DR BTO; BTO:0005897
DR Cosmic; 1211155
RX PubMed=10952317;
RX PubMed=23039341;
RX PubMed=24879157;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-2561
AC CVCL_E116
SY UACC 2561; UACC2561; University of Arizona Cell Culture-2561
DR Cosmic; 730330
RX PubMed=8050085;
DI NCIt; C45543; Lung carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-2565
AC CVCL_M453
SY UACC 2565; UACC2565; University of Arizona Cell Culture-2565
RX PubMed=19383853;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-257
AC CVCL_1779
SY UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257
DR BTO; BTO:0004233
DR EFO; EFO_0005376
DR BioSample; SAMN03473125
DR CCLE; UACC257_SKIN
DR ChEMBL-Cells; CHEMBL3308008
DR ChEMBL-Targets; CHEMBL612796
DR Cosmic; 686478
DR Cosmic; 688056
DR Cosmic; 875890
DR Cosmic; 905977
DR Cosmic; 974070
DR Cosmic; 974259
DR Cosmic; 1054854
DR Cosmic; 1092645
DR Cosmic; 1175874
DR Cosmic; 1303058
DR Cosmic; 1305370
DR Cosmic; 1507612
DR Cosmic; 1998488
DR Cosmic; 2233682
DR Cosmic-CLP; 905977
DR GDSC; 905977
DR GEO; GSM50207
DR GEO; GSM50269
DR GEO; GSM188228
DR GEO; GSM188258
DR GEO; GSM188317
DR GEO; GSM750818
DR GEO; GSM799359
DR GEO; GSM799422
DR GEO; GSM847167
DR GEO; GSM844720
DR GEO; GSM844721
DR GEO; GSM887725
DR GEO; GSM888819
DR GEO; GSM1153430
DR GEO; GSM1181338
DR GEO; GSM1181360
DR GEO; GSM1670561
DR SKY/M-FISH/CGH; 2826
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=17308088;
RX PubMed=19372543;
RX PubMed=22460905;
RX PubMed=23039341;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24879157;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=50
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 38.5 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,13
ST D16S539: 9,11
ST D18S51: 15
ST D19S433: 12,15
ST D21S11: 30,31.2
ST D2S1338: 17,25
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 9,12
ST Penta E: 10
ST TH01: 8
ST TPOX: 9,12
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID UACC-2648
AC CVCL_W021
SY UACC 2648; UACC2648; University of Arizona Cell Culture-2648
DR ATCC; CRL-3121
RX PubMed=9778046;
CC Discontinued: ATCC; CRL-3121; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 8
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 9,11
ST vWA: 14,15
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-2837
AC CVCL_DG40
SY UACC 2837; UACC2837; University of Arizona Cell Culture-2837
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-2972
AC CVCL_1G28
SY UACC 2972; UACC2972; University of Arizona Cell Culture-2972
RX PubMed=12115485;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-2973
AC CVCL_M454
SY UACC 2973; UACC2973; University of Arizona Cell Culture-2973
RX PubMed=10952317;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-2996
AC CVCL_W092
SY UACC 2996; UACC2996; University of Arizona Cell Culture-2996
DR ATCC; CRL-3123
CC Discontinued: ATCC; CRL-3123; probable.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-3074
AC CVCL_M455
SY UACC 3074; UACC3074; University of Arizona Cell Culture-3074
RX PubMed=19383853;
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-3093
AC CVCL_A692
SY UACC 3093; UACC3093; University of Arizona Cell Culture-3093
DR Cosmic; 1211163
RX PubMed=10952317;
RX PubMed=23039341;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-3133
AC CVCL_B221
SY UACC 3133; UACC3133; University of Arizona Cell Culture-3133
DR ATCC; CRL-2988
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 13
ST D16S539: 11
ST D5S818: 9,11
ST D7S820: 8,10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C7950; Invasive lobular breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-3149
AC CVCL_M456
SY UACC 3149; UACC3149; University of Arizona Cell Culture-3149
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-3199
AC CVCL_4042
SY UACC 3199; UACC3199; University of Arizona Cell Culture-3199
DR ATCC; CRL-2983
DR BioSample; SAMN03471703
DR GEO; GSM481329
RX PubMed=9778046;
CC Derived from metastatic site: Axillary lymph node.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 13
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 10,13
ST vWA: 15,17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-325
AC CVCL_4043
SY UACC 325; UACC325; University of Arizona Cell Culture-325
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-3247
AC CVCL_W091
SY UACC 3247; UACC3247; University of Arizona Cell Culture-3247
DR ATCC; CRL-3124
CC Discontinued: ATCC; CRL-3124; probable.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-3291
AC CVCL_IN97
SY UACC 3291; UACC3291; University of Arizona Cell Culture-3291
DR BTO; BTO:0005883
RX PubMed=24879157;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-375
AC CVCL_M457
SY UACC 375; UACC375; University of Arizona Cell Culture-375
DR ChEMBL-Cells; CHEMBL3307880
DR ChEMBL-Targets; CHEMBL614127
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-383
AC CVCL_4044
SY UACC 383; UACC383; University of Arizona Cell Culture-383
RX PubMed=1371813;
RX PubMed=10952317;
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-456
AC CVCL_4045
SY UACC 456; UACC456; University of Arizona Cell Culture-456
RX PubMed=1371813;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-457
AC CVCL_4046
SY UACC 457; UACC457; University of Arizona Cell Culture-457
RX PubMed=10952317;
RX PubMed=19383853;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-462
AC CVCL_4047
SY UACC 462; UACC462; University of Arizona Cell Culture-462
DR ATCC; CRL-2989
RX PubMed=3014534;
CC Derived from metastatic site: Peritoneum.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 13
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 9,9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-502
AC CVCL_M458
SY UACC 502; UACC502; University of Arizona Cell Culture-502
DR BTO; BTO:0005898
RX PubMed=10952317;
RX PubMed=12115485;
RX PubMed=24879157;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-537
AC CVCL_S730
SY UACC 537; UACC537; University of Arizona Cell Culture-537
DR Cosmic; 1020267
RX PubMed=10918183;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-558
AC CVCL_DG41
SY UACC 558; UACC558; University of Arizona Cell Culture-558
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-608
AC CVCL_4048
SY UACC 608; UACC608; University of Arizona Cell Culture-608
RX PubMed=1371813;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-62
AC CVCL_1780
SY UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62
DR BTO; BTO:0004152
DR EFO; EFO_0005377
DR BioSample; SAMN03473228
DR CCLE; UACC62_SKIN
DR ChEMBL-Cells; CHEMBL3307660
DR ChEMBL-Targets; CHEMBL614610
DR Cosmic; 686477
DR Cosmic; 687447
DR Cosmic; 875888
DR Cosmic; 897469
DR Cosmic; 905976
DR Cosmic; 974067
DR Cosmic; 974260
DR Cosmic; 1044267
DR Cosmic; 1092646
DR Cosmic; 1132590
DR Cosmic; 1175875
DR Cosmic; 1303059
DR Cosmic; 1305371
DR Cosmic; 1312352
DR Cosmic; 1537484
DR Cosmic; 1888915
DR Cosmic; 1998489
DR Cosmic-CLP; 905976
DR GDSC; 905976
DR GEO; GSM50208
DR GEO; GSM50271
DR GEO; GSM188229
DR GEO; GSM188259
DR GEO; GSM188318
DR GEO; GSM750828
DR GEO; GSM799360
DR GEO; GSM799423
DR GEO; GSM847168
DR GEO; GSM844722
DR GEO; GSM887726
DR GEO; GSM888820
DR GEO; GSM1153431
DR GEO; GSM1181275
DR GEO; GSM1181277
DR GEO; GSM1670562
DR SKY/M-FISH/CGH; 2827
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19727395;
RX PubMed=20041153;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=49
WW http://www.addexbio.com/productdetail?pid=414
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 31.3 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9,12
ST D18S51: 15
ST D19S433: 15
ST D21S11: 28,31
ST D2S1338: 18,20
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 8,11
ST D8S1179: 10,13
ST FGA: 23
ST Penta D: 11,12
ST Penta E: 5,14
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID UACC-647
AC CVCL_4049
SY UACC 647; UACC647; University of Arizona Cell Culture-647
DR BTO; BTO:0005063
DR Cosmic; 1020270
RX PubMed=10952317;
RX PubMed=23039341;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-732
AC CVCL_4050
SY UACC 732; UACC732; University of Arizona Cell Culture-732
DR ATCC; CRL-3166
DR Cosmic; 1348960
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 9,10
ST D5S818: 13,14
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-793
AC CVCL_S731
SY UACC 793; UACC793; University of Arizona Cell Culture-793
DR Cosmic; 1020268
RX PubMed=10918183;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UACC-812
AC CVCL_1781
SY UACC 812; UACC812; University of Arizona Cell Culture-812
DR CLO; CLO_0009467
DR EFO; EFO_0001258
DR ATCC; CRL-1897
DR BioSample; SAMN03471261
DR BioSample; SAMN03471377
DR CCLE; UACC812_BREAST
DR CCRID; 3111C0001CCC000119
DR ChEMBL-Cells; CHEMBL3308475
DR ChEMBL-Targets; CHEMBL1075604
DR Cosmic; 687501
DR Cosmic; 871158
DR Cosmic; 894093
DR Cosmic; 904396
DR Cosmic; 910910
DR Cosmic; 997926
DR Cosmic; 1046963
DR Cosmic; 1136361
DR Cosmic; 1287902
DR Cosmic; 1289419
DR Cosmic; 1523774
DR Cosmic; 1603227
DR Cosmic; 2165014
DR Cosmic-CLP; 910910
DR GDSC; 910910
DR GEO; GSM1717
DR GEO; GSM73722
DR GEO; GSM115104
DR GEO; GSM217606
DR GEO; GSM344359
DR GEO; GSM344409
DR GEO; GSM350516
DR GEO; GSM481327
DR GEO; GSM783969
DR GEO; GSM847441
DR GEO; GSM847508
DR GEO; GSM844723
DR GEO; GSM887727
DR GEO; GSM888821
DR GEO; GSM1008920
DR GEO; GSM1215270
DR GEO; GSM1670563
DR IGRhCellID; UACC812
DR LINCS; 50556
RX PubMed=1674877;
RX PubMed=10862037;
RX PubMed=12353263;
RX PubMed=12800145;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 100 hours (PubMed=1674877).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 8,11
ST D18S51: 14,20
ST D21S11: 29,32.2
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 9,12 (ATCC; Cosmic-CLP)
ST D7S820: 9 (PubMed=25877200)
ST D8S1179: 12,15
ST FGA: 25
ST Penta D: 10,11
ST Penta E: 14,18
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-827
AC CVCL_4051
SY UACC 827; UACC827; University of Arizona Cell Culture-827
RX PubMed=1371813;
RX PubMed=10952317;
RX PubMed=12115485;
RX PubMed=19383853;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-893
AC CVCL_1782
SY UACC 893; UACC893; University of Arizona Cell Culture-893
DR BTO; BTO:0003443
DR CLO; CLO_0009468
DR EFO; EFO_0002385
DR ATCC; CRL-1902
DR BioSample; SAMN03472115
DR CCLE; UACC893_BREAST
DR ChEMBL-Cells; CHEMBL3308807
DR ChEMBL-Targets; CHEMBL1075605
DR Cosmic; 687502
DR Cosmic; 871151
DR Cosmic; 894092
DR Cosmic; 897416
DR Cosmic; 904397
DR Cosmic; 909778
DR Cosmic; 1017162
DR Cosmic; 1018469
DR Cosmic; 1046943
DR Cosmic; 1044233
DR Cosmic; 1047718
DR Cosmic; 1136362
DR Cosmic; 1287903
DR Cosmic; 1289420
DR Cosmic; 1523773
DR Cosmic; 1603228
DR Cosmic; 2165015
DR Cosmic-CLP; 909778
DR GDSC; 909778
DR GEO; GSM69197
DR GEO; GSM73728
DR GEO; GSM344384
DR GEO; GSM344434
DR GEO; GSM350529
DR GEO; GSM481326
DR GEO; GSM783959
DR GEO; GSM887728
DR GEO; GSM888822
DR GEO; GSM1215273
DR GEO; GSM1670564
DR IGRhCellID; UACC893
DR LINCS; 50557
RX PubMed=1674877;
RX PubMed=9778046;
RX PubMed=10862037;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 120 hours (PubMed=1674877).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 9,13
ST D18S51: 17,18
ST D21S11: 28,30.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 13
ST FGA: 22,25
ST Penta D: 9,12
ST Penta E: 13,17
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UACC-903
AC CVCL_4052
SY UACC 903; UACC903; University of Arizona Cell Culture-903
DR BTO; BTO:0005060
DR ChEMBL-Cells; CHEMBL3307961
DR ChEMBL-Targets; CHEMBL612446
DR Cosmic; 706103
DR Cosmic; 888843
DR Cosmic; 897489
DR Cosmic; 905860
DR Cosmic; 1020269
DR Lonza; 39
RX PubMed=2068080;
RX PubMed=2300817;
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=10952317;
RX PubMed=12115485;
RX PubMed=15009714;
RX PubMed=19383853;
RX PubMed=23039341;
RX PubMed=24879157;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-91
AC CVCL_M447
SY UACC 91; UACC91; UACC-091; UACC 091; UACC091; University of Arizona Cell Culture-91
DR BTO; BTO:0005899
RX PubMed=2300817;
RX PubMed=10952317;
RX PubMed=23039341;
RX PubMed=24879157;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-929
AC CVCL_M459
SY UACC 929; UACC929; University of Arizona Cell Culture-929
RX PubMed=19383853;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UACC-930
AC CVCL_4053
SY UACC 930; UACC930; University of Arizona Cell Culture-930
RX PubMed=10952317;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UAMS-32
AC CVCL_D624
SY UAMS32
DR BTO; BTO:0005307
RX PubMed=10383440;
CC Breed/subspecies: SAMR1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID UAMS-33
AC CVCL_D625
SY U-33
RX PubMed=10412038;
CC Breed/subspecies: SAMR1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID UB/OC-1
AC CVCL_9636
SY University Bristol/Organ of Corti-1; UBOC-1; UBOC1
DR EFO; EFO_0001259
RX PubMed=9753783;
RX PubMed=12382283;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UB/OC-2
AC CVCL_D790
SY University Bristol/Organ of Corti-2
RX PubMed=9753783;
RX PubMed=12382283;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UB/UE-1
AC CVCL_D807
RX PubMed=10531448;
RX PubMed=12382283;
WW http://www.fusioniplicensing.co.uk/NR/rdonlyres/36B43469-4160-423C-A438-421D3395BB0E/0/Materialsalesopportunity27008C.pdf
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID UBE6T-15
AC CVCL_3222
SY UBET-15
DR CLO; CLO_0051558
DR BioSample; SAMN03472472
DR JCRB; JCRB1159
DR JCRB; NIHS0456
DR RCB; RCB2162
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
CC Discontinued: JCRB; NIHS0456; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Telomerase immortalized cell line
//
ID UBE6T-6
AC CVCL_3223
SY UBET-6
DR CLO; CLO_0051552
DR JCRB; JCRB1140
DR JCRB; NIHS0450
DR RCB; RCB2156
RX PubMed=15923633;
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
CC Discontinued: JCRB; NIHS0450; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Telomerase immortalized cell line
//
ID UBE6T-7
AC CVCL_3224
SY UBET-7
DR CLO; CLO_0051553
DR BioSample; SAMN03472463
DR JCRB; JCRB1143
DR JCRB; NIHS0451
DR RCB; RCB2157
RX PubMed=15293342;
RX PubMed=15923633;
RX PubMed=21155951;
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
CC Discontinued: JCRB; NIHS0451; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Telomerase immortalized cell line
//
ID UBE6T-8
AC CVCL_6F33
SY UBET-8
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Telomerase immortalized cell line
//
ID UBM12218693
AC CVCL_F586
SY TER291; TER371; TER451
DR IMGT/HLA; 11509
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UBM13129406
AC CVCL_F587
SY 29036; TER185; TER352
DR IMGT/HLA; 11510
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UBT-10
AC CVCL_6F38
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Telomerase immortalized cell line
//
ID UBT-14
AC CVCL_B971
SY UBT-15
RX PubMed=15923633;
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Telomerase immortalized cell line
//
ID UBT-5
AC CVCL_B972
RX PubMed=15293342;
RX PubMed=15923633;
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Telomerase immortalized cell line
//
ID UC 729-6
AC CVCL_D039
SY UC729-6; UC729.6
DR ATCC; CRL-8061
RX DOI=10.1007/BF01404489;
RX Patent=US4451570;
RX PubMed=6604917;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-447.html
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-8061; probable.
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID UC-11MG
AC CVCL_M421
SY UC-11 MG; UC11MG
RX PubMed=2566365;
RX PubMed=3007688;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UC-302MG
AC CVCL_M422
RX PubMed=3007688;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UC10-4F10-11
AC CVCL_8977
DR CLO; CLO_0009469
DR ATCC; HB-304
RX PubMed=7882171;
CC Monoclonal antibody target: UniProtKB; P09793; Mouse Ctla4/Cd152.
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID UC11
AC CVCL_M872
SY UC 11
DR ATCC; HB-9756
RX Patent=US5292667;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID UC1B
AC CVCL_6462
DR CLO; CLO_0009470
DR ATCC; CRL-6465
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Spontaneously immortalized cell line
//
ID UC1BC1
AC CVCL_6463
DR CLO; CLO_0009471
DR ATCC; CRL-6460
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6460; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6462 ! UC1B
CA Spontaneously immortalized cell line
//
ID UC1BC2
AC CVCL_6464
DR CLO; CLO_0009472
DR ATCC; CRL-6461
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6461; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6462 ! UC1B
CA Spontaneously immortalized cell line
//
ID UC1BC3
AC CVCL_6465
DR CLO; CLO_0009473
DR ATCC; CRL-6462
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6462; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6462 ! UC1B
CA Spontaneously immortalized cell line
//
ID UC1BC4
AC CVCL_6466
DR CLO; CLO_0009474
DR ATCC; CRL-6463
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6463; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6462 ! UC1B
CA Spontaneously immortalized cell line
//
ID UC1BC5
AC CVCL_6467
DR CLO; CLO_0009475
DR ATCC; CRL-6464
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6464; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6462 ! UC1B
CA Spontaneously immortalized cell line
//
ID UC3-10A6
AC CVCL_8978
DR CLO; CLO_0009476
DR ATCC; CRL-1988
RX PubMed=7882171;
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID UC7
AC CVCL_F801
SY UC 7
DR CLO; CLO_0009477
DR ATCC; HB-9753
RX Patent=US5292667;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID UC7-13D5
AC CVCL_8979
DR CLO; CLO_0009478
DR ATCC; CRL-1989
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID UC701
AC CVCL_3225
DR JCRB; JCRB1218
DR JCRB; NIHS0549
CC Discontinued: JCRB; NIHS0549; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,10
ST D16S539: 10,11
ST D5S818: 10,11
ST D7S820: 8,12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID UC702
AC CVCL_3226
DR BioSample; SAMN03472445
DR JCRB; JCRB1220
DR JCRB; NIHS0550
CC Discontinued: JCRB; NIHS0550; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID UC704
AC CVCL_3227
DR BioSample; SAMN03472447
DR JCRB; JCRB1224
DR JCRB; NIHS0551
CC Discontinued: JCRB; NIHS0551; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 10,12
ST D16S539: 9,11
ST D5S818: 8,13
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 9,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID UC705
AC CVCL_8315
DR JCRB; JCRB1227
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID UC706
AC CVCL_T842
DR SKIP; SKIP000169
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID UC8-1B9
AC CVCL_8980
SY UC81B9
DR CLO; CLO_0009479
DR ATCC; CRL-1968
CC Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl (DNP).
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID UCA
AC CVCL_1M77
SY GM08604
DR CLO; CLO_0010608
DR Coriell; GM08604
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UCB302MSCs
AC CVCL_3228
SY UCB302
DR BioSample; SAMN03472509
DR JCRB; JCRB1106
DR JCRB; NIHS0410
DR SKIP; SKIP000284
RX PubMed=21155951;
CC Discontinued: JCRB; NIHS0410; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 10,12
ST D16S539: 11
ST D5S818: 12,14
ST D7S820: 10
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID UCB408E6E7-31
AC CVCL_3229
DR BioSample; SAMN03472450
DR JCRB; JCRB1108
DR JCRB; NIHS0412
DR SKIP; SKIP000286
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0412; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 9,10
ST D5S818: 9,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3231 ! UCB408E6E7TERT-33
OI CVCL_3230 ! UCB408E7-32
OI CVCL_4W85 ! UCB408E7TERT-34
SX Male
CA Transformed cell line
//
ID UCB408E6E7TERT-33
AC CVCL_3231
DR CLO; CLO_0050434
DR JCRB; JCRB1110
DR JCRB; NIHS0414
DR RCB; RCB2080
DR SKIP; SKIP000288
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0414; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 9,10
ST D5S818: 9,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3229 ! UCB408E6E7-31
OI CVCL_3230 ! UCB408E7-32
OI CVCL_4W85 ! UCB408E7TERT-34
SX Male
CA Transformed cell line
//
ID UCB408E7-32
AC CVCL_3230
DR JCRB; JCRB1109
DR JCRB; NIHS0413
DR SKIP; SKIP000287
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
CC Discontinued: JCRB; NIHS0413; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 9,10
ST D5S818: 9,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3229 ! UCB408E6E7-31
OI CVCL_3231 ! UCB408E6E7TERT-33
OI CVCL_4W85 ! UCB408E7TERT-34
SX Male
CA Transformed cell line
//
ID UCB408E7TERT-34
AC CVCL_4W85
SY UCB408E7-TERT34
DR JCRB; JCRB1546
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 9,10
ST D5S818: 9,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3229 ! UCB408E6E7-31
OI CVCL_3231 ! UCB408E6E7TERT-33
OI CVCL_3230 ! UCB408E7-32
SX Male
CA Transformed cell line
//
ID UCBiPS7
AC CVCL_0H61
DR SKIP; SKIP000585
RX PubMed=23326500;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID UCBTERT-21
AC CVCL_3232
SY UCB-TERT-21
DR CLO; CLO_0050433
DR BioSample; SAMN01821720
DR JCRB; JCRB1107
DR JCRB; NIHS0411
DR RCB; RCB2079
DR SKIP; SKIP000285
RX PubMed=15647378;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0411; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 10,12
ST D16S539: 11
ST D5S818: 12,14
ST D7S820: 10
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID UCCA-21
AC CVCL_W502
RX PubMed=15016319;
CC Doubling time: 63.6 hours (PubMed=15016319).
CC Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W503 ! UCCA-22
OI CVCL_W504 ! UCCA-23
OI CVCL_W505 ! UCCA-24
OI CVCL_W506 ! UCCA-25
SX Female
CA Cancer cell line
//
ID UCCA-22
AC CVCL_W503
RX PubMed=15016319;
CC Doubling time: 43.8 hours (PubMed=15016319).
CC Microsatellite instability: Stable (MSS) (PubMed=15016319).
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W502 ! UCCA-21
OI CVCL_W504 ! UCCA-23
OI CVCL_W505 ! UCCA-24
OI CVCL_W506 ! UCCA-25
SX Female
CA Cancer cell line
//
ID UCCA-23
AC CVCL_W504
RX PubMed=15016319;
CC Doubling time: 44.4 hours (PubMed=15016319).
CC Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W502 ! UCCA-21
OI CVCL_W503 ! UCCA-22
OI CVCL_W505 ! UCCA-24
OI CVCL_W506 ! UCCA-25
SX Female
CA Cancer cell line
//
ID UCCA-24
AC CVCL_W505
RX PubMed=15016319;
CC Doubling time: 37.3 hours (PubMed=15016319).
CC Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W502 ! UCCA-21
OI CVCL_W503 ! UCCA-22
OI CVCL_W504 ! UCCA-23
OI CVCL_W506 ! UCCA-25
SX Female
CA Cancer cell line
//
ID UCCA-25
AC CVCL_W506
RX PubMed=15016319;
CC Doubling time: 40.5 hours (PubMed=15016319).
CC Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W502 ! UCCA-21
OI CVCL_W503 ! UCCA-22
OI CVCL_W504 ! UCCA-23
OI CVCL_W505 ! UCCA-24
SX Female
CA Cancer cell line
//
ID UCCA-3
AC CVCL_W507
RX PubMed=15016319;
CC Doubling time: 56.9 hours (PubMed=15016319).
CC Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCD-Dm-mei-218-1
AC CVCL_Z920
SY mei-218-1; mei-218
RX DOI=10.1016/B978-012229460-0/50004-X;
RX DOI=10.1007/BF02618446;
RX PubMed=826452;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCD-Dm-mei-41-1
AC CVCL_Z921
SY mei-41-1
RX DOI=10.1016/B978-012229460-0/50004-X;
RX DOI=10.1007/BF02618446;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCD-Dm-mei-9-1
AC CVCL_Z922
SY mei-9-1; mei-9a-1
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=826452;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCD-Dm-mei-9-2
AC CVCL_Z923
SY UCD Dm mei-9-2; mei-9-2; mei-9a-2; Mei9a
DR ECACC; 90070553
RX DOI=10.1016/B978-012229460-0/50004-X;
RX DOI=10.1007/BF02618446;
RX PubMed=826452;
RX PubMed=3141801;
CC Group: Insect cell line.
CC Caution: It is uncertain whether ECACC Mei9a is UCD-Dm-mei-9-2 or UCD-Dm-mei-9-1. We believe it is the first one based on its use by many investigators.
CC Discontinued: ECACC; 90070553; probable.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCD-Dm-mus103-1
AC CVCL_Z924
SY mus103-1
RX DOI=10.1016/B978-012229460-0/50004-X;
RX DOI=10.1007/BF02618446;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCD-Dm-mus104-1
AC CVCL_Z925
SY mus104-1
RX DOI=10.1007/BF02618446;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCD-Dm-w-1
AC CVCL_Z873
SY w-1
RX DOI=10.1016/B978-012229460-0/50004-X;
RX DOI=10.1007/BF02618446;
RX PubMed=826452;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCD/AB 6.01
AC CVCL_F802
SY UCD/AB6.01
DR CLO; CLO_0009480
DR ATCC; HB-8693
RX Patent=US4775620;
CC Monoclonal antibody target: UniProtKB; P05787; Human KRT8.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID UCD/AB 6.11
AC CVCL_F803
DR CLO; CLO_0009481
DR ATCC; HB-8458
RX Patent=US4775620;
CC Discontinued: ATCC; HB-8458; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID UCD/PR 10.11
AC CVCL_F804
SY UCD/PR10.11
DR CLO; CLO_0009482
DR ATCC; HB-8694
RX Patent=US4775620;
CC Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
CC Monoclonal antibody target: UniProtKB; P05787; Human KRT8.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID UCDK9B1
AC CVCL_GY10
RX PubMed=22136758;
CC Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a female Bullmastiff.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID UCDK9B2
AC CVCL_GY11
RX PubMed=22136758;
CC Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male German Shorthaired Pointer.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID UCDK9B3
AC CVCL_GY12
RX PubMed=22136758;
CC Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male Labrador Retriever.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID UCDK9B4
AC CVCL_GY13
RX PubMed=22136758;
CC Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male Basset Hound.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID UCDK9B5
AC CVCL_GY14
RX PubMed=22136758;
CC Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male Greyhound.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID UCDK9M1
AC CVCL_0C77
RX PubMed=21722969;
RX PubMed=22901430;
CC Miscellaneous: Breed and gender from personal communication of Kent M.S.
CC Derived from metastatic site: Skin.
CC Breed/subspecies: Miniature Poodle.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID UCDK9M2
AC CVCL_0C78
RX PubMed=21722969;
RX PubMed=22901430;
CC Miscellaneous: Breed and gender from personal communication of Kent M.S.
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: Irish Terrier.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID UCDK9M3
AC CVCL_0C79
RX PubMed=21722969;
RX PubMed=22901430;
CC Miscellaneous: Breed and gender from personal communication of Kent M.S.
CC Breed/subspecies: Springer Spaniel x Chow.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID UCDK9M4
AC CVCL_0C80
RX PubMed=21722969;
RX PubMed=22901430;
CC Miscellaneous: Breed and gender from personal communication of Kent M.S.
CC Breed/subspecies: German Shorthaired Pointer.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID UCDK9M5
AC CVCL_0C81
RX PubMed=21722969;
RX PubMed=22901430;
CC Miscellaneous: Breed and gender from personal communication of Kent M.S.
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: Cocker Spaniel.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID UCH1
AC CVCL_4991
DR Cosmic; 1529013
RX PubMed=17454636;
DI NCIt; C4341; Marginal zone lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UCHCC1
AC CVCL_9W59
RX Patent=US8337829;
RX PubMed=2418922;
CC Transformant: Unknown product of UCHT1 (CVCL_9W35) conditioned media.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID UCHT1
AC CVCL_9W35
RX Patent=US8337829;
RX PubMed=954652;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2535.
CC Doubling time: ~24 hours (PubMed=954652).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60369; Rat C-cell carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID UCI 101
AC CVCL_5380
SY UCI-101; UCI101
DR BTO; BTO:0002630
RX PubMed=8428692;
RX PubMed=11314036;
RX PubMed=12080474;
RX PubMed=15677628;
CC Microsatellite instability: Instable (MSI) (PubMed=15677628).
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCI 107
AC CVCL_5381
SY UCI-107; UCI107
DR BTO; BTO:0004036
DR Cosmic; 1113281
DR GEO; GSM459738
RX PubMed=7672698;
RX PubMed=11314036;
RX PubMed=12080474;
RX PubMed=15677628;
CC Microsatellite instability: Instable (MSI) (PubMed=15677628).
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCI-VULV-1
AC CVCL_S961
RX PubMed=7729733;
CC Doubling time: 60 hours (PubMed=7729733).
CC Derived from metastatic site: Lymph node.
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCLA # 1
AC CVCL_M586
RX PubMed=9639523;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID UCLA 1
AC CVCL_9951
SY UCLA1
DR ISCR; 1412
RX PubMed=22058289;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=395
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0058.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCLA 10
AC CVCL_9952
DR ISCR; 1902
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=494
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0146.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID UCLA 11
AC CVCL_C941
DR ISCR; 2240
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=576
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0185.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 12
AC CVCL_C942
DR ISCR; 2241
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=577
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0186.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 13
AC CVCL_W013
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=689
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0293.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 14
AC CVCL_W014
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=690
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0294.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 15
AC CVCL_W015
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=691
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0295.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 16
AC CVCL_W016
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=692
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0296.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 17
AC CVCL_W017
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=707
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0297.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 18
AC CVCL_W018
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=708
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0298.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 19n
AC CVCL_IS73
SY UCLA19n
RX PubMed=26853856;
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 20n
AC CVCL_IS74
SY UCLA20n
RX PubMed=26853856;
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCLA 2
AC CVCL_9953
SY UCLA2
DR ISCR; 1413
RX PubMed=22058289;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=396
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0059.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID UCLA 3
AC CVCL_9954
SY UCLA3
DR ISCR; 1414
RX PubMed=22058289;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=397
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0060.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCLA 4
AC CVCL_9955
SY UCLA4
DR ISCR; 1774
RX PubMed=22058289;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=462
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0087.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCLA 5
AC CVCL_9956
SY UCLA5
DR ISCR; 1775
RX PubMed=22058289;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=463
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0088.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCLA 6
AC CVCL_9957
SY UCLA6
DR ISCR; 1776
RX PubMed=22058289;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=464
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0089.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID UCLA 7
AC CVCL_9958
DR ISCR; 1903
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=491
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0143.
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCLA 8
AC CVCL_9959
DR ISCR; 1904
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=492
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0144.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCLA 9
AC CVCL_9960
DR ISCR; 1905
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=493
CC From: University of California, Los Angeles; Los Angeles; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0145.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCLA-P3
AC CVCL_N513
AS CVCL_7211
SY UCLA P3; UCLA P-3; UCP-3; UCP3
DR BTO; BTO:0004841
DR ChEMBL-Cells; CHEMBL3307243
DR ChEMBL-Targets; CHEMBL612797
RX PubMed=3596831;
RX PubMed=6362852;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCLC11
AC CVCL_S741
SY UCLC-11
DR Cosmic; 844588
DR Cosmic; 877399
DR Cosmic; 1152494
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UCLi001-A
AC CVCL_9S54
SY HHItC9S-V19
DR BioSamples; SAMEA3174455
DR EBiSC; UCLi001-A
DR ECACC; 66540028
DR hPSCreg; UCLi001-A
CC From: University College London; London; UK.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCLi002-A
AC CVCL_9S55
SY HHItC9D-V34; DN19
DR BioSamples; SAMEA3174461
DR EBiSC; UCLi002-A
DR ECACC; 66540029
DR hPSCreg; UCLi002-A
CC From: University College London; London; UK.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCLi003-A
AC CVCL_9S56
SY TSM(Exon10+16)V97
DR BioSamples; SAMEA3174519
DR EBiSC; UCLi003-A
DR ECACC; 66540027
DR hPSCreg; UCLi003-A
CC From: University College London; London; UK.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCLi004-A
AC CVCL_II89
SY RCi173; RCFB60c6
DR BioSamples; SAMEA3964268
DR EBiSC; UCLi004-A
DR ECACC; 66540123
CC From: University College London; London; UK.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE26 ! UCLi004-B
OI CVCL_II90 ! UCLi004-C
SX Male
CA Induced pluripotent stem cell
//
ID UCLi004-B
AC CVCL_EE26
SY RCi177; RCFB60c7
DR BioSamples; SAMEA4084285
DR EBiSC; UCLi004-B
DR ECACC; 66540154
CC From: University College London; London; UK.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_II89 ! UCLi004-A
OI CVCL_II90 ! UCLi004-C
SX Male
CA Induced pluripotent stem cell
//
ID UCLi004-C
AC CVCL_II90
SY RCi172; RCFB60c2
DR BioSamples; SAMEA4085372
DR EBiSC; UCLi004-C
DR ECACC; 66540165
CC From: University College London; London; UK.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_II89 ! UCLi004-A
OI CVCL_EE26 ! UCLi004-B
SX Male
CA Induced pluripotent stem cell
//
ID UCLi005-A
AC CVCL_9S57
SY LGMD2D #4; LGMD2D Pt. 4; LGMD2D Pt.4
DR hPSCreg; UCLi005-A
RX PubMed=22745439;
CC From: University College London; London; UK.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCO-Mel-2
AC CVCL_C264
SY UCO-Mel2
DR ESTDAB; ESTDAB-188
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCONN-L2
AC CVCL_A693
SY UCONN-2
DR Cosmic; 1086005
DR Cosmic; 1086368
DR Cosmic; 1152616
RX PubMed=15356658;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID UCR-SE-1
AC CVCL_Z311
SY UCR-Se-1
RX DOI=10.1016/0022-2011(86)90124-2;
RX PubMed=1367489;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCR-SE-1a
AC CVCL_Z312
SY UCR-SE-1A; UCR-SE1a; SE-UCR-1A
RX DOI=10.1016/0022-1910(94)90067-1;
RX PubMed=1367489;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
HI CVCL_Z311 ! UCR-SE-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCR-SE-1C
AC CVCL_Z313
RX PubMed=8799737;
RX DOI=10.3923/jas.2007.4040.4043;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
HI CVCL_Z311 ! UCR-SE-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCRU-BL-12
AC CVCL_M874
SY BL-12
DR Cosmic; 735764
RX PubMed=2418959;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UCRU-BL-13
AC CVCL_M873
SY UCRU-BL-13 CL; UCRU BL 13/0; UCRU-BL-13/0 CL; BL-13; BL13
DR Cosmic; 735765
DR Cosmic; 928827
DR Cosmic; 1927310
RX PubMed=2418959;
RX PubMed=2685375;
RX PubMed=2759734;
RX PubMed=8873383;
RX PubMed=9246190;
RX PubMed=23401075;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UCRU-BL-17
AC CVCL_M007
SY UCRU-BL-17-CL; UCRU-BL-17CL; UCRU BL 17CL; UCRU-BL 17; BL-17; BL17
DR Cosmic; 735768
DR Cosmic; 928828
DR Cosmic; 1927311
RX Patent=US5622836;
RX PubMed=2328200;
RX PubMed=2418959;
RX PubMed=2685375;
RX PubMed=3335421;
RX PubMed=8635192;
RX PubMed=8873383;
RX PubMed=9246190;
RX PubMed=23401075;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCRU-BL-23
AC CVCL_M008
SY UCRU-BL-23/3; BL-23; BL23; UCRU-BL-17/23alpha
DR Cosmic; 735773
RX Patent=US5622836;
RX PubMed=2685375;
RX PubMed=8635192;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M007 ! UCRU-BL-17
SX Female
CA Cancer cell line
//
ID UCRU-BL-28
AC CVCL_4904
SY UCRU-BL 28; BL-28; BL28
DR Cosmic; 735774
DR Cosmic; 928829
DR Cosmic; 1927312
RX PubMed=8345582;
RX PubMed=8873383;
RX PubMed=9246190;
RX PubMed=23401075;
CC Misspelling: 'BL-128' in Cosmic 1927312.
CC Misspelling: 'BL128' in PubMed=23401075.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UCRU-Pr-2
AC CVCL_4905
SY UCRU-PR-2
RX PubMed=2833415;
WW http://capcelllines.ca/details.asp?id=115
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UCS
AC CVCL_1G59
SY Ussuri Catfish Skin
RX PubMed=24794839;
CC Group: Fish cell line.
OX NCBI_TaxID=78871; ! Tachysurus ussuriensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UCS-2
AC CVCL_W508
RX PubMed=12237927;
DI NCIt; C9118; Sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UCS-4
AC CVCL_W509
RX PubMed=12237927;
CC Derived from metastatic site: Lung.
DI NCIt; C9118; Sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UCS-5
AC CVCL_W510
RX PubMed=12237927;
CC Derived from metastatic site: Lung.
DI NCIt; C9118; Sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCSD-242L
AC CVCL_M009
SY UCSD-242l; UCSD 242L
DR EFO; EFO_0006769
DR BioSample; SAMN03473115
DR Cosmic; 1303060
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,10
ST D16S539: 9,12,13
ST D18S51: 14,16
ST D21S11: 28,31.2
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 10,12
ST FGA: 20,21,23
ST Penta D: 10,12
ST Penta E: 8,10
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UCSD-354L
AC CVCL_M010
SY UCSD 354L
DR Cosmic; 1303061
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UCSD-AML1
AC CVCL_1853
SY UCSD/AML1; UCSD/AML-1; UCSD/AML 1
DR BioSample; SAMN03473441
DR Cosmic; 787484
DR Cosmic; 975308
DR Cosmic; 1281358
DR Cosmic; 2306242
DR Cosmic; 2378089
DR DSMZ; ACC-691
CC Doubling time: ~50-60 hours (DSMZ).
CC Misspelling: 'UCSC-AML1' in Cosmic 1281358.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 8,12
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCSD001i-5-1
AC CVCL_EM44
SY NextGen_5_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD001i-5-1.cmsx
WW http://shared.eagle-i.net/i/00000150-71d8-e25b-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34449; Hypertrophic cardiomyopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD002i-16-1
AC CVCL_EM45
SY NextGen_16_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD002i-16-1.cmsx
WW http://shared.eagle-i.net/i/00000150-81f2-270b-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD003i-16-2
AC CVCL_EM46
SY NextGen_16_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD003i-16-2.cmsx
WW http://shared.eagle-i.net/i/00000150-81f5-cd58-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C84735; Glycogen storage disease type IIb
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD004i-42-1
AC CVCL_EM47
SY NextGen_42_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD004i-42-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a57c-9429-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C99544; Left ventricular non-compaction syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD005i-43-1
AC CVCL_EM48
SY NextGen_43_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD005i-43-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a59c-95e4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C99544; Left ventricular non-compaction syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD006i-21-1
AC CVCL_EM49
SY NextGen_21_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD006i-21-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9058-9935-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD007i-21-2
AC CVCL_EM50
SY NextGen_21_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD007i-21-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9068-a878-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD008i-44-1
AC CVCL_EM51
SY NextGen_44_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD008i-44-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a59e-a357-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C99544; Left ventricular non-compaction syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD009i-5-2
AC CVCL_EM52
SY NextGen_5_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD009i-5-2.cmsx
WW http://shared.eagle-i.net/i/00000150-7211-7dfa-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD010i-5-3
AC CVCL_EM53
SY NextGen_5_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD010i-5-3.cmsx
WW http://shared.eagle-i.net/i/00000150-721e-80a2-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD011i-5-4
AC CVCL_EM54
SY NextGen_5_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD011i-5-4.cmsx
WW http://shared.eagle-i.net/i/00000150-7225-aaa9-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD012i-5-5
AC CVCL_EM55
SY NextGen_5_5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD012i-5-5.cmsx
WW http://shared.eagle-i.net/i/00000150-7234-a6a9-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD013i-16-3
AC CVCL_EM56
SY NextGen_16_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD013i-16-3.cmsx
WW http://shared.eagle-i.net/i/00000150-81d6-bcfb-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C84735; Glycogen storage disease type IIb
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD014i-21-3
AC CVCL_EM57
SY NextGen_21_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD014i-21-3.cmsx
WW http://shared.eagle-i.net/i/00000150-9080-3509-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C84673; Dilated cardiomyopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD015i-3-3
AC CVCL_EM58
SY NextGen_3_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD015i-3-3.cmsx
WW http://shared.eagle-i.net/i/00000150-6d6e-bd21-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD016i-3-4
AC CVCL_EM59
SY NextGen_3_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD016i-3-4.cmsx
WW http://shared.eagle-i.net/i/00000150-715f-35bc-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD017i-3-5
AC CVCL_EM60
SY NextGen_3_5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD017i-3-5.cmsx
WW http://shared.eagle-i.net/i/00000150-7174-e91d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD018i-3-6
AC CVCL_EM61
SY NextGen_3_6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD018i-3-6.cmsx
WW http://shared.eagle-i.net/i/00000150-717f-ba8e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD019i-3-7
AC CVCL_EM62
SY NextGen_3_7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD019i-3-7.cmsx
WW http://shared.eagle-i.net/i/00000150-71bf-4a09-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD020i-3-8
AC CVCL_EM63
SY NextGen_3_8
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD020i-3-8.cmsx
WW http://shared.eagle-i.net/i/00000150-718a-7c5c-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD021i-3-9
AC CVCL_EM64
SY NextGen_3_9
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD021i-3-9.cmsx
WW http://shared.eagle-i.net/i/00000150-71bb-1862-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD022i-8-3
AC CVCL_EM65
SY NextGen_8_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD022i-8-3.cmsx
WW http://shared.eagle-i.net/i/00000150-8104-0cbd-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD023i-8-4
AC CVCL_EM66
SY NextGen_8_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD023i-8-4.cmsx
WW http://shared.eagle-i.net/i/00000150-80ff-7208-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD024i-13-3
AC CVCL_EM67
SY NextGen_13_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD024i-13-3.cmsx
WW http://shared.eagle-i.net/i/00000150-81b4-2131-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD025i-13-4
AC CVCL_EM68
SY NextGen_13_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD025i-13-4.cmsx
WW http://shared.eagle-i.net/i/00000150-81b0-bf98-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD026i-9-1
AC CVCL_EM69
SY NextGen_9_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD026i-9-1.cmsx
WW http://shared.eagle-i.net/i/00000150-810e-a070-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD027i-9-2
AC CVCL_EM70
SY NextGen_9_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD027i-9-2.cmsx
WW http://shared.eagle-i.net/i/00000150-8112-1735-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD028i-9-3
AC CVCL_EM71
SY NextGen_9_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD028i-9-3.cmsx
WW http://shared.eagle-i.net/i/00000150-8119-f549-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD029i-9-4
AC CVCL_EM72
SY NextGen_9_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD029i-9-4.cmsx
WW http://shared.eagle-i.net/i/00000150-8120-3467-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD030i-23-2
AC CVCL_EM73
SY NextGen_23_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD030i-23-2.cmsx
WW http://shared.eagle-i.net/i/00000150-90b7-4764-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD031i-45-1
AC CVCL_EM74
SY NextGen_45_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD031i-45-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5b0-e036-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD032i-41-1
AC CVCL_EM75
SY NextGen_41_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD032i-41-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a575-3cf0-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD033i-41-2
AC CVCL_EM76
SY NextGen_41_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD033i-41-2.cmsx
WW http://shared.eagle-i.net/i/00000150-a578-cf16-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD034i-4-3
AC CVCL_EM77
SY NextGen_4_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD034i-4-3.cmsx
WW http://shared.eagle-i.net/i/00000150-71ce-b3a8-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD035i-4-4
AC CVCL_EM78
SY NextGen_4_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD035i-4-4.cmsx
WW http://shared.eagle-i.net/i/00000150-71d2-3cf2-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD036i-4-5
AC CVCL_EM79
SY NextGen_4_5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD036i-4-5.cmsx
WW http://shared.eagle-i.net/i/00000150-71d4-f8fb-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD037i-26-2
AC CVCL_EM80
SY NextGen_26_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD037i-26-2.cmsx
WW http://shared.eagle-i.net/i/00000150-912b-0c15-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD038i-24-2
AC CVCL_EM81
SY NextGen_24_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD038i-24-2.cmsx
WW http://shared.eagle-i.net/i/00000150-90c0-c9ea-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD039i-14-3
AC CVCL_EM82
SY NextGen_14_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD039i-14-3.cmsx
WW http://shared.eagle-i.net/i/00000150-81c0-535e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD040i-33-1
AC CVCL_EM83
SY NextGen_33_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD040i-33-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9639-6274-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD041i-33-2
AC CVCL_EM84
SY NextGen_33_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD041i-33-2.cmsx
WW http://shared.eagle-i.net/i/00000150-963d-797d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD042i-46-1
AC CVCL_EM85
SY NextGen_46_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD042i-46-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5b7-c353-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50802; Ventricular tachycardia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD043i-47-1
AC CVCL_EM86
SY NextGen_47_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD043i-47-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5d4-78ef-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD044i-48-1
AC CVCL_EM87
SY NextGen_48_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD044i-48-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5d8-3fb1-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD045i-49-1
AC CVCL_EM88
SY NextGen_49_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD045i-49-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5dc-82c8-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD046i-50-1
AC CVCL_EM89
SY NextGen_50_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD046i-50-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5df-d802-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD047i-51-1
AC CVCL_EM90
SY NextGen_51_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD047i-51-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5e1-f7db-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD048i-52-1
AC CVCL_EM91
SY NextGen_52_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD048i-52-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a5e5-f551-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C26732; Coronary artery disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD049i-53-1
AC CVCL_EM92
SY NextGen_53_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD049i-53-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a9ee-bf8b-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD050i-54-1
AC CVCL_EM93
SY NextGen_54_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD050i-54-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa5b-cfa6-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD051i-55-1
AC CVCL_EM94
SY NextGen_55_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD051i-55-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa60-36dc-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD052i-56-1
AC CVCL_EM95
SY NextGen_56_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD052i-56-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa62-a613-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD053i-57-1
AC CVCL_EM96
SY NextGen_57_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD053i-57-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa65-aa65-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD054i-58-1
AC CVCL_EM97
SY NextGen_58_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD054i-58-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa69-6720-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD055i-59-1
AC CVCL_EM98
SY NextGen_59_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD055i-59-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa6e-9590-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34830; Cardiomyopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD056i-60-1
AC CVCL_EM99
SY NextGen_60_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD056i-60-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa76-a729-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34830; Cardiomyopathy
DI NCIt; C50802; Ventricular tachycardia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD057i-61-1
AC CVCL_EN00
SY NextGen_61_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD057i-61-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa83-391f-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD058i-62-1
AC CVCL_EN01
SY NextGen_62_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD058i-62-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aa8b-9c34-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50802; Ventricular tachycardia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD059i-63-1
AC CVCL_EN02
SY NextGen_63_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD059i-63-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aaab-acb4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C50466; Atrial fibrillation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD060i-64-1
AC CVCL_EN03
SY NextGen_64_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD060i-64-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aac2-b9cb-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C54936; Premature ventricular contraction adverse event
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD061i-65-1
AC CVCL_EN04
SY NextGen_65_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD061i-65-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aac6-0405-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C3080; Congestive heart failure
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD062i-66-1
AC CVCL_EN05
SY NextGen_66_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD062i-66-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aaca-8c8a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD063i-20-1
AC CVCL_EN06
SY NextGen_20_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD063i-20-1.cmsx
WW http://shared.eagle-i.net/i/00000150-86e5-8b3f-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD064i-20-2
AC CVCL_EN07
SY NextGen_20_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD064i-20-2.cmsx
WW http://shared.eagle-i.net/i/00000150-86f2-4119-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD065i-20-3
AC CVCL_EN08
SY NextGen_20_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD065i-20-3.cmsx
WW http://shared.eagle-i.net/i/00000150-86f9-37ca-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD066i-67-1
AC CVCL_EN09
SY NextGen_67_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD066i-67-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aacd-fc1a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD067i-19-1
AC CVCL_EN10
SY NextGen_19_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD067i-19-1.cmsx
WW http://shared.eagle-i.net/i/00000150-8680-30af-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD068i-19-2
AC CVCL_EN11
SY NextGen_19_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD068i-19-2.cmsx
WW http://shared.eagle-i.net/i/00000150-869d-d452-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD069i-19-3
AC CVCL_EN12
SY NextGen_19_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD069i-19-3.cmsx
WW http://shared.eagle-i.net/i/00000150-86a6-96a1-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD070i-1-1
AC CVCL_EN13
SY NextGen_1_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD070i-1-1.cmsx
WW http://shared.eagle-i.net/i/00000150-6c30-ddaf-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD071i-1-2
AC CVCL_EN14
SY NextGen_1_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD071i-1-2.cmsx
WW http://shared.eagle-i.net/i/00000150-6c6d-0234-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD072i-1-3
AC CVCL_EN15
SY NextGen_1_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD072i-1-3.cmsx
WW http://shared.eagle-i.net/i/00000150-6c7a-ef65-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD073i-1-4
AC CVCL_EN16
SY NextGen_1_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD073i-1-4.cmsx
WW http://shared.eagle-i.net/i/00000150-6812-9962-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD074i-1-5
AC CVCL_EN17
SY NextGen_1_5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD074i-1-5.cmsx
WW http://shared.eagle-i.net/i/00000150-6c90-82e1-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD075i-1-6
AC CVCL_EN18
SY NextGen_1_6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD075i-1-6.cmsx
WW http://shared.eagle-i.net/i/00000150-6c96-54bb-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD076i-1-7
AC CVCL_EN19
SY NextGen_1_7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD076i-1-7.cmsx
WW http://shared.eagle-i.net/i/00000150-6c9a-4330-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD077i-1-8
AC CVCL_EN20
SY NextGen_1_8
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD077i-1-8.cmsx
WW http://shared.eagle-i.net/i/00000150-6c9e-ba19-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD078i-1-9
AC CVCL_EN21
SY NextGen_1_9
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD078i-1-9.cmsx
WW http://shared.eagle-i.net/i/00000150-6ca2-db4d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD079i-1-12
AC CVCL_EN22
SY NextGen_1_12
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD079i-1-12.cmsx
WW http://shared.eagle-i.net/i/00000150-6ca9-3fc3-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD080i-1-13
AC CVCL_EN23
SY NextGen_1_13
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD080i-1-13.cmsx
WW http://shared.eagle-i.net/i/00000150-6cbe-4e86-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD081i-1-14
AC CVCL_EN24
SY NextGen_1_14
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD081i-1-14.cmsx
WW http://shared.eagle-i.net/i/00000150-6cb6-daf3-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD082i-40-1
AC CVCL_EN25
SY NextGen_40_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD082i-40-1.cmsx
WW http://shared.eagle-i.net/i/00000150-a56e-b74a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD083i-40-2
AC CVCL_EN26
SY NextGen_40_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD083i-40-2.cmsx
WW http://shared.eagle-i.net/i/00000150-a572-9029-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD084i-6-1
AC CVCL_EN27
SY NextGen_6_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD084i-6-1.cmsx
WW http://shared.eagle-i.net/i/00000150-7247-eb0f-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD085i-6-2
AC CVCL_EN28
SY NextGen_6_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD085i-6-2.cmsx
WW http://shared.eagle-i.net/i/00000150-724c-8fbc-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD086i-6-3
AC CVCL_EN29
SY NextGen_6_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD086i-6-3.cmsx
WW http://shared.eagle-i.net/i/00000150-724f-7a9d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD087i-6-4
AC CVCL_EN30
SY NextGen_6_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD087i-6-4.cmsx
WW http://shared.eagle-i.net/i/00000150-723d-be75-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD088i-6-5
AC CVCL_EN31
SY NextGen_6_5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD088i-6-5.cmsx
WW http://shared.eagle-i.net/i/00000150-7238-3510-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD089i-15-1
AC CVCL_EN32
SY NextGen_15_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD089i-15-1.cmsx
WW http://shared.eagle-i.net/i/00000150-81cd-7113-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD090i-15-2
AC CVCL_EN33
SY NextGen_15_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD090i-15-2.cmsx
WW http://shared.eagle-i.net/i/00000150-81d0-2a57-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD091i-15-3
AC CVCL_EN34
SY NextGen_15_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD091i-15-3.cmsx
WW http://shared.eagle-i.net/i/00000150-81d4-2730-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD092i-1-10
AC CVCL_EN35
SY NextGen_1_10
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD092i-1-10.cmsx
WW http://shared.eagle-i.net/i/00000150-6cad-981e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD093i-1-11
AC CVCL_EN36
SY NextGen_1_11
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD093i-1-11.cmsx
WW http://shared.eagle-i.net/i/00000150-6cb2-ee42-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD094i-25-1
AC CVCL_EN37
SY NextGen_25_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD094i-25-1.cmsx
WW http://shared.eagle-i.net/i/00000150-90e6-ac34-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD095i-25-2
AC CVCL_EN38
SY NextGen_25_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD095i-25-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9108-d34b-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD096i-34-1
AC CVCL_EN39
SY NextGen_34_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD096i-34-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9641-bef7-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD097i-34-2
AC CVCL_EN40
SY NextGen_34_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD097i-34-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9645-faea-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD098i-35-1
AC CVCL_EN41
SY NextGen_35_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD098i-35-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9652-1fff-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD099i-35-2
AC CVCL_EN42
SY NextGen_35_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD099i-35-2.cmsx
WW http://shared.eagle-i.net/i/00000150-965a-9467-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD100i-36-1
AC CVCL_EN43
SY NextGen_36_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD100i-36-1.cmsx
WW http://shared.eagle-i.net/i/00000150-965f-42e5-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD101i-36-2
AC CVCL_EN44
SY NextGen_36_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD101i-36-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9667-45a2-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD102i-2-1
AC CVCL_EN45
SY NextGen_2_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD102i-2-1.cmsx
WW http://shared.eagle-i.net/i/00000150-6d50-46c7-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD103i-2-2
AC CVCL_EN46
SY NextGen_2_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD103i-2-2.cmsx
WW http://shared.eagle-i.net/i/00000150-6d56-8d15-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD104i-2-3
AC CVCL_EN47
SY NextGen_2_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD104i-2-3.cmsx
WW http://shared.eagle-i.net/i/00000150-6d4b-4969-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD105i-2-4
AC CVCL_EN48
SY NextGen_2_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD105i-2-4.cmsx
WW http://shared.eagle-i.net/i/00000150-6d3c-00df-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD106i-2-5
AC CVCL_EN49
SY NextGen_2_5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD106i-2-5.cmsx
WW http://shared.eagle-i.net/i/00000150-6d27-3737-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD107i-2-6
AC CVCL_EN50
SY NextGen_2_6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD107i-2-6.cmsx
WW http://shared.eagle-i.net/i/00000150-6ce6-a30b-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD108i-2-7
AC CVCL_EN51
SY NextGen_2_7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD108i-2-7.cmsx
WW http://shared.eagle-i.net/i/00000150-6ccd-2f31-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD109i-2-8
AC CVCL_EN52
SY NextGen_2_8
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD109i-2-8.cmsx
WW http://shared.eagle-i.net/i/00000150-6d1d-68da-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD110i-2-9
AC CVCL_EN53
SY NextGen_2_9
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD110i-2-9.cmsx
WW http://shared.eagle-i.net/i/00000150-6cef-6c41-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD111i-2-10
AC CVCL_EN54
SY NextGen_2_10
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD111i-2-10.cmsx
WW http://shared.eagle-i.net/i/00000150-6d11-5b3c-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD112i-2-11
AC CVCL_EN55
SY NextGen_2_11
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD112i-2-11.cmsx
WW http://shared.eagle-i.net/i/00000150-6cf8-8315-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD113i-68-1
AC CVCL_EN56
SY NextGen_68_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD113i-68-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aad1-ac77-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD114i-69-1
AC CVCL_EN57
SY NextGen_69_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD114i-69-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aad5-19c1-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD115i-70-1
AC CVCL_EN58
SY NextGen_70_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD115i-70-1.cmsx
WW http://shared.eagle-i.net/i/00000150-aae1-9289-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD116i-71-1
AC CVCL_EN59
SY NextGen_71_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD116i-71-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab05-9565-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD117i-72-1
AC CVCL_EN60
SY NextGen_72_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD117i-72-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab08-9a2e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD118i-38-1
AC CVCL_EN61
SY NextGen_38_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD118i-38-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9674-be79-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD119i-38-2
AC CVCL_EN62
SY NextGen_38_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD119i-38-2.cmsx
WW http://shared.eagle-i.net/i/00000150-967f-3849-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD120i-39-1
AC CVCL_EN63
SY NextGen_39_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD120i-39-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9682-759f-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD121i-39-2
AC CVCL_EN64
SY NextGen_39_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD121i-39-2.cmsx
WW http://shared.eagle-i.net/i/00000150-a56b-1e9e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD122i-73-1
AC CVCL_EN65
SY NextGen_73_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD122i-73-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab0b-57d9-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD123i-74-1
AC CVCL_EN66
SY NextGen_74_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD123i-74-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab0e-e3d5-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD124i-7-1
AC CVCL_EN67
SY NextGen_7_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD124i-7-1.cmsx
WW http://shared.eagle-i.net/i/00000150-7261-f4c0-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD125i-7-2
AC CVCL_EN68
SY NextGen_7_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD125i-7-2.cmsx
WW http://shared.eagle-i.net/i/00000150-725d-b905-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD126i-7-3
AC CVCL_EN69
SY NextGen_7_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD126i-7-3.cmsx
WW http://shared.eagle-i.net/i/00000150-7257-3494-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD127i-7-4
AC CVCL_EN70
SY NextGen_7_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD127i-7-4.cmsx
WW http://shared.eagle-i.net/i/00000150-7268-5d1d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD128i-7-5
AC CVCL_EN71
SY NextGen_7_5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD128i-7-5.cmsx
WW http://shared.eagle-i.net/i/00000150-7275-cf88-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD129i-75-1
AC CVCL_EN72
SY NextGen_75_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD129i-75-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab11-42dc-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD130i-76-1
AC CVCL_EN73
SY NextGen_76_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD130i-76-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab14-8809-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD131i-77-1
AC CVCL_EN74
SY NextGen_77_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD131i-77-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab17-5dd4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD132i-78-1
AC CVCL_EN75
SY NextGen_78_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD132i-78-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab1a-31cd-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD133i-79-1
AC CVCL_EN76
SY NextGen_79_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD133i-79-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab1e-8c7e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD134i-80-1
AC CVCL_EN77
SY NextGen_80_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD134i-80-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ab24-2732-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD135i-81-1
AC CVCL_EN78
SY NextGen_81_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD135i-81-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b49e-f140-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD136i-82-1
AC CVCL_EN79
SY NextGen_82_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD136i-82-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b4ad-8d2b-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD137i-83-1
AC CVCL_EN80
SY NextGen_83_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD137i-83-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b4b0-8efb-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD138i-84-1
AC CVCL_EN81
SY NextGen_84_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD138i-84-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b4b3-b5e6-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD139i-85-1
AC CVCL_EN82
SY NextGen_85_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD139i-85-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b4c0-1645-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD140i-37-1
AC CVCL_EN83
SY NextGen_37_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD140i-37-1.cmsx
WW http://shared.eagle-i.net/i/00000150-966c-69e1-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD141i-37-2
AC CVCL_EN84
SY NextGen_37_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD141i-37-2.cmsx
WW http://shared.eagle-i.net/i/00000150-966f-79be-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD142i-86-1
AC CVCL_EN85
SY NextGen_86_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD142i-86-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b4f3-0cb4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD143i-87-1
AC CVCL_EN86
SY NextGen_87_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD143i-87-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b4f9-6c80-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD144i-88-1
AC CVCL_EN87
SY NextGen_88_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD144i-88-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b4fb-b8fc-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD145i-89-1
AC CVCL_EN88
SY NextGen_89_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD145i-89-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b50b-3ce2-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD146i-10-1
AC CVCL_EN89
SY NextGen_10_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD146i-10-1.cmsx
WW http://shared.eagle-i.net/i/00000150-8132-0d2d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD147i-10-2
AC CVCL_EN90
SY NextGen_10_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD147i-10-2.cmsx
WW http://shared.eagle-i.net/i/00000150-812e-b921-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD148i-10-3
AC CVCL_EN91
SY NextGen_10_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD148i-10-3.cmsx
WW http://shared.eagle-i.net/i/00000150-8134-af33-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD149i-10-4
AC CVCL_EN92
SY NextGen_10_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD149i-10-4.cmsx
WW http://shared.eagle-i.net/i/00000150-8127-4c56-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD150i-11-1
AC CVCL_EN93
SY NextGen_11_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD150i-11-1.cmsx
WW http://shared.eagle-i.net/i/00000150-8173-772a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD151i-11-2
AC CVCL_EN94
SY NextGen_11_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD151i-11-2.cmsx
WW http://shared.eagle-i.net/i/00000150-8171-b8f4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD152i-11-3
AC CVCL_EN95
SY NextGen_11_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD152i-11-3.cmsx
WW http://shared.eagle-i.net/i/00000150-8176-a29c-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD153i-11-4
AC CVCL_EN96
SY NextGen_11_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD153i-11-4.cmsx
WW http://shared.eagle-i.net/i/00000150-813e-3296-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD154i-90-1
AC CVCL_EN97
SY NextGen_90_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD154i-90-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b50e-226a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD155i-12-1
AC CVCL_EN98
SY NextGen_12_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD155i-12-1.cmsx
WW http://shared.eagle-i.net/i/00000150-817f-9686-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD156i-12-2
AC CVCL_EN99
SY NextGen_12_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD156i-12-2.cmsx
WW http://shared.eagle-i.net/i/00000150-818d-537d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD157i-12-3
AC CVCL_EP00
SY NextGen_12_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD157i-12-3.cmsx
WW http://shared.eagle-i.net/i/00000150-8187-607e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD158i-12-4
AC CVCL_EP01
SY NextGen_12_4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD158i-12-4.cmsx
WW http://shared.eagle-i.net/i/00000150-818a-e7ff-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD159i-91-1
AC CVCL_EP02
SY NextGen_91_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD159i-91-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b511-6c5d-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD160i-92-1
AC CVCL_EP03
SY NextGen_92_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD160i-92-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b516-7614-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD161i-93-1
AC CVCL_EP04
SY NextGen_93_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD161i-93-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b51f-ac9c-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD162i-94-1
AC CVCL_EP05
SY NextGen_94_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD162i-94-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b523-b085-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD163i-95-1
AC CVCL_EP06
SY NextGen_95_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD163i-95-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b535-288e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD164i-96-1
AC CVCL_EP07
SY NextGen_96_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD164i-96-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b537-6dc3-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD165i-97-1
AC CVCL_EP08
SY NextGen_97_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD165i-97-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b53e-2546-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD166i-98-1
AC CVCL_EP09
SY NextGen_98_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD166i-98-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b540-b984-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD167i-99-1
AC CVCL_EP10
SY NextGen_99_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD167i-99-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b544-c241-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD168i-22-1
AC CVCL_EP11
SY NextGen_22_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD168i-22-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9093-1373-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD169i-22-2
AC CVCL_EP12
SY NextGen_22_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD169i-22-2.cmsx
WW http://shared.eagle-i.net/i/00000150-909b-4ba6-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD170i-22-3
AC CVCL_EP13
SY NextGen_22_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD170i-22-3.cmsx
WW http://shared.eagle-i.net/i/00000150-90a1-4bde-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD171i-100-1
AC CVCL_EP14
SY NextGen_100_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD171i-100-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b547-59d4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD172i-101-1
AC CVCL_EP15
SY NextGen_101_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD172i-101-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b54d-90c8-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD173i-18-1
AC CVCL_EP16
SY NextGen_18_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD173i-18-1.cmsx
WW http://shared.eagle-i.net/i/00000150-865c-964f-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD174i-18-2
AC CVCL_EP17
SY NextGen_18_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD174i-18-2.cmsx
WW http://shared.eagle-i.net/i/00000150-8663-5637-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD175i-18-3
AC CVCL_EP18
SY NextGen_18_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD175i-18-3.cmsx
WW http://shared.eagle-i.net/i/00000150-866e-78fe-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD176i-17-1
AC CVCL_EP19
SY NextGen_17_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD176i-17-1.cmsx
WW http://shared.eagle-i.net/i/00000150-8204-0ddf-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD177i-17-2
AC CVCL_EP20
SY NextGen_17_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD177i-17-2.cmsx
WW http://shared.eagle-i.net/i/00000150-8201-41f5-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD178i-17-3
AC CVCL_EP21
SY NextGen_17_3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD178i-17-3.cmsx
WW http://shared.eagle-i.net/i/00000150-81fe-8dcb-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD179i-27-1
AC CVCL_EP22
SY NextGen_27_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD179i-27-1.cmsx
WW http://shared.eagle-i.net/i/00000150-912f-f1e1-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD180i-27-2
AC CVCL_EP23
SY NextGen_27_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD180i-27-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9145-cfec-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD181i-3-1
AC CVCL_EP24
SY NextGen_3_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD181i-3-1.cmsx
WW http://shared.eagle-i.net/i/00000150-6d60-5ba4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD182i-3-2 (CVCL_EP25).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD182i-3-2
AC CVCL_EP25
SY NextGen_3_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD182i-3-2.cmsx
WW http://shared.eagle-i.net/i/00000150-6d66-8c76-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD181i-3-1 (CVCL_EP24).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD183i-102-1
AC CVCL_EP26
SY NextGen_102_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD183i-102-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b552-5750-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD184i-8-1
AC CVCL_EP27
SY NextGen_8_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD184i-8-1.cmsx
WW http://shared.eagle-i.net/i/00000150-727e-fc99-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD185i-8-2 (CVCL_EP28).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD185i-8-2
AC CVCL_EP28
SY NextGen_8_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD185i-8-2.cmsx
WW http://shared.eagle-i.net/i/00000150-7283-87e0-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD184i-8-1 (CVCL_EP27).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD186i-103-1
AC CVCL_EP29
SY NextGen_103_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD186i-103-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b555-e99a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD187i-104-1
AC CVCL_EP30
SY NextGen_104_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD187i-104-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b559-6921-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD188i-105-1
AC CVCL_EP31
SY NextGen_105_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD188i-105-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b560-0f0a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD189i-28-1
AC CVCL_EP32
SY NextGen_28_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD189i-28-1.cmsx
WW http://shared.eagle-i.net/i/00000150-914d-7bf6-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD190i-28-2 (CVCL_EP33).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD190i-28-2
AC CVCL_EP33
SY NextGen_28_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD190i-28-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9155-a19a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD189i-28-1 (CVCL_EP32).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD191i-13-1
AC CVCL_EP34
SY NextGen_13_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD191i-13-1.cmsx
WW http://shared.eagle-i.net/i/00000150-81a1-ebc4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD192i-13-2 (CVCL_EP35).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD192i-13-2
AC CVCL_EP35
SY NextGen_13_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD192i-13-2.cmsx
WW http://shared.eagle-i.net/i/00000150-81a8-faa3-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD191i-13-1 (CVCL_EP34).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD193i-106-1
AC CVCL_EP36
SY NextGen_106_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD193i-106-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b564-b51f-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD194i-29-1
AC CVCL_EP37
SY NextGen_29_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD194i-29-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9161-8158-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD195i-29-2 (CVCL_EP38).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD195i-29-2
AC CVCL_EP38
SY NextGen_29_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD195i-29-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9168-71e4-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD194i-29-1 (CVCL_EP37).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD196i-30-1
AC CVCL_EP39
SY NextGen_30_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD196i-30-1.cmsx
WW http://shared.eagle-i.net/i/00000150-95c3-c1c8-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD197i-30-2 (CVCL_EP40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD197i-30-2
AC CVCL_EP40
SY NextGen_30_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD197i-30-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9600-6720-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD196i-30-1 (CVCL_EP39).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD198i-23-1
AC CVCL_EP41
SY NextGen_23_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD198i-23-1.cmsx
WW http://shared.eagle-i.net/i/00000150-90aa-b832-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD199i-107-1
AC CVCL_EP42
SY NextGen_107_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD199i-107-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b959-6876-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD200i-4-1
AC CVCL_EP43
SY NextGen_4_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD200i-4-1.cmsx
WW http://shared.eagle-i.net/i/00000150-71c4-ff5e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD201i-4-2 (CVCL_EP44).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD201i-4-2
AC CVCL_EP44
SY NextGen_4_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD201i-4-2.cmsx
WW http://shared.eagle-i.net/i/00000150-71ca-4144-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD200i-4-1 (CVCL_EP43).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD202i-108-1
AC CVCL_EP45
SY NextGen_108_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD202i-108-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b967-9a5e-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD203i-109-1
AC CVCL_EP46
SY NextGen_109_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD203i-109-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b97f-6d70-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD204i-26-1
AC CVCL_EP47
SY NextGen_26_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD204i-26-1.cmsx
WW http://shared.eagle-i.net/i/00000150-911d-30e9-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD205i-110-1
AC CVCL_EP48
SY NextGen_110_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD205i-110-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba2a-3e28-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD206i-31-1
AC CVCL_EP49
SY NextGen_31_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD206i-31-1.cmsx
WW http://shared.eagle-i.net/i/00000150-9615-a697-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD207i-31-2 (CVCL_EP50).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD207i-31-2
AC CVCL_EP50
SY NextGen_31_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD207i-31-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9628-f435-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from monozygotic twin of UCSD206i-31-1 (CVCL_EP49).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD208i-111-1
AC CVCL_EP51
SY NextGen_111_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD208i-111-1.cmsx
WW http://shared.eagle-i.net/i/00000150-b981-c6ea-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD209i-24-1
AC CVCL_EP52
SY NextGen_24_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD209i-24-1.cmsx
WW http://shared.eagle-i.net/i/00000150-90bb-c3a2-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD210i-112-1
AC CVCL_EP53
SY NextGen_112_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD210i-112-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba01-da8a-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD211i-32-1
AC CVCL_EP54
SY NextGen_32_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD211i-32-1.cmsx
WW http://shared.eagle-i.net/i/00000150-962d-71ea-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from dizygotic twin of UCSD212i-32-2 (CVCL_EP55).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD212i-32-2
AC CVCL_EP55
SY NextGen_32_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD212i-32-2.cmsx
WW http://shared.eagle-i.net/i/00000150-9634-ce05-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from dizygotic twin of UCSD211i-32-1 (CVCL_EP54).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD213i-14-1
AC CVCL_EP56
SY NextGen_14_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD213i-14-1.cmsx
WW http://shared.eagle-i.net/i/00000150-81ba-f517-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from dizygotic twin of UCSD214i-14-2 (CVCL_EP57).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD214i-14-2
AC CVCL_EP57
SY NextGen_14_2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD214i-14-2.cmsx
WW http://shared.eagle-i.net/i/00000150-81c3-2e6f-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
CC Miscellaneous: Established from dizygotic twin of UCSD213i-14-1 (CVCL_EP56).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD215i-113-1
AC CVCL_EP58
SY NextGen_113_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD215i-113-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba24-2e04-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD216i-114-1
AC CVCL_EP59
SY NextGen_114_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD216i-114-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba0c-4d50-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD217i-115-1
AC CVCL_EP60
SY NextGen_115_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD217i-115-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba10-8880-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD218i-116-1
AC CVCL_EP61
SY NextGen_116_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD218i-116-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba13-35da-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD219i-117-1
AC CVCL_EP62
SY NextGen_117_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD219i-117-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba16-b1d0-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD220i-118-1
AC CVCL_EP63
SY NextGen_118_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD220i-118-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba21-1465-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD221i-119-1
AC CVCL_EP64
SY NextGen_119_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD221i-119-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba18-f724-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UCSD222i-120-1
AC CVCL_EP65
SY NextGen_120_1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD222i-120-1.cmsx
WW http://shared.eagle-i.net/i/00000150-ba1a-ea26-e23c-e57880000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Frazer K.A.; University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UCSD223i-NDC1-1
AC CVCL_EJ84
SY NDC1.1
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD223i-NDC1-1.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ85 ! UCSD224i-NDC1-2
OI CVCL_EJ86 ! UCSD225i-NDC1-3
SX Male
CA Induced pluripotent stem cell
//
ID UCSD224i-NDC1-2
AC CVCL_EJ85
SY NDC1.2
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD224i-NDC1-2.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ84 ! UCSD223i-NDC1-1
OI CVCL_EJ86 ! UCSD225i-NDC1-3
SX Male
CA Induced pluripotent stem cell
//
ID UCSD225i-NDC1-3
AC CVCL_EJ86
SY NDC1.3
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD225i-NDC1-3.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ84 ! UCSD223i-NDC1-1
OI CVCL_EJ85 ! UCSD224i-NDC1-2
SX Male
CA Induced pluripotent stem cell
//
ID UCSD226i-NDC2-1
AC CVCL_EJ87
SY NDC2.1
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD226i-NDC2-1.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ88 ! UCSD227i-NDC2-2
OI CVCL_EJ89 ! UCSD228i-NDC2-3
SX Male
CA Induced pluripotent stem cell
//
ID UCSD227i-NDC2-2
AC CVCL_EJ88
SY NDC2.2
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD227i-NDC2-2.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ87 ! UCSD226i-NDC2-1
OI CVCL_EJ89 ! UCSD228i-NDC2-3
SX Male
CA Induced pluripotent stem cell
//
ID UCSD228i-NDC2-3
AC CVCL_EJ89
SY NDC2.3
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD228i-NDC2-3.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ87 ! UCSD226i-NDC2-1
OI CVCL_EJ88 ! UCSD227i-NDC2-2
SX Male
CA Induced pluripotent stem cell
//
ID UCSD229i-SAD1-1
AC CVCL_EJ90
SY sAD1.1; SAD1.1
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD229i-SAD1-1.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ91 ! UCSD230i-SAD1-2
OI CVCL_EJ92 ! UCSD231i-SAD1-3
SX Female
CA Induced pluripotent stem cell
//
ID UCSD230i-SAD1-2
AC CVCL_EJ91
SY sAD1.2; SAD1.2
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD230i-SAD1-2.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ90 ! UCSD229i-SAD1-1
OI CVCL_EJ92 ! UCSD231i-SAD1-3
SX Female
CA Induced pluripotent stem cell
//
ID UCSD231i-SAD1-3
AC CVCL_EJ92
SY sAD1.3; SAD1.3
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD231i-SAD1-3.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ90 ! UCSD229i-SAD1-1
OI CVCL_EJ91 ! UCSD230i-SAD1-2
SX Female
CA Induced pluripotent stem cell
//
ID UCSD232i-SAD2-1
AC CVCL_EJ93
SY sAD2.1; SAD2.1
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD232i-SAD2-1.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1N91 ! UCSD233i-SAD2-2
OI CVCL_EJ94 ! UCSD234i-SAD2-3
OI CVCL_EJ95 ! UCSD235i-SAD2-4
SX Male
CA Induced pluripotent stem cell
//
ID UCSD233i-SAD2-2
AC CVCL_1N91
SY sAD2.2; SAD2.2; GM24666
DR Coriell; GM24666
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD233i-SAD2-2.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ93 ! UCSD232i-SAD2-1
OI CVCL_EJ94 ! UCSD234i-SAD2-3
OI CVCL_EJ95 ! UCSD235i-SAD2-4
SX Male
CA Induced pluripotent stem cell
//
ID UCSD234i-SAD2-3
AC CVCL_EJ94
SY sAD2.3; SAD2.3
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD234i-SAD2-3.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ93 ! UCSD232i-SAD2-1
OI CVCL_1N91 ! UCSD233i-SAD2-2
OI CVCL_EJ95 ! UCSD235i-SAD2-4
SX Male
CA Induced pluripotent stem cell
//
ID UCSD235i-SAD2-4
AC CVCL_EJ95
SY sAD2.4; SAD2.4
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD235i-SAD2-4.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ93 ! UCSD232i-SAD2-1
OI CVCL_1N91 ! UCSD233i-SAD2-2
OI CVCL_EJ94 ! UCSD234i-SAD2-3
SX Male
CA Induced pluripotent stem cell
//
ID UCSD236i-APP1-1
AC CVCL_EJ96
SY APPDp1.1; APP1.1
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD236i-APP1-1.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ97 ! UCSD237i-APP1-2
OI CVCL_EJ98 ! UCSD238i-APP1-3
SX Male
CA Induced pluripotent stem cell
//
ID UCSD237i-APP1-2
AC CVCL_EJ97
SY APPDp1.2; Appdp1.2
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD237i-APP1-2.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ96 ! UCSD236i-APP1-1
OI CVCL_EJ98 ! UCSD238i-APP1-3
SX Male
CA Induced pluripotent stem cell
//
ID UCSD238i-APP1-3
AC CVCL_EJ98
SY APPDp1.3; Appdp1.3
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD238i-APP1-3.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ96 ! UCSD236i-APP1-1
OI CVCL_EJ97 ! UCSD237i-APP1-2
SX Male
CA Induced pluripotent stem cell
//
ID UCSD239i-APP2-1
AC CVCL_EJ99
SY APPDp2.1; Appdp2.1
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD239i-APP2-1.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK00 ! UCSD240i-APP2-2
OI CVCL_1N92 ! UCSD241i-APP2-3
SX Female
CA Induced pluripotent stem cell
//
ID UCSD240i-APP2-2
AC CVCL_EK00
SY APPDp2.2; Appdp2.2
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD240i-APP2-2.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ99 ! UCSD239i-APP2-1
OI CVCL_1N92 ! UCSD241i-APP2-3
SX Female
CA Induced pluripotent stem cell
//
ID UCSD241i-APP2-3
AC CVCL_1N92
SY APPDp2.3; Appdp2.3; APP2.3; GM24675
DR Coriell; GM24675
RX PubMed=22278060;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD241i-APP2-3.cmsx
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ99 ! UCSD239i-APP2-1
OI CVCL_EK00 ! UCSD240i-APP2-2
SX Female
CA Induced pluripotent stem cell
//
ID UCSF1
AC CVCL_A019
SY UCSF-1; UCSFe004-A
DR hPSCreg; UCSFe004-A
CC From: University of California, San Francisco; San Francisco; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCSF2
AC CVCL_A020
SY UCSF-2; UCSFe005-A
DR hPSCreg; UCSFe005-A
CC From: University of California, San Francisco; San Francisco; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID UCSF3
AC CVCL_A021
SY UCSF-3
DR ISCR; 1521
CC From: University of California, San Francisco; San Francisco; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSF4
AC CVCL_A022
SY UCSF-4
DR EFO; EFO_0007116
DR ENCODE; ENCBS274MNP
DR ENCODE; ENCBS281XEU
DR ENCODE; ENCBS296VOU
DR ENCODE; ENCBS311CPE
DR ENCODE; ENCBS488VWE
DR ENCODE; ENCBS496TQG
DR ENCODE; ENCBS838AWQ
DR ISCR; 875
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=200
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0044.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UCSFB-1
AC CVCL_A023
SY UCSFB1
DR ISCR; 1522
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-10
AC CVCL_A024
SY UCSFB10
DR ISCR; 1546
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-2
AC CVCL_A025
SY UCSFB2
DR ISCR; 1523
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-3
AC CVCL_A026
SY UCSFB3
DR ISCR; 1524
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-4
AC CVCL_A027
SY UCSFB4
DR ISCR; 1525
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-5
AC CVCL_A028
SY UCSFB5
DR ISCR; 1541
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-6
AC CVCL_A029
SY UCSFB6
DR ISCR; 1542
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-7
AC CVCL_A030
SY UCSFB7
DR ISCR; 1543
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-8
AC CVCL_A031
SY UCSFB8
DR ISCR; 1544
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCSFB-9
AC CVCL_A032
SY UCSFB9
DR ISCR; 1545
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of California, San Francisco; San Francisco; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UCT-Mel 1
AC CVCL_T304
SY UCT Mel-1; University of Cape Town - Melanoma cell line 1
RX PubMed=3091056;
RX PubMed=6814752;
CC Characteristics: Pigmented.
CC Doubling time: 41 hours (PubMed=3091056).
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCT-Mel 2
AC CVCL_T305
SY UCT Mel-2; University of Cape Town - Melanoma cell line 2
RX PubMed=3091056;
RX PubMed=6814752;
CC Characteristics: Pigmented.
CC Doubling time: 50 hours (PubMed=3091056).
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCT-Mel 3
AC CVCL_T306
SY UCT Mel-3; University of Cape Town - Melanoma cell line 3
RX PubMed=3091056;
RX PubMed=3335422;
CC Doubling time: 50 hours (PubMed=3091056).
CC Derived from metastatic site: Liver.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCT-Mel 4
AC CVCL_T307
SY UCT Mel-4; University of Cape Town - Melanoma cell line 4
RX PubMed=3091056;
CC Doubling time: 52 hours (PubMed=3091056).
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UCT-Mel 5
AC CVCL_T308
SY UCT Mel-5; University of Cape Town - Melanoma cell line 5
RX PubMed=3091056;
CC Doubling time: 58 hours (PubMed=3091056).
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UCT-Mel 6
AC CVCL_T309
SY UCT Mel-6; University of Cape Town - Melanoma cell line 6
RX PubMed=3091056;
CC Doubling time: 33 hours (PubMed=3091056).
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UCT-Mel 7
AC CVCL_T310
SY UCT Mel-7; UCT-Mel-7; University of Cape Town - Melanoma cell line 7
RX PubMed=1562456;
RX PubMed=3091056;
CC Doubling time: 95 hours (PubMed=3091056).
CC Derived from metastatic site: Femoral lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UCVA-1
AC CVCL_1G10
SY UCVA
RX PubMed=6092175;
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UCW 10
AC CVCL_0F82
RX PubMed=6965094;
RX PubMed=7193212;
RX PubMed=7444715;
CC Selected for resistance to: ChEBI; CHEBI:4781; Emetine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0F81 ! CHO-tsH1
SX Female
CA Spontaneously immortalized cell line
//
ID UCW 113
AC CVCL_5T99
RX PubMed=6965094;
RX PubMed=7193212;
RX PubMed=7444715;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID UCW 124
AC CVCL_5U00
RX PubMed=6965094;
RX PubMed=7444715;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5T99 ! UCW 113
SX Male
CA Spontaneously immortalized cell line
//
ID UCW 181
AC CVCL_5U01
RX PubMed=6965094;
RX PubMed=7444715;
CC Selected for resistance to: ChEBI; CHEBI:4781; Emetine.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5U00 ! UCW 124
SX Male
CA Spontaneously immortalized cell line
//
ID UCW 206
AC CVCL_0F85
SY UCW206; Asn-5; lys 65a; CHO lys 65a
RX PubMed=618867;
RX PubMed=6836455;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID UCW 282
AC CVCL_5U02
SY UCW-282
RX PubMed=6965094;
CC Selected for resistance to: ChEBI; CHEBI:4781; Emetine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_L858 ! B14-150
SX Female
CA Transformed cell line
//
ID UCW 296
AC CVCL_5U03
RX PubMed=6965094;
CC Selected for resistance to: ChEBI; CHEBI:4781; Emetine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_L858 ! B14-150
SX Female
CA Transformed cell line
//
ID UCW 56
AC CVCL_0F83
SY UCW56
RX PubMed=7193212;
RX PubMed=9732752;
CC Selected for resistance to: ChEBI; CHEBI:4781; Emetine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0F82 ! UCW 10
SX Female
CA Spontaneously immortalized cell line
//
ID UD-PTC
AC CVCL_W337
RX PubMed=24567186;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UD-SCC-1
AC CVCL_E324
SY UD-SCC 1; UD-SCC1; UDSCC1
DR Cosmic; 932281
RX PubMed=10628319;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UD-SCC-2
AC CVCL_E325
SY UD-SCC 2; UD-SCC2; UDSCC2
DR Cosmic; 932282
DR Cosmic; 2296311
DR Cosmic-CLP; 1299073
DR GDSC; 1299073
RX PubMed=10628319;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=25275298
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,13
ST D18S51: 12,17
ST D21S11: 30,31.2
ST D3S1358: 14,16
ST D5S818: 10,11
ST D7S820: 8,9
ST D8S1179: 13,15
ST FGA: 20,27
ST Penta D: 9,13
ST Penta E: 10
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,18
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UD-SCC-3
AC CVCL_E326
SY UD-SCC 3; UD-SCC3
DR Cosmic; 932283
RX PubMed=10628319;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UD-SCC-4
AC CVCL_E327
SY UD-SCC 4; UD-SCC4
DR Cosmic; 932284
RX PubMed=10628319;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UD-SCC-5
AC CVCL_L548
SY UD-SCC 5; UD-SCC5
DR Cosmic; 932285
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UD-SCC-6
AC CVCL_M120
SY UD-SCC 6; UD-SCC6
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UD-SCC-7A
AC CVCL_M118
SY UD-SCC 7A; UD-SCC7A; UD-SCC7a
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UD-SCC-7B
AC CVCL_M119
SY UD-SCC 7B; UD-SCC7B
DR Cosmic; 932286
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UE6E7-16
AC CVCL_3233
SY UEE-16
DR CLO; CLO_0051559
DR JCRB; JCRB1160
DR JCRB; NIHS0457
DR RCB; RCB2163
RX PubMed=15923633;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0457; true.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE6E7T-1
AC CVCL_8306
SY UEET-1; Th-1; ThMSC1
DR JCRB; JCRB1131
DR JCRB; NIHS0446
RX PubMed=15293342;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0446; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE6E7T-11
AC CVCL_3234
AS CVCL_4070
SY UEET-11
DR CLO; CLO_0051555
DR JCRB; JCRB1149
DR JCRB; NIHS0453
DR RCB; RCB2159
RX PubMed=15293342;
RX PubMed=15923633;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0453; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE6E7T-12
AC CVCL_3235
AS CVCL_4071
SY UEET-12
DR CLO; CLO_0051557
DR JCRB; JCRB1151
DR JCRB; NIHS0454
DR RCB; RCB2160
RX PubMed=15923633;
RX PubMed=21155951;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0454; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE6E7T-2
AC CVCL_3236
SY UEET-2; Th-2
DR CLO; CLO_0051550
DR GEO; GSM827241
DR JCRB; JCRB1133
DR JCRB; NIHS0447
DR RCB; RCB2153
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0447; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11 (JCRB)
ST TPOX: 11 (RCB)
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE6E7T-3
AC CVCL_3237
SY UEET-3; Th-3
DR CLO; CLO_0051551
DR JCRB; JCRB1136
DR JCRB; NIHS0448
DR RCB; RCB2154
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0448; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE6E7TC-4
AC CVCL_8307
SY UEETC-4; TdHC1
DR BioSample; SAMN03472383
DR JCRB; JCRB1137
DR JCRB; NIHS0449
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Discontinued: JCRB; NIHS0449; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE7T-13
AC CVCL_3238
SY UET-13
DR CLO; CLO_0051556
DR JCRB; JCRB1154
DR JCRB; NIHS0455
DR RCB; RCB2161
RX PubMed=15293342;
RX PubMed=15923633;
RX PubMed=21155951;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
CC Discontinued: JCRB; NIHS0455; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE7T-9
AC CVCL_3239
SY UET-9
DR CLO; CLO_0051554
DR JCRB; JCRB1147
DR JCRB; NIHS0452
DR RCB; RCB2158
RX PubMed=15923633;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
CC Discontinued: JCRB; NIHS0452; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6F32 ! H4-1 [Human bone marrow]
SX Female
CA Transformed cell line
//
ID UE8
AC CVCL_5T89
RX DOI=10.2108/zsj.15.277;
RX PubMed=9358279;
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID UEC-4
AC CVCL_D808
SY Utricular Epithelial Cell line-4
RX PubMed=9557974;
RX PubMed=12382283;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID UF-1
AC CVCL_0567
DR MCCL; MCC:0000472
DR Cosmic; 787485
DR Cosmic; 975309
DR Cosmic; 1281359
RX PubMed=8781440;
RX PubMed=15234573;
CC Doubling time: 72 hours (PubMed=8781440); 96 hours (PubMed=15234573).
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UFL-AG-286
AC CVCL_Z440
SY UFL-Ag-286; UFL-AG286; UFL-Ag286
RX DOI=10.1007/BF02623546;
RX PubMed=1367489;
RX PubMed=12623313;
RX PubMed=15926859;
RX PubMed=19002870;
CC Group: Insect cell line.
OX NCBI_TaxID=129554; ! Anticarsia gemmatalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UG3
AC CVCL_5382
SY UG-3
DR Cosmic; 787486
DR Cosmic; 975310
DR Cosmic; 1281360
RX PubMed=9616150;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=UG3
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UGA-CiE1
AC CVCL_AV43
RX PubMed=20381615;
CC Group: Insect cell line.
OX NCBI_TaxID=68927; ! Chrysodeixis includens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UHG-NP
AC CVCL_A436
SY UHGNP
DR Cosmic; 1109109
DR Cosmic; 1518081
DR Cosmic; 1526658
DR Cosmic; 1543777
DR GEO; GSM692876
RX PubMed=7838528;
RX PubMed=9516836;
RX PubMed=11319804;
RX PubMed=22213050;
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UHG-RaC '93
AC CVCL_5U49
RX PubMed=7586205;
CC Breed/subspecies: Wistar.
DI NCIt; C60511; Rat squamous cell carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID UHKT-42
AC CVCL_K243
RX PubMed=7517692;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UHKT-893
AC CVCL_M522
RX PubMed=23290585;
CC Characteristics: IL6 dependent.
CC Doubling time: 3.4-3.8 days (PubMed=23290585).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UHKT-893a
AC CVCL_HX22
RX PubMed=23290585;
CC Characteristics: In contrast to the parent cell line it is no longer IL6 dependent.
CC Doubling time: 4.2-5.4 days (PubMed=23290585).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M522 ! UHKT-893
SX Female
CA Cancer cell line
//
ID UHKT-944
AC CVCL_1K05
RX PubMed=25600340;
CC Characteristics: IL6 dependent.
CC Doubling time: 65-77 hours (PubMed=23290585).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UIA-MM1
AC CVCL_A694
SY UIA-MM 1
DR Cosmic; 1016277
RX PubMed=9072005;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UIA-MM2
AC CVCL_A695
SY UIA-MM 2
DR Cosmic; 1016278
RX PubMed=9072005;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UIA-MM3
AC CVCL_A696
SY UIA-MM 3
DR Cosmic; 1016279
RX PubMed=9072005;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UIA-MM4
AC CVCL_M479
SY UIA-MM 4
RX PubMed=9072005;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UIA-MM5
AC CVCL_A697
SY UIA-MM 5
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UIA-MM6
AC CVCL_M480
SY UIA-MM 6
RX PubMed=9072005;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UIA-MM7
AC CVCL_A698
SY UIA-MM 7
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UIA-MM8
AC CVCL_A699
SY UIA-MM 8
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UISO-BCA-1
AC CVCL_D249
SY UISO BCA 1
RX DOI=10.1016/0165-4608(96)85254-X;
RX PubMed=1377894;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UISO-BCA-2
AC CVCL_D250
SY UISO BCA 2
RX DOI=10.1016/0165-4608(96)85254-X;
RX PubMed=1377894;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UISO-BCA-3
AC CVCL_D251
SY UISO BCA 3
RX DOI=10.1016/0165-4608(96)85254-X;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UISO-BCA-4
AC CVCL_D252
SY UISO BCA 4
RX DOI=10.1016/0165-4608(96)85254-X;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UISO-MCC-1
AC CVCL_E996
SY UISO-MCC 1; UISO-MCC1; UISO-mcc1; UISO
DR Cosmic; 1693074
DR Cosmic; 1699814
DR GDSC; 1299074
RX PubMed=8227544;
RX PubMed=12209990;
RX PubMed=20444890;
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UISO-RS-3
AC CVCL_Y581
RX PubMed=2243060;
RX PubMed=23882450;
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UIV-SL-373
AC CVCL_AV44
RX DOI=10.1007/BF02618358;
CC Group: Insect cell line.
OX NCBI_TaxID=7109; ! Spodoptera littoralis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UIV-SL-573
AC CVCL_AV45
RX DOI=10.1007/BF02618358;
CC Group: Insect cell line.
OX NCBI_TaxID=7109; ! Spodoptera littoralis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UIV-SL-673
AC CVCL_AV46
RX DOI=10.1007/BF02618358;
CC Group: Insect cell line.
OX NCBI_TaxID=7109; ! Spodoptera littoralis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UKBi005-A
AC CVCL_1E85
SY iLB-C-31f-r1; iLB-C-31f-R1; LB-31-1
DR BioSamples; SAMEA4584351
DR EBiSC; UKBi005-A
DR ECACC; 66540008
DR hPSCreg; UKBi005-A
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UKBi006-A
AC CVCL_1E86
SY iLB-C-35m-R1; LB-35-1
DR BioSamples; SAMEA2590936
DR EBiSC; UKBi006-A
DR ECACC; 66540004
DR hPSCreg; UKBi006-A
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UKBi010-A
AC CVCL_IU29
SY iLB-DS-95f-r8
DR BioSamples; SAMEA104008300
DR hPSCreg; UKBi010-A
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
DI NCIt; C116573; Dravet syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UKE-1
AC CVCL_0104
SY UKE1; GM23245
DR BTO; BTO:0004765
DR EFO; EFO_0006307
DR Coriell; GM23245
DR Cosmic; 1012055
DR Cosmic; 1281361
DR Cosmic; 1519161
DR Cosmic; 1633514
DR Cosmic; 2306996
DR GEO; GSM1374976
RX PubMed=10640966;
RX PubMed=16408098;
RX PubMed=22829968;
RX PubMed=25485619;
CC Characteristics: Patient had a essential thrombocythemia transformed into acute leukemia.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3407; Essential thrombocythemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKE-1/TGR
AC CVCL_4Z62
RX PubMed=21976548;
CC Selected for resistance to: ChEBI; CHEBI:90304; TG101209 (N-(tert-butyl)-3-((5-methyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide).
DI NCIt; C3407; Essential thrombocythemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0104 ! UKE-1
SX Female
CA Cancer cell line
//
ID UKEAC-99
AC CVCL_EJ02
RX PubMed=12680226;
RX PubMed=26951071;
CC Miscellaneous: Cell line has been discarded (PubMed=26951071).
DI NCIt; C6650; Ampulla of Vater adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKERi001-A
AC CVCL_IT77
SY UKERiG3G-R1-047
DR hPSCreg; UKERi001-A
DR BioSamples; SAMEA104010735
CC From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UKERi004-A
AC CVCL_IT78
SY UKERi88H-R1-001
DR hPSCreg; UKERi004-A
DR BioSamples; SAMEA104010911
CC From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UKERi005-A
AC CVCL_IT79
SY UKERiO3H-R1-001
DR hPSCreg; UKERi005-A
DR BioSamples; SAMEA104010913
CC From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UKERi006-A
AC CVCL_IT80
SY UKERi82A-R1-002
DR hPSCreg; UKERi006-A
DR BioSamples; SAMEA104011169
CC From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UKF-NB-2
AC CVCL_9902
SY UKF-NB2
RX CelloPub=CLPUB00123;
RX PubMed=9201287;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9904 ! UKF-NB-3
CA Cancer cell line
//
ID UKF-NB-2 CDDP
AC CVCL_9908
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9902 ! UKF-NB-2
CA Cancer cell line
//
ID UKF-NB-2 DOXO
AC CVCL_9909
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9902 ! UKF-NB-2
CA Cancer cell line
//
ID UKF-NB-2 VCR
AC CVCL_9910
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9902 ! UKF-NB-2
CA Cancer cell line
//
ID UKF-NB-2AD169
AC CVCL_9903
RX PubMed=9443419;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9902 ! UKF-NB-2
CA Cancer cell line
//
ID UKF-NB-3
AC CVCL_9904
SY UKF-NB3
RX CelloPub=CLPUB00123;
RX PubMed=9201287;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9902 ! UKF-NB-2
CA Cancer cell line
//
ID UKF-NB-3 CDDP
AC CVCL_M478
RX PubMed=17505515;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9904 ! UKF-NB-3
CA Cancer cell line
//
ID UKF-NB-3 DOXO
AC CVCL_9911
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9904 ! UKF-NB-3
CA Cancer cell line
//
ID UKF-NB-3 VCR
AC CVCL_9912
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9904 ! UKF-NB-3
CA Cancer cell line
//
ID UKF-NB-3rDOX20
AC CVCL_9906
RX PubMed=16142320;
RX PubMed=19147553;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9904 ! UKF-NB-3
CA Cancer cell line
//
ID UKF-NB-3rVCR10
AC CVCL_9905
RX PubMed=16142320;
RX PubMed=19147553;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9904 ! UKF-NB-3
CA Cancer cell line
//
ID UKF-NB-4
AC CVCL_9907
SY UKF-NB4
RX CelloPub=CLPUB00123;
RX PubMed=9201287;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKF-NB-4 CDDP
AC CVCL_9913
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9907 ! UKF-NB-4
CA Cancer cell line
//
ID UKF-NB-4 DOXO
AC CVCL_9914
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9907 ! UKF-NB-4
CA Cancer cell line
//
ID UKF-NB-4 VCR
AC CVCL_9915
RX PubMed=16151587;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9907 ! UKF-NB-4
CA Cancer cell line
//
ID UKF-NB-6
AC CVCL_M474
CC From: Cinatl J. Jr.; Goethe University; Frankfurt; Germany.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKF-NB-6 CDDP
AC CVCL_M475
RX PubMed=17505515;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M474 ! UKF-NB-6
CA Cancer cell line
//
ID UKF-NB-6 DOX
AC CVCL_M476
RX PubMed=17505515;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M474 ! UKF-NB-6
CA Cancer cell line
//
ID UKF-NB-6 VCR
AC CVCL_M477
RX PubMed=17505515;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M474 ! UKF-NB-6
CA Cancer cell line
//
ID UKF-Rhb-1
AC CVCL_4Z17
RX PubMed=19147553;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKF-Rhb-1rVCR10
AC CVCL_4Z18
RX PubMed=19147553;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4Z17 ! UKF-Rhb-1
CA Cancer cell line
//
ID UKKi006-A
AC CVCL_9S59
SY NP0053-5; M4C4; iP-MSC D4 cB; D4-CB
DR BioSamples; SAMEA2825851
DR EBiSC; UKKi006-A
DR ECACC; 66540018
DR hPSCreg; UKKi006-A
RX PubMed=23032973;
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UKKi007-A
AC CVCL_2Z94
SY NP0014-6; NP0014
DR BioSamples; SAMEA2629464
DR EBiSC; UKKi007-A
DR ECACC; 66540001
DR hPSCreg; UKKi007-A
RX PubMed=22178870;
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
DI NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S36 ! UKKi007-B
SX Female
CA Induced pluripotent stem cell
//
ID UKKi007-B
AC CVCL_9S36
SY NP0014-5
DR BioSamples; SAMEA2698638
DR EBiSC; UKKi007-B
DR ECACC; 66540013
DR hPSCreg; UKKi007-B
RX PubMed=22178870;
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
DI NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z94 ! UKKi007-A
SX Female
CA Induced pluripotent stem cell
//
ID UKKi008-A
AC CVCL_9S60
SY NP0016-3; V240M-LQTS-3
DR BioSamples; SAMEA4583697
DR EBiSC; UKKi008-A
DR ECACC; 66540015
DR hPSCreg; UKKi008-A
RX PubMed=24349418;
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UKKi009-A
AC CVCL_9S61
SY NP0011-8
DR BioSamples; SAMEA4583816
DR EBiSC; UKKi009-A
DR ECACC; 66540002
DR ECACC; 66540031
DR hPSCreg; UKKi009-A
RX PubMed=27345990;
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
CC Discontinued: ECACC; 66540031; probable.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S62 ! UKKi009-B
SX Female
CA Induced pluripotent stem cell
//
ID UKKi009-B
AC CVCL_9S62
SY NP0011-19
DR BioSamples; SAMEA2825897
DR EBiSC; UKKi009-B
DR ECACC; 66540032
DR hPSCreg; UKKi009-B
RX PubMed=27345990;
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S61 ! UKKi009-A
SX Female
CA Induced pluripotent stem cell
//
ID UKKi011-A
AC CVCL_9S63
SY NP0040-8
DR BioSamples; SAMEA2774610
DR EBiSC; UKKi011-A
DR ECACC; 66540010
DR hPSCreg; UKKi011-A
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UKKi012-A
AC CVCL_9S64
SY NP0041-17; NP0041
DR BioSamples; SAMEA2825964
DR EBiSC; UKKi012-A
DR ECACC; 66540019
DR hPSCreg; UKKi012-A
CC From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UKRV-Mel-01
AC CVCL_N789
SY UKRV-Mel-1
DR Cosmic; 1846688
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-02
AC CVCL_A700
SY UKRV-Mel-2
DR BTO; BTO:0005335
DR Cosmic; 1846689
DR Cosmic; 2163821
DR ECACC; 13012436
DR ESTDAB; ESTDAB-109
RX PubMed=17311103;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12,13
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,9
ST FGA: 20
ST TH01: 6,9.3
ST TPOX: 10
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKRV-Mel-03
AC CVCL_A701
SY UKRV-Mel-3
DR Cosmic; 1846690
DR Cosmic; 2163858
DR ECACC; 13012499
DR ESTDAB; ESTDAB-176
RX PubMed=17311103;
CC Derived from metastatic site: Cutaneous/subcutaneous.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10,11
ST FGA: 22
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKRV-Mel-04
AC CVCL_A702
SY UKRV-Mel-4
DR BTO; BTO:0005334
DR Cosmic; 906467
RX PubMed=15760917;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-05
AC CVCL_A703
SY UKRV-Mel-5
DR Cosmic; 906468
DR Cosmic; 1846692
DR ESTDAB; ESTDAB-145
RX PubMed=15760917;
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D3S1358: 16,17
ST D5S818: 9
ST D7S820: 10
ST FGA: 21
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKRV-Mel-06a
AC CVCL_A704
SY UKRV-Mel-6a
DR BTO; BTO:0005347
DR ESTDAB; ESTDAB-111
RX PubMed=10594685;
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 12,13
ST FGA: 23
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A705 ! UKRV-Mel-06b
SX Female
CA Cancer cell line
//
ID UKRV-Mel-06b
AC CVCL_A705
SY UKRV-Mel-6b
DR Cosmic; 1846693
DR ECACC; 13012538
DR ESTDAB; ESTDAB-222
RX PubMed=17311103;
CC Derived from metastatic site: Cutaneous/subcutaneous.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X
ST CSF1PO: 11 (ECACC)
ST CSF1PO: 7,11 (ESTDAB)
ST D13S317: 11
ST D16S539: 9,11
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 12,13
ST FGA: 23
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A704 ! UKRV-Mel-06a
SX Female
CA Cancer cell line
//
ID UKRV-Mel-07
AC CVCL_A706
SY UKRV-Mel-7; UKRV MEL7
DR Cosmic; 972285
DR Cosmic; 1846694
RX PubMed=10594685;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-10
AC CVCL_A707
SY UKRV-MEL-10
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-11
AC CVCL_A708
DR Cosmic; 906469
RX PubMed=15760917;
RX PubMed=17311103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-12
AC CVCL_A709
DR Cosmic; 1846696
RX PubMed=17311103;
CC Derived from metastatic site: Cutaneous/subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-12a
AC CVCL_C659
DR Cosmic; 1846697
DR ESTDAB; ESTDAB-223
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 8,11
ST FGA: 22,25
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C660 ! UKRV-Mel-12b
CA Cancer cell line
//
ID UKRV-Mel-12b
AC CVCL_C660
DR Cosmic; 1846698
DR ESTDAB; ESTDAB-224
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 8,11
ST FGA: 22,25
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C659 ! UKRV-Mel-12a
CA Cancer cell line
//
ID UKRV-Mel-13
AC CVCL_C408
DR Cosmic; 2163859
DR ESTDAB; ESTDAB-179
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 11,12
ST D3S1358: 17
ST D5S818: 13,14
ST D7S820: 8
ST FGA: 23.2,24
ST TH01: 7,9.3
ST TPOX: 8,12
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-14a
AC CVCL_A710
DR Cosmic; 2163822
DR ESTDAB; ESTDAB-110
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,10
ST FGA: 25
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A711 ! UKRV-Mel-14b
OI CVCL_C409 ! UKRV-Mel-14c
SX Female
CA Cancer cell line
//
ID UKRV-Mel-14b
AC CVCL_A711
DR Cosmic; 1846700
DR ECACC; 13012529
DR ESTDAB; ESTDAB-225
RX PubMed=17311103;
CC Derived from metastatic site: Lymph node.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 11
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,10
ST FGA: 25
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A710 ! UKRV-Mel-14a
OI CVCL_C409 ! UKRV-Mel-14c
SX Female
CA Cancer cell line
//
ID UKRV-Mel-14c
AC CVCL_C409
DR Cosmic; 1846701
DR ESTDAB; ESTDAB-226
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,10
ST FGA: 25
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A710 ! UKRV-Mel-14a
OI CVCL_A711 ! UKRV-Mel-14b
SX Female
CA Cancer cell line
//
ID UKRV-Mel-15
AC CVCL_A712
SY UKRV-MEL-15
DR Cosmic; 1846702
RX PubMed=17311103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKRV-Mel-15a
AC CVCL_A713
SY UKRV-Mel-15A
DR Cosmic; 2163819
DR ESTDAB; ESTDAB-107
RX PubMed=10594685;
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,12
ST FGA: 21,22
ST TH01: 6
ST TPOX: 8,12
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C397 ! UKRV-Mel-15b
OI CVCL_C398 ! UKRV-Mel-15c
OI CVCL_A714 ! UKRV-Mel-15d
CA Cancer cell line
//
ID UKRV-Mel-15b
AC CVCL_C397
DR Cosmic; 1846703
DR ESTDAB; ESTDAB-227
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,12
ST FGA: 21,22
ST TH01: 6
ST TPOX: 8,12
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A713 ! UKRV-Mel-15a
OI CVCL_C398 ! UKRV-Mel-15c
OI CVCL_A714 ! UKRV-Mel-15d
CA Cancer cell line
//
ID UKRV-Mel-15c
AC CVCL_C398
DR ESTDAB; ESTDAB-228
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A713 ! UKRV-Mel-15a
OI CVCL_C397 ! UKRV-Mel-15b
OI CVCL_A714 ! UKRV-Mel-15d
CA Cancer cell line
//
ID UKRV-Mel-15d
AC CVCL_A714
DR Cosmic; 906463
DR Cosmic; 1846704
DR ESTDAB; ESTDAB-229
RX PubMed=15760917;
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,12
ST FGA: 21,22
ST TH01: 6
ST TPOX: 8,12
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A713 ! UKRV-Mel-15a
OI CVCL_C397 ! UKRV-Mel-15b
OI CVCL_C398 ! UKRV-Mel-15c
CA Cancer cell line
//
ID UKRV-Mel-16
AC CVCL_A715
DR ESTDAB; ESTDAB-180
RX PubMed=17311103;
CC Derived from metastatic site: Cutaneous/subcutaneous.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D3S1358: 16
ST D5S818: 9,12
ST D7S820: 8
ST FGA: 26
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-17
AC CVCL_A716
DR Cosmic; 2163837
DR ECACC; 13012514
DR ESTDAB; ESTDAB-147
RX PubMed=10594685;
RX PubMed=17311103;
CC Derived from metastatic site: Lymph node.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 10,13
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8
ST FGA: 21,24
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-18a
AC CVCL_A717
SY UKRV-Mel-18A
DR ESTDAB; ESTDAB-106
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A718 ! UKRV-Mel-18b
SX Male
CA Cancer cell line
//
ID UKRV-Mel-18b
AC CVCL_A718
SY UKRV-Mel-18B
DR ESTDAB; ESTDAB-230
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10,11
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 8,11
ST FGA: 19,22
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A717 ! UKRV-Mel-18a
SX Male
CA Cancer cell line
//
ID UKRV-Mel-19
AC CVCL_A719
RX PubMed=17311103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKRV-Mel-19a
AC CVCL_A720
DR Cosmic; 906464
DR Cosmic; 1846707
RX PubMed=10594685;
RX PubMed=15760917;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C399 ! UKRV-Mel-19b
OI CVCL_C400 ! UKRV-Mel-19c
SX Female
CA Cancer cell line
//
ID UKRV-Mel-19b
AC CVCL_C399
DR Cosmic; 1846708
DR ECACC; 13012536
DR ESTDAB; ESTDAB-231
CC Derived from metastatic site: Lymph node.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11
ST D3S1358: 14,20
ST D5S818: 11
ST D7S820: 11,12
ST FGA: 22,23
ST TH01: 9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A720 ! UKRV-Mel-19a
OI CVCL_C400 ! UKRV-Mel-19c
SX Female
CA Cancer cell line
//
ID UKRV-Mel-19c
AC CVCL_C400
DR ESTDAB; ESTDAB-232
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,13
ST D3S1358: 14,20
ST D5S818: 11
ST D7S820: 11,12
ST FGA: 22,23
ST TH01: 9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A720 ! UKRV-Mel-19a
OI CVCL_C399 ! UKRV-Mel-19b
SX Female
CA Cancer cell line
//
ID UKRV-Mel-20a
AC CVCL_A721
DR Cosmic; 1846710
RX PubMed=17311103;
CC Derived from metastatic site: Cutaneous/subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C401 ! UKRV-Mel-20b
OI CVCL_C402 ! UKRV-Mel-20c
OI CVCL_C403 ! UKRV-Mel-20e
OI CVCL_C404 ! UKRV-Mel-20f
OI CVCL_C405 ! UKRV-Mel-20h
SX Male
CA Cancer cell line
//
ID UKRV-Mel-20b
AC CVCL_C401
DR ESTDAB; ESTDAB-233
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A721 ! UKRV-Mel-20a
OI CVCL_C402 ! UKRV-Mel-20c
OI CVCL_C403 ! UKRV-Mel-20e
OI CVCL_C404 ! UKRV-Mel-20f
OI CVCL_C405 ! UKRV-Mel-20h
SX Male
CA Cancer cell line
//
ID UKRV-Mel-20c
AC CVCL_C402
DR Cosmic; 1846711
DR ESTDAB; ESTDAB-234
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 12
ST D3S1358: 16,17
ST D5S818: 12,14
ST D7S820: 10,12
ST FGA: 21,25
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A721 ! UKRV-Mel-20a
OI CVCL_C401 ! UKRV-Mel-20b
OI CVCL_C403 ! UKRV-Mel-20e
OI CVCL_C404 ! UKRV-Mel-20f
OI CVCL_C405 ! UKRV-Mel-20h
SX Male
CA Cancer cell line
//
ID UKRV-Mel-20e
AC CVCL_C403
DR Cosmic; 1846712
DR ESTDAB; ESTDAB-235
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D3S1358: 16,17
ST D5S818: 12,14
ST D7S820: 10,12
ST FGA: 21,25
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A721 ! UKRV-Mel-20a
OI CVCL_C401 ! UKRV-Mel-20b
OI CVCL_C402 ! UKRV-Mel-20c
OI CVCL_C404 ! UKRV-Mel-20f
OI CVCL_C405 ! UKRV-Mel-20h
SX Male
CA Cancer cell line
- 公告/新闻
免费订购电话: 400-800-2947